Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026989	p-t3-v	pmol/l (pmol/l)	17579	62682	0.05%
3026989	s-t3-v	pmol/l (pmol/l)	7242	15586	0.00%
3026989	p-t3-v	— (—)	4327	8714	100.00%	Distribution not available
3026989	s-t3-v	— (—)	1000	1739	100.00%	Distribution not available
3026989	trijodityroniini,vapaa(t3v)	pmol/l (pmol/l)	255	392	0.00%
3026989	p-trijodityroniini,vapaa	pmol/l (pmol/l)	132	199	0.00%
3026989	trijodityroniini,vapaa	pmol/l (pmol/l)	85	107	0.00%
3026989	p-trijodityroniini,vapaa,plasmasta	pmol/l (pmol/l)	80	107	0.00%
3026989	trijodityroniini,vapaa(t3v)	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormalities of breathing

4788

15498

1.91

319.04

3.3

3.4

4.46

4.56

pmol/l

8.87

4269

13950

Neurotic, stress-related and somatoform disorders

4890

19385

1.87

316.34

3.0

3.4

4.49

4.55

pmol/l

2.96

4243

17486

Anxiety disorders

4924

19497

1.87

316.32

3.0

3.4

4.49

4.55

pmol/l

2.82

4272

17589

Disorders of orbit

528

910

7.98

313.41

6.9

3.2

4.53

4.52

pmol/l

0.02

500

805

Recurrent or chronic depression

2411

7542

2.45

310.88

3.0

3.8

4.46

4.58

pmol/l

5.15

2113

6950

Disorders of lacrimal system and orbit in diseases classified elsewhere

443

511

15.91

307.65

7.7

3.2

4.57

4.55

pmol/l

0.10

419

450

Hypothyroidism (congenital or acquired)

4457

2094

15.77

307.65

4.4

3.2

4.54

4.81

pmol/l

18.11

4050

1930

Other heart diseases, wide

4908

16688

1.90

307.65

3.5

3.3

4.43

4.58

pmol/l

17.56

4445

14915

Disorders of the thyroid gland

12483

9800

10.33

307.65

4.6

1.7

4.52

4.53

pmol/l

0.38

11289

8674

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

1748

1603

25.17

307.65

7.2

3.0

4.50

4.52

pmol/l

0.24

1699

1412

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1535

1388

27.18

307.65

7.3

3.0

4.51

4.52

pmol/l

0.20

1491

1220

Hypothyroidism, levothyroxine purchases

4407

2083

15.67

307.65

4.4

3.2

4.53

4.81

pmol/l

18.63

4003

1921

Anaemias

1425

1865

5.53

307.65

3.4

3.1

4.34

4.80

pmol/l

30.75

1266

1721

Thyroiditis, ILD-related definition

1475

2931

6.72

307.65

4.2

3.2

4.46

4.51

pmol/l

0.81

1333

2625

Hypothyreosis and Thyroxine purchase for inclusion criteria

10641

12835

6.53

307.65

4.1

2.8

4.40

4.60

pmol/l

44.12

9532

11500

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

6719

7080

15.93

307.65

6.0

2.4

4.64

4.43

pmol/l

23.21

6255

6204

Depression

5325

19634

1.95

307.65

3.0

3.5

4.47

4.55

pmol/l

6.06

4622

17741

Thyrotoxicosis with toxic multinodular goitre

1118

947

23.02

307.65

5.4

2.4

4.82

4.32

pmol/l

25.61

1035

809

Depression medications

1832

2187

4.49

307.65

3.1

4.54

4.83

pmol/l

16.01

1636

2020

Disorders of thyroid, IBD co-morbidities

5354

2396

30.62

307.65

6.6

2.7

4.77

4.55

pmol/l

11.52

5004

2143

Amiodarone users

1482

1237

19.24

307.65

4.5

3.0

4.02

4.48

pmol/l

24.69

1403

1061

Hypothyroidism and >3 levothyroxin purchases

4407

2083

15.67

307.65

4.4

3.2

4.53

4.81

pmol/l

18.63

4003

1921

Hypothyroidism, strict autoimmune, 3 medication purchases required

7161

12437

4.42

307.65

2.9

2.8

4.29

4.60

pmol/l

93.81

6249

11142

Atrial fibrillation and flutter

1905

4287

3.12

307.65

3.8

3.4

4.38

4.54

pmol/l

7.17

1763

3804

Used for control exclusion in common control thyroid runs

8649

8532

5.69

307.65

4.2

1.7

4.55

4.59

pmol/l

1.56

7813

7563

Carbimazole or st.post thyroidectomy, condition for graves disease

5189

4699

24.28

307.65

7.5

2.4

4.71

4.43

pmol/l

33.10

4895

4134

Atrial fibrillation and flutter with reimbursement

1577

3043

3.61

307.65

3.7

3.4

4.33

4.53

pmol/l

8.54

1458

2690

Autoimmune diseases

7096

14090

2.73

307.65

3.5

3.2

4.45

4.62

pmol/l

28.51

6304

12720

Mood disorders

5668

20134

1.93

307.65

2.9

3.5

4.45

4.54

pmol/l

7.74

4896

18169

Exclusions for E4_PCOS_BROAD

1331

3830

4.01

307.65

3.3

4.37

4.54

pmol/l

6.90

1217

3416

Heart failure and antihypertensive medication

1323

2592

3.64

307.65

3.7

3.1

4.18

4.52

pmol/l

18.59

1215

2273

Hypothyroidism, other/unspecified

10370

9350

8.83

307.65

4.1

1.7

4.40

4.52

pmol/l

16.35

9300

8274

Graves disease, strict definition

2623

2462

27.54

307.65

8.6

2.7

4.82

4.46

pmol/l

22.82

2483

2189

Thyrotoxicosis

5907

5357

21.84

307.65

6.7

2.4

4.75

4.38

pmol/l

60.18

5489

4700

Mood disorders, excluding more controls

5258

16600

2.02

307.65

2.9

3.5

4.44

4.54

pmol/l

8.78

4550

15075

Cardiac arrhythmias

3760

11859

2.21

307.65

3.6

3.4

4.43

4.60

pmol/l

17.90

3417

10645

Nontoxic goitre/thyroid nodule

2442

7410

3.81

307.65

3.7

3.2

4.53

4.40

pmol/l

7.21

2199

6491

Malignant neoplasm of endocrine gland

1596

1483

24.15

307.65

7.4

3.0

4.47

4.48

pmol/l

0.08

1547

1306

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

1789

1765

20.73

307.65

7.1

3.0

4.49

4.51

pmol/l

0.15

1737

1553

Endocrine, nutritional and metabolic diseases

6600

6167

6.00

307.65

4.0

1.6

4.58

4.64

pmol/l

2.80

5974

5497

Autoimmune hyperthyroidism

1336

1056

25.28

307.65

8.0

2.7

4.74

4.53

pmol/l

3.92

1256

948

Nontoxic multinodular goitre

1647

2390

8.29

307.65

3.5

1.7

4.50

4.44

pmol/l

1.02

1475

2074

Thyrotoxicosis with diffuse goitre

3323

1822

38.02

307.65

7.8

1.6

4.76

4.50

pmol/l

12.82

3124

1607

Graves ophthalmopathy, strict

408

471

16.93

307.65

7.8

3.0

4.57

4.55

pmol/l

0.09

386

409

Hypothyroidism, drug reimbursement

2699

1283

21.26

307.65

5.8

3.1

4.50

4.74

pmol/l

8.30

2522

1188

Thyrotoxicosis, other and/or unspecified

5087

2541

44.83

307.65

7.1

1.7

4.77

4.49

pmol/l

22.00

4741

2234

Hypopituitarism

645

1107

7.29

307.65

3.3

3.4

4.34

4.68

pmol/l

9.53

594

999

Metabolic disorders

5468

15366

2.34

307.65

4.2

3.1

4.45

4.51

pmol/l

3.30

4909

13690

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2104

2834

11.75

307.65

6.7

3.0

4.53

4.49

pmol/l

0.70

1969

2530

Other antidepressants

5281

15114

1.89

307.65

2.9

3.6

4.45

4.55

pmol/l

9.06

4596

13687

Graves ophthalmopathy

441

534

15.32

307.65

7.7

3.1

4.58

4.52

pmol/l

0.30

417

468

Other metabolic disorders

2142

3048

10.65

307.65

6.6

3.1

4.53

4.50

pmol/l

0.48

2001

2724

Thyroiditis

757

1407

6.98

307.65

4.4

2.3

4.59

4.41

pmol/l

2.97

683

1224

Other and/or unspecified nontoxic goitre

618

892

8.31

307.65

3.4

1.7

4.53

4.48

pmol/l

0.62

562

781

Hypothyroidism, strict autoimmune

6756

8565

5.95

307.65

3.0

2.2

4.31

4.58

pmol/l

59.57

5927

7623

Anxiety disorders, excluding more controls

4599

15928

2.00

307.65

3.0

3.6

4.48

4.55

pmol/l

4.47

3984

14484

Disorders of other endocrine glands

2838

11188

2.71

307.65

3.4

3.3

4.41

4.51

pmol/l

5.41

2529

9931

Malignant neoplasm of thyroid gland

1573

1409

27.04

307.65

7.5

3.0

4.48

4.49

pmol/l

0.10

1526

1237

Papillary adenocarcinoma of thyroid gland

1169

1117

24.91

307.65

7.5

3.2

4.48

pmol/l

0.01

1129

977

Mood [affective] disorders

5665

20113

1.94

307.65

2.9

3.5

4.45

4.54

pmol/l

7.80

4893

18152

Cardiodefibrillation

1831

5830

3.42

307.65

3.9

3.2

4.20

4.40

pmol/l

13.21

1690

5063

Other arrhythmias

3328

12705

2.11

305.37

3.3

4.36

4.54

pmol/l

21.75

2987

11313

Malaise and fatigue

2521

9536

2.33

300.03

3.1

3.4

4.33

4.51

pmol/l

14.14

2208

8492

General symptoms and signs

5719

16609

1.78

297.70

3.2

3.4

4.46

4.57

pmol/l

10.55

5073

14920

Anxiety (asthma-related co-morbidities)

3455

13999

2.05

294.14

3.0

3.5

4.52

4.59

pmol/l

2.91

3014

12755

Nontoxic single thyroid nodule

487

797

7.16

293.34

4.0

1.7

4.56

4.47

pmol/l

1.10

441

702

Autoimmune thyroiditis

263

203

20.05

292.34

4.8

1.5

4.66

4.51

pmol/l

0.66

239

179

Other heart diseases

2807

8713

2.25

291.78

3.6

3.4

4.44

4.60

pmol/l

12.06

2560

7832

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

236

165

38.83

290.15

8.8

3.4

4.61

4.49

pmol/l

0.65

231

143

Abnormalities of heart beat

1945

8149

2.53

284.18

3.4

3.3

4.45

4.49

pmol/l

0.82

1699

7264

Antihypertensive medication - note that there are other indications

3592

10063

2.04

282.39

3.9

3.1

4.61

4.63

pmol/l

0.23

3255

9022

Depression or dysthymia

3515

10005

2.04

281.84

3.0

3.7

4.46

4.54

pmol/l

4.04

3057

9147

Any reimbursement code in KELA

3332

8304

2.09

275.94

3.6

3.1

4.56

4.67

pmol/l

6.37

3041

7448

Symptoms and signs involving the circulatory and respiratory systems

5320

15545

1.77

271.37

3.3

3.4

4.53

4.56

pmol/l

1.28

4704

13990

All anxiety disorders

3503

15047

1.97

267.89

3.0

3.5

4.52

4.58

pmol/l

2.52

3056

13637

Cardiomyopathy

857

2399

3.89

265.04

4.0

3.2

4.19

4.51

pmol/l

12.44

792

2110

Paroxysmal tachycardia

1356

4186

2.96

259.35

3.9

3.4

4.26

4.57

pmol/l

20.91

1242

3742

Headache

3474

15629

1.94

258.97

3.0

3.4

4.47

4.57

pmol/l

6.69

3094

14028

Cardiomyopathies, Primary/intrinsic

642

1487

4.77

258.65

4.1

3.3

4.17

4.52

pmol/l

11.01

594

1316

Heart failure, not strict

3303

11936

1.99

256.35

3.4

3.3

4.20

4.50

pmol/l

44.53

2965

10532

Vocal cord dysfunction

887

2434

3.72

249.55

4.6

3.6

4.53

4.60

pmol/l

1.00

805

2196

Episodal and paroxysmal disorders

5634

17620

1.69

244.15

3.1

3.4

4.48

4.55

pmol/l

4.52

4996

15807

Cardiomyopathy (excluding other)

651

1597

4.49

243.25

4.1

3.3

4.17

4.53

pmol/l

12.00

603

1411

Medical observation and evaluation for suspected diseases and conditions

3417

9207

1.97

242.82

3.4

3.5

4.50

4.55

pmol/l

1.63

2987

8334

Pain in joint

2976

10155

2.02

240.07

3.2

3.5

4.51

4.57

pmol/l

1.87

2620

9158

Selective serotonin reuptake inhibitors

4879

15190

1.74

238.76

2.9

3.6

4.46

4.56

pmol/l

7.77

4247

13761

Other soft tissue disorders, not elsewhere classified

4617

16823

1.76

237.83

3.1

3.5

4.44

4.55

pmol/l

11.01

4067

15107

Neurological diseases, wide definition

1661

3253

2.68

236.86

3.1

2.6

4.57

4.64

pmol/l

1.47

1497

2908

Autoimmune diseases related-to ILD

4184

21612

1.77

234.27

3.5

3.3

4.47

4.52

pmol/l

1.68

3725

19321

Heart failure,strict

2095

6976

2.27

231.07

3.5

3.3

4.14

4.48

pmol/l

34.62

1892

6109

Benzodiazepine use

4862

21039

1.70

229.80

3.0

3.4

4.37

4.53

pmol/l

17.50

4135

18981

Examination and observation for other reasons

2918

9157

2.01

229.28

3.2

3.5

4.44

4.55

pmol/l

6.39

2588

8291

Pain in throat and chest

4094

14429

1.79

227.22

3.2

3.4

4.48

4.55

pmol/l

3.04

3642

12964

Sleep disorders (combined)

4726

18819

1.70

220.79

3.1

3.4

4.47

4.50

pmol/l

1.04

4173

16873

Dyspnoea

4152

18966

1.74

214.38

3.3

4.37

4.50

pmol/l

14.42

3698

16890

Adjustment and management of implanted device

875

2868

3.31

210.94

3.8

3.1

4.15

4.39

pmol/l

7.98

811

2468

Asthma, excluding more controls

3791

11591

1.80

207.79

3.2

3.3

4.48

4.57

pmol/l

5.52

3385

10365

Subacute thyroiditis

283

385

8.99

203.97

3.4

1.5

4.63

4.50

pmol/l

0.81

253

327

Psychiatric diseases

5263

16553

1.64

202.23

3.0

3.6

4.45

4.54

pmol/l

7.58

4567

15045

Any mental disorder

5331

16822

1.63

201.97

3.0

3.5

4.44

4.54

pmol/l

7.89

4625

15276

Other anxiety disorders

2550

12020

1.98

201.35

2.8

3.5

4.53

4.60

pmol/l

2.22

2237

10899

Heart failure, strict

2184

7779

2.11

200.84

3.5

3.2

4.14

4.44

pmol/l

28.46

1972

6792

Persons encountering health services for specific procedures and health care

5137

20387

1.61

190.59

3.4

3.3

4.41

4.55

pmol/l

16.31

4630

18194

Persons encountering health services in other circumstances, wide

5674

19142

1.58

189.70

3.2

3.4

4.46

4.54

pmol/l

5.99

5096

17045

Sleep apnoea, including avohilmo

4424

17819

1.66

189.60

3.2

3.4

4.48

pmol/l

0.00

3925

15942

Asthma (mode)

3803

12372

1.74

187.51

3.2

3.4

4.48

4.55

pmol/l

3.62

3395

11074

Asthma

3856

12283

1.74

187.28

3.2

3.4

4.47

4.55

pmol/l

4.15

3442

10991

Hypothyroidism due to medicaments and other exogenous substances

153

102

24.61

185.20

6.1

1.5

4.29

4.44

pmol/l

0.60

140

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5187

19076

1.59

183.54

3.1

3.4

4.45

4.54

pmol/l

7.20

4682

16991

First line medication for Crohn's disease

5332

18850

1.58

182.85

3.4

3.3

4.44

4.57

pmol/l

13.79

4768

16859

All-cause Heart Failure

2081

7620

2.05

177.79

3.4

3.2

4.14

4.43

pmol/l

26.06

1876

6643

Benign neoplasm: Pituitary gland, craniopharyngeal duct

416

945

5.32

176.99

3.2

3.1

4.34

4.55

pmol/l

3.23

390

830

Neurological diseases

4368

13659

1.66

175.77

3.1

3.5

4.52

4.58

pmol/l

3.22

3908

12327

Other nutritional deficiencies

3208

18664

1.75

175.02

3.1

3.4

4.47

4.52

pmol/l

2.40

2811

16785

Pain in limb

3657

16084

1.70

173.42

3.1

3.5

4.40

4.54

pmol/l

12.91

3216

14434

Oral corticosteroids

4984

19618

1.58

172.11

3.3

3.4

4.42

4.53

pmol/l

10.48

4455

17526

Cardiovascular diseases

3360

10752

1.76

171.08

3.3

3.4

4.55

4.66

pmol/l

7.29

3026

9725

ILD medications: prednisolone, methylprednisolone, prednisone

5206

19290

1.57

170.88

3.2

3.4

4.42

4.55

pmol/l

11.94

4640

17264

General examination and investigation of persons without complaint and reported diagnosis

3038

9201

1.81

170.46

3.1

3.5

4.47

4.55

pmol/l

3.69

2725

8329

Asthma (only as main-diagnosis), excluding more controls

3305

11591

1.75

169.62

3.1

3.3

4.47

4.57

pmol/l

6.10

2944

10365

Pacemaker

1219

5102

2.44

168.92

3.5

3.1

4.13

4.36

pmol/l

8.28

1100

4381

Nontoxic diffuse goitre

226

301

9.04

165.38

4.3

1.7

4.63

4.47

pmol/l

1.38

194

258

Codeine

4637

16394

1.60

164.83

3.2

3.4

4.46

4.55

pmol/l

6.96

4141

14660

Cardiovascular diseases (excluding rheumatic etc)

3456

12013

1.72

163.27

3.4

4.53

4.63

pmol/l

6.16

3138

10807

Sleep apnoea

4023

17222

1.63

162.32

3.2

3.4

4.47

pmol/l

0.04

3560

15414

Benign neoplasm: Pituitary gland, craniopharyngeal duct

416

1023

4.89

160.10

3.2

3.4

4.34

4.52

pmol/l

2.58

390

908

Disorders of parathyroid gland

1036

4252

2.59

158.33

3.5

3.1

4.31

4.42

pmol/l

2.61

896

3693

Benign neoplasm of other and unspecified endocrine glands

700

2409

3.21

157.00

3.2

3.0

4.35

4.50

pmol/l

3.28

641

2125

Disorders of mineral metabolism

483

1343

4.06

153.54

4.2

3.1

4.39

4.46

pmol/l

0.41

431

1183

Asthma (only as main-diagnosis)

3350

12283

1.69

153.19

3.1

3.4

4.47

4.55

pmol/l

4.46

2982

10991

Parasetamol

3843

12228

1.65

152.53

3.3

3.4

4.52

4.59

pmol/l

3.61

3457

10962

Disorders of calcium metabolism

403

1002

4.64

150.77

4.4

3.0

4.40

4.46

pmol/l

0.31

361

873

Neoplasms

3758

12568

1.65

150.71

3.8

3.1

4.56

4.62

pmol/l

2.70

3431

11234

Any gastric operation

4076

12964

1.62

150.71

3.5

3.2

4.49

4.61

pmol/l

9.78

3633

11662

GASTRO-related operations

4076

12964

1.62

150.71

3.5

3.2

4.49

4.61

pmol/l

9.78

3633

11662

Codeine or tramadol medication

5327

19956

1.52

150.50

3.2

3.4

4.45

4.52

pmol/l

4.81

4763

17807

Non-invasive ventilation

1007

3939

2.54

149.89

3.4

3.5

4.57

4.58

pmol/l

0.08

932

3562

Low back pain

3392

16260

1.66

148.32

3.1

3.5

4.47

4.53

pmol/l

2.39

2972

14611

Disorders of eyelid, lacrimal system and orbit

3750

18791

1.61

147.67

3.9

3.2

4.44

4.48

pmol/l

1.59

3348

16752

Migraine

2635

13182

1.77

147.49

3.1

3.5

4.53

4.58

pmol/l

1.25

2368

11890

Personality disorders, excluding more controls

1365

6548

2.21

147.44

2.9

3.7

4.43

4.60

pmol/l

8.28

1175

6017

Dorsalgia

4685

16780

1.55

146.47

3.1

3.4

4.48

4.54

pmol/l

3.64

4136

15073

Disorders of lipoprotein metabolism and other lipidaemias

3146

12001

1.69

145.53

3.0

3.1

4.40

4.48

pmol/l

3.49

2768

10631

Other special examinations and investigations of persons without complaint or reported diagnosis

3057

9207

1.73

144.54

3.2

3.5

4.48

4.55

pmol/l

3.16

2738

8334

Other specific joint derangements/joint disorders

3575

15124

1.63

144.41

3.3

3.5

4.53

4.57

pmol/l

1.37

3169

13602

Inflammatory bowel disease treatment related agents

5279

20437

1.50

144.24

3.3

3.4

4.42

4.55

pmol/l

12.34

4720

18272

ILD medications

5268

19675

1.50

144.02

3.3

3.4

4.44

4.56

pmol/l

10.65

4710

17610

Other headache syndromes

2124

11927

1.86

143.35

3.1

3.5

4.46

4.52

pmol/l

2.03

1860

10710

Opioids

4751

16628

1.54

142.13

3.2

3.4

4.47

4.56

pmol/l

5.83

4247

14873

Use of hypnotics and sedatives

4784

18556

1.53

142.00

3.2

3.4

4.38

4.52

pmol/l

15.61

4174

16698

Asthma, unspecified (mode), excluding more controls

2332

10450

1.81

141.56

3.1

3.4

4.42

4.54

pmol/l

7.17

2072

9335

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2294

12929

1.80

140.64

3.9

3.3

4.49

pmol/l

0.01

2079

11558

Lower back pain or/and sciatica

4641

21668

1.52

140.41

3.1

3.4

4.45

4.52

pmol/l

3.85

4096

19395

Fever of other and unknown origin

2318

12395

1.79

139.24

3.3

3.4

4.38

4.55

pmol/l

10.22

2071

11091

Thyroiditis, unspecified

148

145

13.37

138.81

4.0

1.5

4.44

4.45

pmol/l

0.01

132

127

Asthma, including avohilmo

5323

21331

1.48

137.43

3.2

3.4

4.51

4.52

pmol/l

0.55

4737

19073

Hypertensive diseases (excluding secondary)

2585

8801

1.77

135.07

3.3

3.4

4.48

4.57

pmol/l

4.48

2342

7918

Tramadol

3501

14324

1.62

134.69

3.0

3.4

4.40

4.52

pmol/l

8.32

3073

12790

Other disorders of fluid, electrolyte and acid-base balance

1170

5258

2.25

134.12

3.0

4.09

4.43

pmol/l

20.48

1008

4617

Adrenocortical insufficiency

294

641

5.63

132.19

3.8

3.3

4.29

4.53

pmol/l

3.43

270

568

Benign neoplasm of other and unspecified endocrine glands

700

2650

2.90

131.60

3.2

4.35

4.44

pmol/l

1.56

641

2348

Cardiomyopathy, other and unspecified

395

1057

4.12

131.53

4.0

3.2

4.17

4.55

pmol/l

8.23

361

929

Congenital iodine-deficiency syndrome/hypothyroidism

192

277

8.13

130.46

3.3

1.5

4.29

4.50

pmol/l

1.53

172

235

Obesity and other hyperalimentation

2937

18237

1.65

130.46

3.1

3.4

4.47

4.52

pmol/l

2.15

2572

16400

Obesity

2919

18160

1.65

129.03

3.1

3.4

4.47

4.52

pmol/l

2.11

2555

16329

Other disorders of adrenal gland

341

848

4.79

129.01

3.9

3.2

4.35

4.55

pmol/l

2.53

313

747

Other dorsopathies, not elsewhere classified

4699

16849

1.51

128.06

3.1

3.4

4.51

4.54

pmol/l

0.98

4159

15136

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1825

4823

1.96

128.00

3.3

3.5

4.55

4.64

pmol/l

2.84

1629

4377

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3998

15643

1.55

127.25

4.4

3.1

4.47

4.51

pmol/l

1.08

3677

13879

Malignant neoplasm, wide definition for exclusion

3998

15644

1.55

127.24

4.4

3.1

4.47

4.51

pmol/l

1.08

3677

13880

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3996

15645

1.55

126.86

4.4

3.1

4.47

4.51

pmol/l

1.06

3675

13881

Asthma, unspecified (mode)

2360

11069

1.75

126.24

3.1

3.4

4.42

4.52

pmol/l

5.61

2097

9894

Bipolar affective disorders

1042

4807

2.32

125.30

2.7

3.6

4.35

4.58

pmol/l

10.94

881

4370

Other pulmonary diagnosis

3791

12383

1.57

124.08

3.3

3.4

4.47

4.55

pmol/l

3.54

3386

11080

Exclusions for E4_PCOS_CONSORTIUM

3833

15960

1.56

122.95

3.3

4.45

4.53

pmol/l

5.14

3438

14266

Other diseases of intestines

4825

19417

1.48

122.21

3.2

3.4

4.46

4.55

pmol/l

5.64

4296

17470

Excluding asthma or asthma-COPD overlap

3779

12383

1.57

121.94

3.3

3.4

4.47

4.55

pmol/l

3.44

3383

11080

Hypoparathyroidism

289

665

5.32

121.75

5.0

3.2

4.27

4.46

pmol/l

2.18

261

578

Infections, IBD-co-morbidities

642

1676

2.92

120.52

3.0

2.9

4.32

4.54

pmol/l

4.91

568

1485

Care involving use of rehabilitation procedures

2720

16176

1.65

119.94

3.2

3.3

4.45

4.51

pmol/l

2.67

2474

14373

Thyrotoxicosis with toxic single thyroid nodule

131

140

15.58

119.61

5.7

2.3

4.81

4.34

pmol/l

3.99

118

119

Heart failure and bmi 25plus

1272

4302

2.13

119.20

3.5

3.3

4.15

4.44

pmol/l

17.25

1135

3742

COPD differential diagnosis

3750

12377

1.55

117.08

3.3

3.4

4.47

4.55

pmol/l

3.76

3360

11079

ILD differential diagnosis

3745

12372

1.55

116.41

3.3

3.4

4.47

4.55

pmol/l

4.11

3355

11074

Cystitis

4049

16783

1.51

115.93

3.2

3.4

4.45

4.50

pmol/l

2.41

3549

15094

Implicit Sepsis

2885

14259

1.62

115.45

3.1

3.3

4.23

4.50

pmol/l

35.35

2509

12683

Any event in cancer register

4201

17008

1.50

115.36

4.4

3.1

4.47

4.51

pmol/l

1.45

3843

15113

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4172

20537

1.49

114.69

3.3

4.32

4.53

pmol/l

22.69

3672

18375

Malignant neoplasm

3908

15613

1.52

114.62

4.5

3.1

4.46

4.49

pmol/l

1.06

3590

13841

Soft tissue disorders

4712

17026

1.47

113.51

3.1

3.4

4.50

4.56

pmol/l

3.20

4177

15286

Dysphagia

1031

4912

2.21

113.05

3.1

3.3

4.38

4.43

pmol/l

0.84

901

4354

Hypertension, essential

3428

12836

1.56

112.71

3.3

3.4

4.45

4.51

pmol/l

2.59

3055

11517

Obesity due to excess calories

2158

13030

1.72

112.43

3.1

3.4

4.46

4.52

pmol/l

2.31

1892

11731

Benign neoplasms

3510

13110

1.55

111.74

3.4

3.1

4.52

4.60

pmol/l

4.29

3181

11706

Symptoms and signs involving the digestive system and abdomen

4399

15151

1.48

111.63

3.2

3.4

4.49

4.55

pmol/l

3.23

3896

13586

Valvular heart disease excluding rheumatic fever

1634

6555

1.88

110.81

3.4

3.3

4.27

4.51

pmol/l

14.95

1460

5785

Symptoms and signs involving cognition, perception, emotional state and behaviour

4143

20035

1.48

110.76

3.1

3.4

4.37

4.52

pmol/l

15.72

3625

17974

Non-rheumatic valve diseases

1624

6507

1.88

110.19

3.4

3.3

4.27

4.50

pmol/l

14.78

1450

5740

Diseases of oesophagus, stomach and duodenum

4605

19651

1.45

108.88

3.0

3.4

4.41

4.52

pmol/l

9.51

4035

17635

Other disorders of lacrimal gland

1569

8761

1.88

108.64

3.8

3.2

4.42

4.45

pmol/l

0.60

1389

7746

Abdominal and pelvic pain

4362

15151

1.48

107.85

3.2

3.4

4.50

4.55

pmol/l

2.40

3837

13586

Presence of cardiac and vascular implants and grafts

1498

6149

1.90

106.42

3.6

3.2

4.21

4.44

pmol/l

10.72

1345

5363

Constipation

3578

17338

1.51

106.16

3.0

3.4

4.35

4.49

pmol/l

11.38

3117

15520

Asthma (diagnoses ohter than nonallergic)

3769

22158

1.49

106.14

3.2

3.4

4.46

4.52

pmol/l

3.29

3358

19782

Other diseases of upper respiratory tract

4803

17753

1.44

104.51

3.4

3.3

4.51

4.50

pmol/l

0.12

4292

15829

Other diseases of urinary system

4571

18133

1.45

104.47

3.2

3.4

4.46

4.51

pmol/l

1.96

4042

16325

Unspecified mental disorder

1874

11108

1.75

104.22

2.5

3.5

4.38

4.55

pmol/l

10.85

1564

9987

Irritable bowel syndrome

1395

7631

1.92

103.43

3.2

3.4

4.49

4.50

pmol/l

0.15

1212

6803

Other functional intestinal disorders

1864

10537

1.74

101.88

2.9

3.4

4.36

4.48

pmol/l

6.05

1650

9376

Condition for Implicit Sepsis (Organ dysfunction codes)

3414

16793

1.51

101.04

3.2

3.4

4.28

4.53

pmol/l

36.45

2994

14991

Pain, not elsewhere classified

1226

6482

1.98

100.36

3.1

3.4

4.38

4.54

pmol/l

6.80

1093

5805

Diseases of the eye and adnexa

3919

13481

1.49

100.24

3.4

3.3

4.52

4.59

pmol/l

4.15

3500

12154

Triptan medication for migraine, single purchase ok

3743

17494

1.49

100.06

3.3

3.4

4.54

pmol/l

0.09

3384

15656

Migraine, single triptan purchase ok & required. ICD-code if available is included

3743

17494

1.49

100.06

3.3

3.4

4.54

pmol/l

0.09

3384

15656

Disorders of lacrimal system

1843

11026

1.74

99.54

3.7

3.2

4.41

4.45

pmol/l

0.90

1633

9728

Non-ischemic cardiomyopathy

1070

4390

2.09

98.96

3.4

3.3

4.25

4.43

pmol/l

5.87

968

3824

Acute upper respiratory infections

4552

20379

1.43

98.30

3.2

3.3

4.50

pmol/l

0.13

4046

18181

Pure hypercholesterolaemia

2521

10745

1.61

98.22

3.0

3.1

4.40

4.46

pmol/l

1.81

2216

9493

Dronedarone medication

184

341

6.36

98.21

3.6

3.1

4.27

4.49

pmol/l

1.11

165

298

Hypertensive diseases

3459

13262

1.51

97.58

3.3

3.4

4.46

4.53

pmol/l

3.00

3111

11897

5018

19188

1.41

96.95

3.2

3.4

4.46

4.51

pmol/l

2.55

4445

17147

Hypertension

3454

13255

1.51

96.89

3.3

3.4

4.46

4.53

pmol/l

2.97

3106

11890

Obesity related asthma

1445

8138

1.85

96.88

3.1

3.3

4.43

4.48

pmol/l

0.93

1282

7240

Follow-up examination after treatment for conditions other than malignant neoplasms

2025

8011

1.71

96.87

3.4

3.5

4.50

4.54

pmol/l

0.99

1814

7240

Other reaction to severe stress, and adjustment disorders

1793

10744

1.74

96.21

3.2

3.5

4.45

4.58

pmol/l

6.29

1549

9743

Complications of surgical and medical care, not elsewhere classified

4104

20833

1.44

95.98

3.4

3.3

4.40

4.51

pmol/l

8.49

3646

18589

Nausea and vomiting

1153

5963

1.99

95.45

3.2

3.4

4.36

4.52

pmol/l

3.89

1028

5291

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1960

7713

1.73

95.26

3.7

3.4

4.59

4.60

pmol/l

0.04

1791

6976

Schizophrenia or delusion, excluding more controls

1288

6966

1.91

95.20

2.3

3.6

4.39

4.58

pmol/l

8.73

1070

6335

Haemorrhage from respiratory passages

1188

5823

1.96

95.10

3.2

3.3

4.31

4.46

pmol/l

4.25

1030

5165

Persons encountering health services in other circumstances

1654

9711

1.76

94.91

3.2

3.4

4.45

4.53

pmol/l

2.64

1477

8635

Chronic lower respiratory diseases

5292

21007

1.39

94.64

3.2

3.4

4.48

4.54

pmol/l

3.30

4744

18780

Dermatitis and eczema

4658

22092

1.41

94.39

3.1

3.4

4.46

4.53

pmol/l

4.31

4103

19795

Behavioural syndromes associated with physiological disturbances and physical factors

1569

9124

1.80

94.18

3.1

3.4

4.43

4.59

pmol/l

7.96

1363

8234

Voice disturbances

1229

6671

1.94

93.66

3.7

3.3

4.43

4.46

pmol/l

0.53

1096

5927

Symptoms and signs involving speech and voice

1431

8123

1.84

93.57

3.7

3.3

4.42

4.44

pmol/l

0.28

1273

7194

Other obstetric conditions, not elsewhere classified

1990

7906

1.72

93.47

3.7

3.4

4.59

pmol/l

0.04

1820

7149

Symptoms and signs involving the skin and subcutaneous tissue

2901

19441

1.53

93.14

3.4

3.3

4.49

4.48

pmol/l

0.17

2591

17346

Personality disorders

1365

7665

1.87

92.93

2.9

3.5

4.43

4.57

pmol/l

6.15

1175

6938

Gastro-oesophageal reflux disease

2758

16236

1.54

92.55

3.1

3.4

4.45

4.49

pmol/l

1.02

2381

14521

Disorders of adult personality and behaviour

1422

8091

1.84

92.45

2.9

3.4

4.44

4.58

pmol/l

6.46

1222

7319

Symptoms and signs involving the nervous and musculoskeletal systems

2357

15214

1.60

92.25

3.0

3.4

4.44

4.48

pmol/l

1.24

2104

13543

Kela-code for severe mental illness

1637

9676

1.76

92.12

2.4

3.4

4.35

4.55

pmol/l

11.59

1353

8687

Benign neoplasms

4256

16910

1.43

91.88

3.4

4.50

4.56

pmol/l

2.93

3844

15153

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4071

19713

1.43

90.89

3.3

4.37

4.54

pmol/l

18.68

3649

17615

Fibromyalgia

564

2322

2.68

90.16

3.3

3.5

4.48

4.53

pmol/l

0.49

493

2096

Persons encountering health services for examination and investigation

2805

9207

1.56

89.88

3.2

3.5

4.50

4.55

pmol/l

1.90

2500

8334

COPD/asthma/ILD related infections

4750

17273

1.40

89.34

3.3

3.4

4.43

4.54

pmol/l

8.65

4213

15459

COPD/asthma related infections

4750

17273

1.40

89.34

3.3

3.4

4.43

4.54

pmol/l

8.65

4213

15459

Other disorders of urethra and urinary system

3085

15761

1.50

89.22

3.0

3.4

4.40

4.49

pmol/l

4.30

2719

14153

Pain (limb, back, neck, head abdominally)

3102

10414

1.52

89.20

3.3

3.5

4.49

4.57

pmol/l

3.47

2747

9386

Nonorganic sleeping disorders, excluding more controls

843

4081

2.18

89.10

3.2

3.6

4.48

4.58

pmol/l

1.93

733

3722

Hyperparathyroidism

781

3639

2.24

88.38

2.9

3.1

4.30

4.42

pmol/l

2.21

667

3150

Asthma-related infections

2396

15428

1.57

87.75

3.1

3.3

4.45

4.52

pmol/l

2.63

2118

13731

Asthma, hospital admission 2, infections

2396

15428

1.57

87.75

3.1

3.3

4.45

4.52

pmol/l

2.63

2118

13731

Somatoform disorder

828

4023

2.19

87.42

2.8

3.4

4.42

4.52

pmol/l

2.26

710

3637

Dorsopathies

4575

16938

1.40

86.74

3.2

3.4

4.51

4.55

pmol/l

1.20

4072

15221

Generalized anxiety disorder

819

3993

2.18

85.64

2.9

3.5

4.52

4.63

pmol/l

2.58

720

3637

Nerve, nerve root and plexus disorders

4412

20178

1.40

85.50

3.0

3.4

4.42

4.50

pmol/l

5.21

3929

18020

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1295

7326

1.84

85.29

2.9

3.7

4.49

4.60

pmol/l

2.51

1125

6723

Non-selective monoamine reuptake inhibitors

1550

8922

1.74

85.18

2.8

3.5

4.31

4.47

pmol/l

9.10

1331

8005

Visual disturbances

1934

12168

1.64

85.10

3.4

3.3

4.41

4.48

pmol/l

2.10

1736

10787

Sciatica+with lumbago

2125

12948

1.60

84.81

3.2

3.5

4.42

4.49

pmol/l

2.71

1897

11616

Visual disturbances and blindness

2049

13082

1.62

84.54

3.4

3.3

4.40

4.48

pmol/l

3.10

1835

11588

Disorder of thyroid, unspecified

101

115

10.97

84.47

4.0

1.5

4.66

4.44

pmol/l

0.84

101

Other intervertebral disc disorders

3475

14889

1.46

84.02

3.0

3.5

4.48

4.50

pmol/l

0.71

3058

13357

Continuous positive airway pressure

669

2580

2.33

82.84

3.0

3.5

4.36

4.58

pmol/l

5.96

577

2321

Other diseases of hard tissues of teeth

2712

13651

1.52

82.16

3.2

3.5

4.45

4.53

pmol/l

3.60

2397

12287

Renal failure

1358

7153

1.79

81.65

3.1

3.2

3.88

4.44

pmol/l

66.56

1186

6263

Dizziness and giddiness

2987

16758

1.48

81.28

3.2

3.4

4.37

4.49

pmol/l

7.96

2627

14991

Syncope and collapse

1624

8717

1.70

80.87

3.2

3.4

4.33

4.51

pmol/l

10.38

1420

7764

Gastrointestinal diseases

2940

9979

1.51

80.73

3.3

3.5

4.51

4.62

pmol/l

6.26

2627

9016

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2308

14111

1.55

80.67

3.3

4.37

4.43

pmol/l

1.83

2037

12465

1872

11763

1.63

79.77

3.2

3.3

4.49

4.54

pmol/l

1.20

1666

10472

Oedema, not elsewhere classified

1177

6567

1.85

79.33

3.2

3.3

4.35

4.49

pmol/l

4.37

1026

5818

Hyperkinetic disorders, excluding more controls

516

2088

2.57

78.56

2.8

3.8

4.85

4.78

pmol/l

0.52

458

1935

Hyperlipidaemia, other/unspecified

1204

6431

1.83

78.31

3.0

3.1

4.27

4.43

pmol/l

5.79

1067

5639

Acute upper respiratory infections of multiple and unspecified sites

3218

16979

1.45

78.18

3.3

4.52

4.53

pmol/l

0.19

2873

15197

677

3185

2.27

77.89

3.6

3.3

4.42

4.52

pmol/l

1.90

608

2848

Chronic kidney disease

908

4691

1.99

77.74

3.1

3.2

3.83

4.42

pmol/l

53.10

799

4087

Diseases of the skin and subcutaneous tissue

4492

16587

1.38

77.43

3.2

3.4

4.47

4.55

pmol/l

5.86

3963

14919

Complications of procedures, not elsewhere classified

3279

20137

1.44

77.34

3.5

3.3

4.41

4.50

pmol/l

4.91

2927

17972

Implicit bacterial Sepsis

1264

6652

1.80

77.24

3.0

3.3

4.04

4.45

pmol/l

35.91

1097

5866

Temporomandibular joint disorders

817

4125

2.09

77.21

3.0

3.5

4.48

4.56

pmol/l

1.19

723

3716

Type 1 diabetes

1068

5879

1.89

76.50

3.0

3.4

4.36

4.59

pmol/l

9.97

945

5277

Spondylopathies

3085

13049

1.47

76.46

3.1

3.4

4.40

4.48

pmol/l

3.14

2721

11682

Insulin, fast-acting

1388

8245

1.74

76.28

3.1

3.4

4.32

4.53

pmol/l

10.00

1221

7326

Migraine with aura

1210

6960

1.82

75.95

3.2

3.4

4.51

4.57

pmol/l

1.49

1110

6275

Type 1 diabetes, wide definition, subgroup 1

929

4915

1.97

75.82

3.1

3.4

4.38

4.61

pmol/l

7.76

827

4421

Cough

1593

9409

1.67

75.74

3.2

3.3

4.49

4.52

pmol/l

0.54

1411

8404

Specific personality disorders

1165

6657

1.83

74.92

2.7

3.4

4.42

4.57

pmol/l

5.69

998

6032

Conduction disorders

931

4058

1.97

74.83

3.2

4.34

4.50

pmol/l

2.59

823

3563

Spondylosis

1972

10946

1.59

74.46

3.1

3.4

4.40

4.45

pmol/l

1.49

1738

9770

Symptoms and signs concerning food and fluid intake

453

1823

2.65

74.22

3.3

3.2

4.36

4.56

pmol/l

3.29

391

1605

Bronchitis

4464

21887

1.36

73.50

3.3

4.47

4.52

pmol/l

1.85

3957

19565

Intestinal infectious diseases

3858

22056

1.39

73.27

3.2

3.3

4.45

4.53

pmol/l

4.06

3419

19708

Insulin, fast-acting or short human

1396

8408

1.71

72.77

3.0

3.4

4.32

4.52

pmol/l

9.51

1229

7467

Dental caries

1002

5460

1.89

72.03

3.5

4.38

4.57

pmol/l

4.35

905

4896

Diarrhoea and gastroenteritis of presumed infectious origin

2879

18436

1.45

71.65

3.2

3.4

4.44

4.54

pmol/l

4.91

2558

16469

Dentofacial anomalies [including malocclusion]

1307

7726

1.74

70.97

3.0

3.5

4.54

4.56

pmol/l

0.24

1174

6984

Persistent mood disorders

866

4588

1.98

70.90

2.9

3.5

4.36

4.53

pmol/l

5.32

721

4115

Viral Sepsis

719

3568

2.11

70.78

3.2

3.3

4.18

4.50

pmol/l

14.51

621

3143

Asthma, hospital admissions , main diagnosis only

3435

22405

1.40

70.33

3.1

3.4

4.47

4.52

pmol/l

2.22

3058

20001

Implicit viral Sepsis

716

3557

2.11

70.27

3.2

4.17

4.50

pmol/l

14.84

619

3133

Diseases of the respiratory system

2919

10168

1.47

70.25

3.3

3.4

4.47

4.54

pmol/l

2.41

2619

9063

Panic disorder

764

3913

2.06

69.66

3.2

3.5

4.57

4.62

pmol/l

0.42

660

3559

Hypo-osmolality and hyponatraemia

602

2806

2.24

69.26

3.0

4.01

4.42

pmol/l

14.55

514

2431

Type 1 diabetes, wide definition

948

5199

1.90

69.00

3.1

3.4

4.37

4.60

pmol/l

8.21

844

4670

Other/unspecified dorsalgia

1545

9660

1.64

68.16

3.3

3.5

4.43

4.49

pmol/l

1.53

1378

8615

Other CVD (FINNGEN)

412

1269

2.69

67.43

2.9

3.2

4.12

4.52

pmol/l

10.83

344

1107

Myalgia

1051

6009

1.83

67.31

3.2

3.4

4.45

4.52

pmol/l

1.28

900

5370

Disturbances of skin sensation

1239

7417

1.74

67.24

3.4

4.51

pmol/l

0.02

1094

6654

Certain infectious and parasitic diseases

4443

16721

1.35

67.18

3.2

3.4

4.42

4.57

pmol/l

15.09

3942

15018

Bacterial Sepsis

1429

7823

1.67

67.02

3.1

3.3

4.09

4.47

pmol/l

32.08

1246

6900

KRA_PSY_EATING, excluding more controls

492

2158

2.45

66.96

2.9

3.7

4.30

4.71

pmol/l

16.91

428

1985

Irregular menses

2521

14276

1.48

66.70

3.1

3.4

4.43

4.54

pmol/l

7.10

2289

12824

Oxycodone

1204

6910

1.74

66.01

3.4

4.27

4.44

pmol/l

4.75

1061

6103

Other joint disorders

3903

15399

1.37

65.76

3.1

3.5

4.55

4.57

pmol/l

0.57

3472

13837

Complications of medical and surgical care

2850

19403

1.43

64.82

3.4

3.3

4.37

4.48

pmol/l

6.20

2534

17282

Diseases of pulp and periapical tissues

1343

8264

1.68

64.59

3.3

3.5

4.44

4.51

pmol/l

1.35

1182

7422

Nonischemic cardiomyopathy

249

791

3.43

63.95

4.2

3.5

4.35

4.53

pmol/l

1.40

235

704

Sleep disorders

961

5436

1.85

63.95

3.1

3.4

4.47

4.54

pmol/l

1.28

836

4874

Dentinal caries

865

4703

1.90

63.72

3.6

3.5

4.39

4.56

pmol/l

2.95

777

4219

Obesity, other/unspecified

1500

9537

1.63

63.71

3.0

3.4

4.46

4.52

pmol/l

1.59

1329

8601

Factors influencing health status and contact with health services

1152

3286

1.80

63.68

3.3

3.5

4.53

4.62

pmol/l

1.66

1027

2958

Renal tubulo-interstitial diseases

3400

19229

1.38

62.96

3.2

3.4

4.24

4.53

pmol/l

36.55

3005

17154

Chronic sinusitis

1763

11620

1.56

62.96

3.3

4.44

4.48

pmol/l

0.98

1565

10371

Diseases of oral cavity, salivary glands and jaws

3751

14257

1.37

62.53

3.1

3.4

4.46

4.52

pmol/l

2.34

3318

12777

Chronic rhinitis, nasopharyngitis and pharyngitis

1319

8171

1.67

62.14

3.1

3.3

4.52

4.49

pmol/l

0.59

1150

7294

Myocarditis

231

714

3.51

61.84

3.7

3.4

4.37

4.62

pmol/l

3.07

223

638

Thyrotoxicosis factitia

23.80

61.79

7.0

1.8

4.45

4.44

pmol/l

0.02

Other symptoms and signs involving the nervous and musculoskeletal systems

1689

11096

1.57

61.53

3.0

3.4

4.47

4.48

pmol/l

0.24

1521

9877

AV-block

487

1969

2.33

61.44

3.1

3.0

4.30

4.45

pmol/l

1.17

436

1711

Disorders of conjunctiva

3454

21531

1.37

61.19

3.2

3.3

4.50

4.53

pmol/l

1.01

3066

19257

Diseases of the musculoskeletal system and connective tissue

2503

8705

1.47

61.17

3.3

3.6

4.56

4.62

pmol/l

2.04

2230

7898

Phobic anxiety disorders

648

3279

2.08

61.00

2.9

3.5

4.54

4.65

pmol/l

1.51

568

3000

Diverticular disease of intestine

2510

11694

1.45

60.97

3.0

3.4

4.38

4.45

pmol/l

2.49

2193

10429

Shoulder lesions

2979

13159

1.41

60.83

3.1

3.4

4.44

4.49

pmol/l

1.40

2672

11777

Oral lichen ruber planus wide, hypothyreosis or thyroxin

305

1133

3.02

60.58

3.8

3.1

4.26

4.42

pmol/l

2.38

263

997

3682

17246

1.36

60.40

3.2

3.4

4.36

4.54

pmol/l

16.20

3239

15433

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3682

17246

1.36

60.40

3.2

3.4

4.36

4.54

pmol/l

16.20

3239

15433

Special screening examination for infectious and parasitic diseases

1100

4829

1.75

60.16

3.1

3.6

4.52

4.65

pmol/l

3.94

901

4422

Other endocrine disorders

283

964

3.10

60.14

3.4

3.3

4.61

4.74

pmol/l

0.80

253

858

Hyperfunction of pituitary gland

305

1135

2.99

60.13

2.9

3.2

4.35

4.57

pmol/l

3.61

283

1016

Autoimmune diseases excluding thyroid diseases

3245

13138

1.39

59.97

2.6

2.8

4.50

4.60

pmol/l

5.43

2894

11819

Diabetes mellitus

4261

19425

1.33

59.59

3.2

3.4

4.40

4.53

pmol/l

13.21

3753

17398

Other and unspecified nonorganic psychotic disorders

859

4815

1.86

58.83

2.3

3.5

4.43

4.59

pmol/l

4.69

719

4337

Undetermined asthma, excluding more controls

534

2551

2.20

58.41

3.3

4.39

4.54

pmol/l

2.88

472

2235

Asthma/COPD (KELA code 203)

3905

20923

1.34

58.09

3.2

3.4

4.48

4.53

pmol/l

2.88

3504

18703

Excessive, frequent and irregular menstruation

2082

7895

1.51

58.05

3.1

3.4

4.49

4.56

pmol/l

2.76

1849

7047

Chronic diseases of tonsils and adenoids

3373

15856

1.37

58.01

3.4

3.3

4.61

4.53

pmol/l

3.18

3048

14219

Lumbar disc prolapse

2472

13951

1.44

57.96

3.0

3.5

4.48

4.49

pmol/l

0.12

2193

12540

Dialysis, with operation codes

463

2101

2.32

57.81

3.4

3.86

4.52

pmol/l

29.16

424

1852

Diabetes, varying definitions

4219

19316

1.33

57.75

3.2

3.4

4.40

4.53

pmol/l

12.42

3713

17298

Nephropathy related operations

450

2021

2.35

57.68

3.4

3.85

4.50

pmol/l

28.18

413

1775

Polycystic ovarian syndrome, consortium definition

3611

16398

1.36

57.27

3.1

3.3

4.43

4.52

pmol/l

6.20

3226

14645

Benign neoplasm of colon, rectum, anus and anal canal

1847

8856

1.52

57.20

3.0

4.35

4.45

pmol/l

3.99

1609

7781

Schizophrenia or delusion

1288

8095

1.64

57.11

2.3

3.4

4.39

4.55

pmol/l

6.68

1070

7267

Triptan medication for migraine, min. 3 purchases

2709

15510

1.41

56.87

3.3

3.4

4.53

4.55

pmol/l

0.24

2462

13987

Other symptoms and signs involving cognitive functions and awareness

1461

8842

1.59

56.78

2.9

3.3

4.28

4.44

pmol/l

7.29

1238

7813

Insulin, intermediate and long-acting

1851

12327

1.51

56.77

3.0

3.4

4.31

4.48

pmol/l

9.73

1628

10963

Schizophrenia, schizotypal and delusional disorders

1288

8122

1.64

56.31

2.3

3.4

4.39

4.55

pmol/l

6.58

1070

7289

Dental caries 3 and operation codes

3607

13854

1.36

56.28

3.2

3.4

4.47

4.51

pmol/l

1.05

3179

12407

Diseases of arteries, arterioles and capillaries (FINNGEN)

804

3057

1.89

55.97

3.1

3.4

4.22

4.55

pmol/l

14.84

713

2723

Rheumatism, unspecified

690

3685

1.98

55.93

3.3

3.4

4.36

4.45

pmol/l

1.82

605

3287

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

913

4793

1.81

55.89

2.8

3.4

4.79

4.74

pmol/l

0.50

804

4356

Any operation in hilmo

185

223

4.37

55.85

3.8

3.1

4.78

4.89

pmol/l

0.33

162

196

Heart failure and hypertrophic cardiomyopathy

111

219

6.03

55.69

4.5

3.1

4.01

4.40

pmol/l

2.51

102

189

Cerebrovascular diseases (FINNGEN)

1161

5041

1.69

55.67

3.2

3.4

4.31

4.54

pmol/l

10.39

1033

4486

Other disorders of thyroid

103

192

6.58

55.39

4.1

2.2

4.63

4.40

pmol/l

1.00

162

Migraine without aura

988

5871

1.76

55.37

3.0

3.5

4.57

4.61

pmol/l

0.52

886

5329

Type 2 diabetes, wide definition

2872

13666

1.39

55.22

3.1

3.3

4.31

4.47

pmol/l

12.38

2511

12139

Genitourinary diseases

2299

8019

1.46

54.92

3.2

3.5

4.53

4.67

pmol/l

6.50

2058

7259

Spinal stenosis

1660

8647

1.54

54.67

3.0

3.4

4.30

4.41

pmol/l

4.14

1424

7672

Osteopathies and chondropathies

2051

13575

1.47

54.59

3.2

3.3

4.38

4.47

pmol/l

3.34

1759

12034

Abnormal results of function studies

392

1710

2.46

54.46

3.1

3.4

4.45

4.51

pmol/l

0.44

348

1527

Chronic thyroiditis

21.33

54.46

4.1

1.6

4.34

pmol/l

0.01

Sub-endpoint used in defining T1D endpoints

1092

6552

1.69

54.16

3.0

3.3

4.35

4.55

pmol/l

7.41

963

5844

Other and unspecified iron deficiency

1207

7574

1.64

53.84

3.3

4.26

4.47

pmol/l

8.96

1051

6697

TMD related operations

775

4346

1.88

53.59

3.0

3.4

4.51

4.50

pmol/l

0.16

684

3899

Migraine with aura and triptan purchases

798

4522

1.86

53.52

3.3

3.4

4.53

4.56

pmol/l

0.48

728

4071

Nonorganic sleeping disorders

843

4841

1.82

53.44

3.2

3.4

4.48

4.55

pmol/l

1.21

733

4338

Nutritional anaemias

1734

11454

1.51

53.42

3.3

4.23

4.44

pmol/l

13.05

1511

10138

Undetermined asthma

534

2640

2.12

53.36

3.3

4.39

4.53

pmol/l

2.45

472

2314

Other systemic involvement of connective tissue (FG)

1074

6546

1.69

52.79

2.8

3.4

4.37

4.46

pmol/l

1.80

940

5797

Benign neoplasm of thyroid gland

202

647

3.55

52.37

4.6

3.1

4.44

4.50

pmol/l

0.40

184

554

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2266

16190

1.42

52.00

3.4

3.3

4.38

4.47

pmol/l

3.73

2007

14400

Dental caries 1 and operation codes

3385

13034

1.35

51.91

3.2

3.4

4.47

4.50

pmol/l

0.91

2987

11657

Valvular operations

389

1709

2.36

51.80

3.7

3.1

4.30

4.52

pmol/l

2.72

356

1502

Benign neoplasm: Colon

1573

8019

1.54

51.54

3.0

4.35

4.43

pmol/l

2.44

1360

7020

Iron deficiency anaemia

1504

9911

1.54

51.45

3.3

3.2

4.26

4.45

pmol/l

9.60

1308

8764

Hypokalaemia

432

2000

2.28

51.43

2.9

3.0

4.20

4.46

pmol/l

5.77

381

1749

Gingivitis and periodontal diseases

3625

14211

1.34

51.43

3.2

3.4

4.48

4.52

pmol/l

1.23

3192

12741

Endocrine disorders, other/unspecified

146

386

4.46

51.11

4.1

3.4

4.33

4.62

pmol/l

1.95

126

342

Conjunctivitis

3155

20776

1.35

50.99

3.2

3.3

4.50

4.54

pmol/l

0.85

2815

18582

Benign neoplasm of thyroid gland

202

658

3.48

50.94

4.6

3.2

4.44

4.48

pmol/l

0.21

184

576

Ischaemic heart disease, wide definition

2604

11860

1.40

50.75

3.2

3.3

4.31

4.46

pmol/l

9.81

2308

10482

Other medical care

1356

8642

1.57

50.49

4.0

3.3

4.31

4.46

pmol/l

4.89

1220

7592

Covid-19 confirmed case

1068

6624

1.67

50.15

3.3

4.36

4.51

pmol/l

4.76

987

5872

Concussion

1876

11287

1.47

49.99

3.2

3.6

4.46

4.59

pmol/l

6.14

1667

10177

Insulin, combination of fast acting with intermediate-acting or long-acting

2063

13487

1.44

49.70

3.1

3.4

4.30

4.49

pmol/l

12.68

1814

11991

Arthropathies

3929

15426

1.32

49.59

3.2

3.5

4.52

4.57

pmol/l

1.93

3501

13862

Diseases of pulp and periapical tissues, including avohilmo

4495

18348

1.29

49.40

3.4

3.3

4.52

pmol/l

0.01

3976

16424

Mouth breathing

1407

9310

1.55

49.27

3.2

3.4

4.52

4.51

pmol/l

0.14

1241

8337

Hypertrophic cardiomyopathy

183

571

3.53

48.79

4.2

3.4

4.09

4.50

pmol/l

4.71

169

502

Dental pulpitis 4

4491

18370

1.29

48.51

3.4

3.3

4.52

pmol/l

0.01

3975

16442

Dental pulpitis 1

4490

18372

1.29

48.45

3.4

3.3

4.52

pmol/l

0.01

3974

16444

Influenza and pneumonia

4222

21817

1.29

48.39

3.2

3.4

4.39

4.55

pmol/l

18.26

3728

19564

Ischemic heart diseases

2642

12168

1.38

48.27

3.2

3.3

4.32

4.46

pmol/l

9.07

2348

10757

Temporomandibular joint disorders, including avohilmo

1917

13549

1.45

48.21

3.1

3.4

4.51

4.55

pmol/l

1.06

1703

12189

Preparation and fitting of bite rail to mouth

631

3442

1.93

47.88

2.9

3.4

4.51

pmol/l

0.08

563

3093

Aplastic and other anaemias

1397

8793

1.54

47.78

3.2

4.12

4.42

pmol/l

22.84

1230

7702

Drug-induced adrenocortical insufficiency

128

325

4.74

47.67

4.5

3.3

4.34

4.50

pmol/l

1.09

117

287

Chronic periapical parodontitis

740

4218

1.82

47.65

3.6

3.5

4.39

4.50

pmol/l

1.42

653

3775

Other arthrosis

1878

9381

1.46

47.63

3.1

3.5

4.43

4.47

pmol/l

0.71

1663

8362

Non-allergic asthma (mode), excluding more controls

729

4094

1.82

47.60

3.1

3.3

4.53

4.54

pmol/l

0.13

650

3612

Insomnia

703

3970

1.86

47.38

3.2

3.4

4.46

4.54

pmol/l

1.46

618

3568

Poisoning by drugs, medicaments and biological substances

1027

6412

1.66

47.23

2.8

3.4

4.45

4.56

pmol/l

3.00

888

5786

Other and unspecified anaemias

1276

8074

1.57

46.93

3.2

4.12

4.42

pmol/l

20.54

1125

7057

Insulin medication

2060

12595

1.42

46.91

3.1

3.4

4.30

4.50

pmol/l

13.89

1811

11201

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1876

8304

1.46

46.81

3.3

3.4

4.45

4.55

pmol/l

4.07

1707

7451

Abnormal findings on examination of blood, without diagnosis

1388

8644

1.54

46.74

3.0

3.3

4.38

4.45

pmol/l

1.78

1237

7676

Osteoporosis

894

5142

1.72

46.70

3.3

3.1

4.24

4.40

pmol/l

4.24

739

4468

Symptoms and signs involving the urinary system

2666

15350

1.37

46.43

3.2

3.3

4.35

4.47

pmol/l

5.81

2301

13636

Provisional assignment of new diseases of uncertain etiology

1761

12339

1.46

46.43

3.1

3.4

4.41

4.54

pmol/l

6.13

1602

11003

Codes for special purposes

1762

12352

1.46

46.33

3.1

3.4

4.41

4.54

pmol/l

6.14

1603

11013

Other anaemias

1287

8163

1.56

46.23

3.2

4.12

4.42

pmol/l

20.77

1135

7140

Dental caries 3

3214

12456

1.34

46.04

3.2

3.4

4.48

4.50

pmol/l

0.45

2835

11169

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

303

898

2.57

45.75

2.8

3.0

4.24

4.48

pmol/l

2.66

261

789

Emotional disorders starting during childhood or adolecense, excluding more controls

231

834

2.91

45.36

2.9

3.9

4.81

4.92

pmol/l

0.80

205

771

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1286

7437

1.55

45.30

4.6

3.0

4.30

4.42

pmol/l

4.05

1180

6507

Disturbance of activity and attention

496

2512

2.06

45.18

2.8

3.6

4.86

4.72

pmol/l

1.33

439

2292

Disorders of synovium and tendon

2069

13456

1.41

45.06

3.0

3.5

4.45

4.52

pmol/l

2.52

1859

12082

Endometriosis

1752

7245

1.48

44.99

3.1

3.4

4.45

4.54

pmol/l

3.32

1563

6460

Inflammatory diseases of female pelvic organs

2954

16959

1.34

44.93

3.2

3.3

4.47

4.50

pmol/l

0.93

2599

15181

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1295

8623

1.55

44.78

2.9

3.4

4.49

4.56

pmol/l

1.37

1125

7795

Exposure to unspecified factor

3777

23023

1.29

44.60

3.1

3.4

4.43

4.53

pmol/l

7.89

3316

20632

Rotator cuff syndrome

2176

11728

1.40

44.55

3.1

3.4

4.44

4.46

pmol/l

0.44

1940

10482

Menorrhagia

1741

6692

1.48

44.09

3.3

3.4

4.48

4.52

pmol/l

0.81

1536

5950

Weight loss

382

1799

2.25

43.96

3.0

3.3

4.33

4.50

pmol/l

2.28

335

1583

Finngen Rheumatological endpoints

4008

18007

1.29

43.88

3.0

3.5

4.46

4.55

pmol/l

4.95

3548

16168

Acute renal failure

594

3247

1.89

43.80

3.3

3.2

3.89

4.44

pmol/l

26.01

521

2844

Emotionally unstable personality disorder

626

3510

1.88

43.57

2.7

3.4

4.45

4.61

pmol/l

3.79

538

3187

Abnormal involuntary movements

516

2715

1.99

43.50

3.1

3.3

4.35

4.48

pmol/l

2.23

449

2405

Dental caries 3, only avohilmo

3243

12696

1.33

43.42

3.2

3.4

4.48

4.49

pmol/l

0.36

2850

11387

Poisoning by medicine

933

5818

1.66

43.24

2.8

3.4

4.44

4.56

pmol/l

3.10

802

5260

Hypotension

480

2458

2.03

43.24

2.9

3.2

4.08

4.37

pmol/l

7.31

398

2107

Monoamine oxidase A inhibitors

471

2406

2.05

43.20

2.9

3.6

4.41

4.50

pmol/l

1.08

400

2169

Functional dyspepsia

1060

6816

1.61

42.97

3.0

3.3

4.43

4.48

pmol/l

1.07

935

6070

Hyperkinetic disorders

519

2716

1.99

42.92

2.8

3.5

4.86

4.72

pmol/l

1.27

461

2477

Heart failure and coronary heart disease

856

3836

1.70

42.87

3.4

3.1

4.01

4.32

pmol/l

13.93

754

3301

Dental pulpitis 4, only avohilmo

4515

18859

1.27

42.81

3.3

4.53

4.51

pmol/l

0.38

3998

16880

Systemic connective tissue disorders

1352

9167

1.52

42.65

2.8

3.3

4.35

4.45

pmol/l

2.97

1178

8086

Other systemic involvement of connective tissue

1085

7029

1.59

42.62

2.9

3.3

4.38

4.44

pmol/l

1.29

949

6197

Dental pulpitis 1, only avohilmo

4524

18920

1.26

42.49

3.3

4.53

4.51

pmol/l

0.54

4007

16934

Other disorders of skin and subcutaneous tissue

2421

16582

1.36

42.33

3.2

3.3

4.35

4.46

pmol/l

5.42

2083

14753

Subjective visual disturbances

952

5996

1.64

42.32

3.2

3.3

4.43

4.48

pmol/l

1.10

853

5319

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2080

15220

1.39

42.30

3.4

3.3

4.38

4.46

pmol/l

3.01

1840

13543

Diabetes medication

4101

19816

1.28

42.27

3.1

3.4

4.41

4.52

pmol/l

9.49

3588

17744

Post-traumatic stress disorder

427

2135

2.13

42.23

3.0

3.5

4.53

4.63

pmol/l

1.16

378

1948

Dental caries, including avohilmo

2972

11538

1.34

42.14

3.1

3.4

4.48

4.49

pmol/l

0.22

2628

10330

Autoimmune diseases excluding thyroid diseases, strict definition

2485

10241

1.37

42.08

1.8

2.0

4.54

4.62

pmol/l

3.42

2187

9116

Migraine without aura and triptan purchases

810

4928

1.72

41.97

2.8

3.4

4.54

4.58

pmol/l

0.47

722

4455

Pneumonia, organism unspecified

3407

19239

1.30

41.87

3.2

3.4

4.34

4.54

pmol/l

23.43

2990

17211

Dental caries 1

2972

11547

1.33

41.86

3.1

3.4

4.48

4.49

pmol/l

0.24

2628

10339

All pneumoniae

3915

21439

1.28

41.85

3.2

3.4

4.36

4.55

pmol/l

20.29

3447

19210

Cervical disc disorders

1284

8635

1.52

41.82

3.1

3.5

4.46

4.45

pmol/l

0.10

1131

7718

Polyuria

709

4143

1.77

41.80

3.2

4.37

4.44

pmol/l

1.18

609

3665

Obsessive-compulsive disorder

329

1493

2.36

41.77

2.6

3.6

4.48

4.70

pmol/l

3.36

287

1360

Diseases of the ear and mastoid process

4889

20017

1.25

41.67

3.2

3.4

4.50

4.53

pmol/l

1.17

4315

17994

Acute sinusitis

2112

14465

1.39

41.66

3.2

3.4

4.51

4.54

pmol/l

0.47

1882

12966

Allergic asthma (mode), excluding more controls

1003

6286

1.61

41.50

3.3

3.4

4.59

pmol/l

0.09

897

5602

Pain and other conditions associated with female genital organs and menstrual cycle

1018

6277

1.62

41.48

3.1

3.5

4.56

4.60

pmol/l

0.34

906

5647

Other sleep disorders

410

2023

2.12

41.39

3.4

3.3

4.47

4.53

pmol/l

0.69

366

1799

Non-allergic asthma (mode)

729

4265

1.75

41.29

3.1

3.3

4.53

4.51

pmol/l

0.11

650

3763

Abnormal weight loss

341

1575

2.30

41.25

3.0

3.3

4.33

4.48

pmol/l

1.78

295

1377

Asthma-related pneumonia

1187

7881

1.54

40.82

3.0

3.2

4.34

4.46

pmol/l

3.59

1035

6942

Diseases of the digestive system

1472

10184

1.47

40.79

3.3

3.2

4.36

4.46

pmol/l

3.39

1292

8985

Asthma, hospital admissions 3, pneumonia

1190

7908

1.54

40.74

3.0

3.2

4.34

4.46

pmol/l

3.63

1038

6964

Asthma-related pneumonia or sepsis

1190

7908

1.54

40.74

3.0

3.2

4.34

4.46

pmol/l

3.63

1038

6964

Benign neoplasm of colon, rectum, anus and anal canal

1932

12654

1.40

40.74

3.0

3.3

4.35

4.40

pmol/l

1.58

1676

11157

Dermatitis

2243

16710

1.37

40.71

3.0

3.4

4.39

4.49

pmol/l

5.10

1977

14928

Vasomotor and allergic rhinitis

1558

10777

1.46

40.66

3.0

3.3

4.60

4.56

pmol/l

0.74

1372

9679

Substance abuse, excluding more controls

1786

11179

1.42

40.64

2.7

3.6

4.47

4.54

pmol/l

2.18

1511

10184

Chronic gastritis

925

5829

1.63

40.59

2.9

3.3

4.26

4.42

pmol/l

4.94

794

5128

Urticaria and erythema

1496

10449

1.47

40.45

3.2

3.4

4.51

4.52

pmol/l

0.16

1323

9347

Other neurological diseases

2420

14606

1.35

40.37

3.1

3.3

4.35

4.44

pmol/l

4.10

2138

12922

Insulin, fast-acting (human)

598

3370

1.85

40.36

3.0

3.4

4.36

4.55

pmol/l

4.05

533

3014

Disorders of gallbladder, biliary tract and pancreas

3728

19014

1.28

40.32

3.2

3.4

4.37

4.48

pmol/l

9.15

3294

16992

Pneumonias (Asthma/COPD co-morbidities)

3873

21365

1.27

40.23

3.2

3.4

4.36

4.55

pmol/l

19.61

3408

19150

Hyperhidrosis

179

625

3.18

39.81

2.5

3.3

4.62

4.61

pmol/l

0.02

151

557

Dental caries 1, only avohilmo

3012

11817

1.32

39.74

3.2

3.4

4.48

4.49

pmol/l

0.19

2658

10586

Infections of the skin and subcutaneous tissue

2063

15160

1.38

39.74

3.2

3.4

4.45

4.55

pmol/l

3.69

1868

13544

Cholelithiasis

3224

17651

1.30

39.63

3.2

3.4

4.39

4.47

pmol/l

4.23

2845

15763

Extrapyramidal and movement disorders

1196

8024

1.53

39.53

2.9

3.3

4.39

4.40

pmol/l

0.20

1026

7072

Cardiac arrest

201

624

2.90

39.48

4.1

3.2

4.08

4.61

pmol/l

8.97

181

543

Other disorders of teeth and supporting structures

744

4476

1.72

39.47

3.4

3.5

4.31

4.48

pmol/l

4.76

667

3995

Dental operations

2384

9088

1.37

39.28

3.2

3.4

4.46

4.49

pmol/l

0.60

2121

8089

Pain in thoracic spine

625

3601

1.81

39.22

3.1

3.4

4.42

4.49

pmol/l

1.09

554

3221

Fenamates

652

2508

1.81

39.18

3.1

3.6

4.41

4.44

pmol/l

0.32

592

2234

Heartburn

417

2117

2.07

39.08

3.0

3.3

4.48

4.52

pmol/l

0.27

354

1898

Type 2 diabetes

3824

18065

1.27

39.04

3.2

3.4

4.39

4.51

pmol/l

10.61

3345

16169

Other CVD

554

3073

1.86

39.02

2.9

3.2

4.11

4.38

pmol/l

7.30

464

2663

Amenorrhoea

399

2008

2.13

39.01

3.1

3.5

4.25

4.63

pmol/l

11.51

362

1804

Other general symptoms and signs

238

955

2.65

38.90

3.6

3.3

4.51

4.65

pmol/l

1.39

218

853

Hypothyroidism, autoimmune, DX-based

10.15

38.62

4.4

3.5

4.39

4.82

pmol/l

1.37

Other and unspecified dermatitis

1897

13898

1.39

38.54

3.0

3.4

4.40

4.49

pmol/l

3.98

1670

12413

Disorders of ocular muscles, binocular movement, accommodation and refraction

1850

13392

1.40

38.48

3.5

3.3

4.52

4.55

pmol/l

0.61

1665

11965

Intracranial trauma

2130

11785

1.37

38.38

3.2

3.6

4.44

4.59

pmol/l

8.82

1888

10631

Ovarian cyst

1817

7562

1.43

38.31

3.3

3.4

4.49

4.55

pmol/l

1.84

1639

6746

Transplanted organ and tissue status

344

1640

2.20

38.17

3.5

3.4

4.11

4.56

pmol/l

12.93

321

1453

Enlarged lymph nodes

578

3275

1.83

38.16

3.6

3.3

4.48

4.55

pmol/l

1.16

508

2918

Type 1 diabetes, definitions combined

459

2422

1.98

38.15

3.3

3.4

4.53

4.68

pmol/l

2.09

418

2192

Urticaria

1253

8567

1.51

38.10

3.3

4.52

4.53

pmol/l

0.13

1108

7668

Cardiomyopathy, Hypertrophic obstructive

216

4.82

38.00

4.2

3.3

3.94

4.63

pmol/l

9.22

191

Allergic asthma (mode)

1003

6416

1.58

37.99

3.3

3.4

4.59

4.58

pmol/l

0.02

897

5730

Type 1 diabetes, strict (exclude DM2)

456

2405

1.98

37.97

3.3

3.4

4.53

4.68

pmol/l

2.06

415

2178

Cholelithiasis, broad definition with cholecystitis

3303

17848

1.29

37.36

3.2

3.4

4.38

4.47

pmol/l

4.77

2919

15944

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3734

20994

1.27

37.30

3.2

3.4

4.35

4.54

pmol/l

23.16

3279

18798

Coxibs

1048

3591

1.59

37.21

3.1

3.6

4.56

4.48

pmol/l

1.38

917

3219

Other disorders of eye and adnexa

580

3328

1.82

37.16

3.3

4.46

4.50

pmol/l

0.51

516

2974

Bacterial infection, other or unspecified

1638

10597

1.42

37.08

3.1

3.3

4.17

4.48

pmol/l

24.88

1440

9353

Dental pulpitis 2

2642

10296

1.33

36.97

3.2

3.4

4.47

4.50

pmol/l

0.43

2329

9219

Acetic acid derivatives and related substances

1052

3534

1.58

36.86

3.2

3.6

4.48

pmol/l

0.05

935

3168

Other extrapyramidal and movement disorders in other diseases

771

4770

1.67

36.85

3.1

3.3

4.39

4.44

pmol/l

0.75

653

4191

Persons encountering health services for specific procedures, not carried out

317

1489

2.25

36.80

2.9

3.3

4.42

4.58

pmol/l

2.08

266

1325

Benign neoplasm: Colon

1582

11087

1.42

36.79

3.0

3.3

4.35

4.39

pmol/l

0.90

1367

9783

Coronary atherosclerosis

2082

9941

1.37

36.72

3.1

3.3

4.29

4.45

pmol/l

10.44

1834

8763

Iron deficiency

150

503

3.43

36.49

3.5

3.3

4.57

4.59

pmol/l

0.08

142

455

Eating disorder

492

2712

1.92

36.46

2.9

3.4

4.30

4.66

pmol/l

14.40

428

2453

Diaphragmatic hernia

1218

8346

1.50

36.31

2.9

3.3

4.42

4.41

pmol/l

0.07

1056

7373

Other gastritis (incl. Duodenitis)

753

4645

1.67

36.20

3.0

3.4

4.35

4.44

pmol/l

1.34

660

4112

STROKE

1998

10249

1.38

36.16

3.2

3.4

4.32

4.50

pmol/l

12.32

1770

9074

Substance use, excluding alcohol

738

4539

1.68

36.09

2.6

3.4

4.45

4.55

pmol/l

1.88

625

4082

Other bacterial diseases

3351

18384

1.28

35.87

3.1

3.3

4.27

4.53

pmol/l

33.58

2956

16397

Certain disorders involving the immune mechanism

699

4259

1.70

35.60

3.6

3.3

4.38

4.49

pmol/l

1.82

627

3799

Diplopia

476

2605

1.91

35.57

3.8

3.2

4.41

4.45

pmol/l

0.42

430

2309

Other acute lower respiratory infections

1826

12842

1.38

35.30

3.2

3.3

4.45

4.52

pmol/l

1.66

1595

11404

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3601

17593

1.27

35.26

3.1

3.4

4.38

4.52

pmol/l

12.49

3162

15736

Dental pulpitis 2, only avohilmo

2681

10538

1.32

35.16

3.1

3.4

4.48

4.49

pmol/l

0.19

2366

9438

Abnormal findings on diagnostic imaging of lung

1390

9544

1.45

35.09

3.3

4.32

4.39

pmol/l

1.49

1220

8422

Bleeding

2720

15373

1.30

34.81

3.2

3.3

4.34

4.47

pmol/l

7.77

2376

13634

Type 1 diabetes, strict definition, subgroup 1

370

1885

2.06

34.34

3.3

3.5

4.59

4.73

pmol/l

1.43

337

1705

Falls/tendency to fall

4621

19001

1.23

34.25

3.2

3.4

4.50

4.55

pmol/l

2.00

4075

17121

Other and unspecified polyneuropathies, also in other diseases

551

3178

1.79

34.15

3.0

3.3

4.23

4.42

pmol/l

4.51

485

2787

Other eating disorders

298

1421

2.26

33.95

3.0

3.3

4.33

4.69

pmol/l

9.55

265

1279

Cervicalgia

769

4851

1.64

33.93

2.9

3.4

4.47

4.46

pmol/l

0.14

675

4318

Cerebral cysts

248

1094

2.42

33.80

3.4

3.3

4.52

4.57

pmol/l

0.42

219

978

Hyperkalaemia

170

623

2.88

33.76

2.9

3.0

3.93

4.39

pmol/l

4.48

142

545

Benign neoplasm: Colon, unspecified

678

4125

1.68

33.67

2.9

3.0

4.31

4.41

pmol/l

2.03

574

3603

Hypertensive heart and/or renal disease

676

3166

1.69

33.52

3.0

3.1

4.15

4.41

pmol/l

8.24

580

2765

Statin medication

2848

12484

1.30

33.45

3.1

3.5

4.42

4.53

pmol/l

6.75

2539

11200

Allergic conjunctivitis

2397

18287

1.31

33.08

3.2

3.3

4.50

4.53

pmol/l

0.48

2128

16368

Other retinal disorders

1948

11727

1.36

32.96

3.1

3.3

4.30

4.43

pmol/l

6.11

1702

10357

Ocular pain

367

1903

2.05

32.90

3.6

3.3

4.51

pmol/l

0.01

331

1703

Acute tubulo-interstitial nephritis

2225

15119

1.33

32.78

3.1

3.3

4.33

4.51

pmol/l

10.11

1970

13439

Gout

673

3749

1.67

32.78

3.0

3.5

4.15

4.41

pmol/l

8.42

591

3306

Dental operations, only avohilmo

2503

9856

1.32

32.66

3.1

3.4

4.45

4.49

pmol/l

0.72

2233

8776

Cholecystectomy

2594

17943

1.30

32.58

3.2

3.3

4.42

4.45

pmol/l

0.53

2293

15963

Asthma and allergy, excluding more controls

580

3401

1.75

32.57

3.2

3.4

4.63

4.62

pmol/l

0.16

509

3060

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2295

17429

1.32

32.50

3.2

3.3

4.50

4.53

pmol/l

0.56

2039

15596

Benign neoplasm of other and ill-defined parts of digestive system

576

3418

1.74

32.44

3.3

3.0

4.38

4.44

pmol/l

0.73

510

2971

Hernia of abdominal wall, postoperative

565

3329

1.75

32.39

3.0

3.1

4.31

4.54

pmol/l

6.91

490

2992

Polyneuropathies and other disorders of the peripheral nervous system

627

3799

1.70

32.39

3.3

4.24

4.42

pmol/l

4.88

558

3356

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

656

4021

1.68

32.38

5.0

3.0

4.25

4.40

pmol/l

3.28

601

3522

Convulsions, not elsewhere classified

768

4826

1.61

32.23

2.9

3.4

4.40

4.61

pmol/l

5.84

683

4329

Explicit Sepsis

1303

8843

1.44

32.18

3.1

3.3

4.18

4.50

pmol/l

19.94

1155

7826

Acute bronchitis

1379

9678

1.42

32.00

3.2

3.3

4.38

4.49

pmol/l

3.09

1198

8574

Other and unspecified mood [affective] disorders

325

1628

2.11

31.92

3.0

3.5

4.50

4.63

pmol/l

1.46

286

1476

Other specified and unspecified personality disorders

407

2203

1.94

31.84

2.6

3.4

4.41

4.55

pmol/l

2.15

345

1986

Social phobias

361

1877

2.02

31.73

2.6

3.5

4.58

4.68

pmol/l

1.01

308

1716

Benign neoplasm: Adrenal gland

268

1253

2.27

31.60

3.2

3.0

4.35

4.46

pmol/l

1.17

236

1085

Asthma and allergy

580

3431

1.73

31.54

3.2

3.4

4.63

4.61

pmol/l

0.23

509

3091

Hypertensive Heart Disease

598

2918

1.71

31.45

3.0

4.16

4.40

pmol/l

6.53

514

2540

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

835

5464

1.57

31.39

3.1

3.4

4.44

4.48

pmol/l

0.60

731

4918

Type 1 diabetes, strict definition

377

1993

1.98

31.34

3.3

3.5

4.59

4.72

pmol/l

1.43

344

1803

Eating disorders

533

3140

1.78

31.30

2.8

3.3

4.32

4.63

pmol/l

11.72

463

2835

Volume depletion

265

1232

2.24

31.17

2.9

3.0

3.98

4.45

pmol/l

4.14

228

1076

External causes of morbidity and mortality

2963

11734

1.28

31.11

3.3

3.4

4.47

4.56

pmol/l

5.21

2639

10579

Other maternal disorders predominantly related to pregnancy

2735

13568

1.29

31.11

3.3

3.4

4.52

4.51

pmol/l

0.26

2484

12171

Localized swelling, mass and lump of skin and subcutaneous tissue

1086

7508

1.48

31.05

3.7

3.3

4.49

4.46

pmol/l

0.39

989

6678

Other diseases of blood and blood-forming organs, wide

747

4786

1.61

30.91

3.3

4.48

4.47

pmol/l

0.03

630

4246

All influenza

798

5184

1.58

30.75

3.1

3.3

4.46

4.55

pmol/l

1.03

712

4598

Other external causes of accidental injury

3569

14461

1.25

30.62

3.2

3.4

4.46

4.55

pmol/l

4.71

3182

13014

Disorders of skin appendages

1811

13655

1.35

30.50

3.4

4.47

4.54

pmol/l

2.37

1608

12227

Other and unspecified urticaria

805

5270

1.58

30.48

3.3

3.4

4.55

4.53

pmol/l

0.26

712

4722

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

444

2490

1.85

30.45

4.0

3.0

4.36

4.46

pmol/l

1.23

412

2167

Noninflammatory disorders of female genital tract

2106

8053

1.34

30.40

3.2

3.4

4.50

4.57

pmol/l

2.48

1891

7199

Disorder of lipoprotein metabolism, unspecified

370

1961

1.95

30.25

3.0

3.1

4.24

4.42

pmol/l

2.65

328

1702

Mycoses

910

6112

1.53

30.24

3.2

3.3

4.33

4.48

pmol/l

4.48

774

5425

Fall on same level

4577

21287

1.21

30.12

3.2

3.4

4.44

4.55

pmol/l

8.32

4028

19146

Other noninfective gastroenteritis and colitis

865

5753

1.54

29.97

3.5

3.2

4.38

4.53

pmol/l

3.80

768

5104

Chronic laryngitis and laryngotracheitis

496

2891

1.78

29.93

3.4

3.3

4.35

4.44

pmol/l

1.38

418

2554

Psychotic depression

243

1116

2.29

29.80

2.8

3.7

4.34

4.55

pmol/l

2.92

205

1023

Presence of other functional implants

1700

8953

1.37

29.73

3.1

3.3

4.28

4.43

pmol/l

5.92

1488

7854

Correction of physiology of bite - demanding therapy visit

338

1768

2.04

29.71

3.2

4.43

4.53

pmol/l

1.14

296

1580

Carpal tunnel syndrome

2224

15600

1.31

29.67

3.0

3.4

4.44

4.47

pmol/l

0.87

1979

13887

Secondary hypertension

255

1181

2.23

29.60

2.6

3.4

4.11

4.60

pmol/l

9.39

234

1052

Inflammatory disease of uterus

697

4469

1.63

29.43

3.0

3.4

4.52

pmol/l

0.01

622

4024

Cervicobrachial syndrome

847

5653

1.54

29.10

3.1

3.4

4.50

4.48

pmol/l

0.15

772

5064

Other septicaemia

1059

7224

1.47

29.06

3.0

3.3

4.13

4.48

pmol/l

19.54

933

6346

Hyperprolactinaemia

196

841

2.55

29.01

2.8

3.3

4.39

4.60

pmol/l

2.53

181

761

Disorders of choroid and retina

2592

14922

1.28

28.98

3.2

3.3

4.33

4.45

pmol/l

6.72

2291

13204

Schizoaffective disorder

337

1773

2.01

28.87

2.1

3.4

4.29

4.56

pmol/l

4.74

284

1595

Angina pectoris

1748

8847

1.35

28.84

3.0

3.3

4.28

4.44

pmol/l

7.86

1533

7792

Problems related to lifestyle

392

2161

1.89

28.67

3.2

3.4

4.52

4.57

pmol/l

0.38

345

1934

Maternal care for other conditions predominantly related to pregnancy

1043

7203

1.48

28.56

3.2

3.4

4.56

4.54

pmol/l

0.12

933

6514

Cushing syndrome

197

4.59

28.35

2.7

3.3

4.23

4.52

pmol/l

1.44

174

Polyarthropathies

2459

12893

1.29

28.28

3.0

3.5

4.34

4.51

pmol/l

10.80

2178

11565

Hard cardiovascular diseases

2506

12676

1.29

28.23

3.1

3.3

4.32

4.46

pmol/l

7.98

2229

11201

Sequelae of external causes of morbidity and mortality

818

5456

1.54

28.12

3.1

3.3

4.42

4.46

pmol/l

0.39

732

4804

Mental disorders, not otherwise specified

374

2054

1.92

28.06

2.7

3.4

4.47

4.56

pmol/l

1.11

332

1850

Diabetes mellitus in pregnancy

1668

8115

1.37

28.06

3.5

4.59

4.58

pmol/l

0.22

1535

7368

Accidents

3538

14461

1.24

28.02

3.2

3.4

4.46

4.55

pmol/l

5.38

3162

13014

Congenital malformations, deformations and chromosomal abnormalities

2317

17482

1.29

28.00

3.4

4.55

4.56

pmol/l

0.25

2069

15693

Diabetes, insulin treatment (Kela reimbursement)

3707

18661

1.23

27.98

3.1

3.4

4.38

4.51

pmol/l

11.58

3257

16661

Persons with potential health hazards related to communicable diseases

1559

11565

1.36

27.98

3.5

3.4

4.57

4.61

pmol/l

0.58

1428

10420

Viral hepatitis, IBD co-morbidity

172

695

2.58

27.97

2.4

2.7

4.51

4.67

pmol/l

1.01

142

616

Cervicocranial syndrome

428

2447

1.82

27.84

2.9

3.4

4.61

4.48

pmol/l

1.36

386

2187

Emotional disorders and disorders of social functioning with onset specific to childhood

250

1181

2.22

27.83

3.3

3.5

4.81

4.83

pmol/l

0.07

220

1079

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1223

8728

1.42

27.76

3.4

4.60

pmol/l

0.08

1093

7890

Disorders of vitreous body and globe

1595

11695

1.35

27.42

3.1

3.3

4.35

4.40

pmol/l

1.40

1403

10313

Endometriosis of pelvic peritoneum

756

4948

1.56

27.11

3.0

3.5

4.50

4.55

pmol/l

0.79

669

4427

Disorders of pituitary gland, other and/or unspecified

6.66

26.93

2.8

3.2

4.09

4.63

pmol/l

2.21

Diagnoses used for exclusion with ILD

760

5036

1.54

26.80

3.3

3.2

4.33

4.43

pmol/l

1.82

674

4450

ILD medications: immunosuppressive drugs

2226

16817

1.29

26.78

3.1

3.4

4.38

4.54

pmol/l

8.98

2002

15062

Disorders of vitreous body

1553

11431

1.35

26.71

3.2

3.3

4.35

4.40

pmol/l

1.30

1364

10078

Left bundle-branch block

215

984

2.28

26.49

3.2

3.1

4.40

4.48

pmol/l

0.35

189

860

Injuries to the ankle and foot

2648

19404

1.26

26.49

3.1

3.4

4.54

4.56

pmol/l

0.45

2338

17477

Tonsillectomy and adenotomy

2438

13485

1.28

26.49

3.5

3.4

4.66

4.59

pmol/l

1.93

2195

12216

Other symptoms and signs involving the digestive system and abdomen

633

4052

1.61

26.48

3.3

4.38

4.47

pmol/l

1.70

553

3615

Direct fill therapy

482

2891

1.73

26.27

3.6

3.3

4.43

4.56

pmol/l

1.72

441

2585

False labour

1521

7137

1.37

26.26

3.4

3.5

4.57

pmol/l

0.11

1387

6474

Benign neoplasm: Adrenal gland

268

1346

2.10

26.26

3.2

3.3

4.35

4.42

pmol/l

0.65

236

1189

Septicaemia

1171

8118

1.41

26.11

3.0

3.3

4.16

4.48

pmol/l

17.18

1036

7150

Cutaneous abscess, furuncle and carbuncle

869

5957

1.49

26.08

3.2

3.4

4.44

4.53

pmol/l

1.57

782

5316

Gout, FINNGEN

673

4365

1.57

26.02

3.0

3.2

4.15

4.39

pmol/l

7.19

591

3839

Other disorders of bladder

344

1875

1.90

25.96

3.2

3.4

4.32

4.42

pmol/l

1.11

303

1656

Adenomyosis (Endometriosis of uterus)

570

3589

1.65

25.87

3.2

3.3

4.41

4.45

pmol/l

0.40

508

3147

Primary_lymphoid and hematopoietic malignant neoplasms

640

4116

1.59

25.81

3.2

3.0

4.31

4.45

pmol/l

3.12

572

3597

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

276

1402

2.04

25.72

4.4

3.0

4.27

4.43

pmol/l

1.28

247

1206

Suicide or other Intentional self-harm

936

6530

1.47

25.72

2.7

3.4

4.46

4.55

pmol/l

1.50

801

5889

Other and unspecified effects of external causes

1039

7389

1.44

25.66

3.1

3.4

4.52

4.55

pmol/l

0.36

924

6640

Pulmonary heart disease, diseases of pulmonary circulation

921

6395

1.47

25.64

3.2

4.24

4.41

pmol/l

5.85

801

5598

Mixed and other personality disorders

351

1945

1.90

25.61

3.1

3.5

4.42

4.58

pmol/l

2.57

300

1765

Anankastic personality disorder

194

874

2.40

25.57

2.9

3.3

4.45

4.55

pmol/l

0.76

163

787

Melanocytic naevi

1019

7226

1.44

25.51

3.4

3.1

4.48

4.52

pmol/l

0.49

936

6403

Osteoporosis with pathological fracture (FG)

248

1225

2.14

25.45

2.8

3.0

4.18

4.39

pmol/l

2.61

193

1063

Other diseases of anus and rectum

936

6525

1.46

25.44

3.0

3.4

4.36

4.45

pmol/l

1.98

804

5767

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

680

4468

1.57

25.42

2.8

3.4

4.47

4.57

pmol/l

1.84

579

4036

Manic episode

140

544

2.78

25.32

2.6

3.5

4.33

4.66

pmol/l

3.48

115

492

Other bacterial intestinal infections

568

3578

1.63

25.28

3.1

3.2

4.26

4.47

pmol/l

6.06

494

3148

Deforming dorsopathies

997

7052

1.45

25.28

3.1

3.4

4.47

4.49

pmol/l

0.22

876

6302

Care involving dialysis

242

1184

2.13

25.20

2.4

3.3

3.62

4.53

pmol/l

26.81

219

1038

Disorders of vestibular function (Vertigo)

1543

11623

1.34

25.12

3.2

3.3

4.35

4.42

pmol/l

2.30

1358

10246

Soft tissue disorders related to use, overuse and pressure

873

6033

1.48

25.09

3.0

3.4

4.42

4.46

pmol/l

0.49

772

5359

Neuromuscular dysfunction of bladder

307

1636

1.96

25.08

3.2

3.3

4.27

4.48

pmol/l

3.82

271

1455

Procreative management

1206

7413

1.40

25.07

3.3

3.4

4.57

4.59

pmol/l

0.32

1092

6631

Type 2 diabetes, definitions combined

3456

17046

1.22

24.96

3.2

3.4

4.41

4.50

pmol/l

5.20

3020

15243

Meniscus derangement

1916

10165

1.31

24.96

3.1

3.5

4.45

4.48

pmol/l

0.58

1724

9076

Deviated nasal septum

956

6717

1.45

24.82

3.2

3.3

4.46

4.49

pmol/l

0.31

851

5987

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3450

18602

1.22

24.78

3.2

3.4

4.40

4.48

pmol/l

3.70

3058

16612

Retention of urine

830

4783

1.49

24.70

3.3

4.20

4.42

pmol/l

7.16

732

4241

Excessive attrition of teeth

1567

6399

1.35

24.67

3.2

3.4

4.48

4.55

pmol/l

2.02

1395

5790

Type1 diabetes, definitions combined, early onset

310

1665

1.95

24.65

3.3

3.5

4.62

4.75

pmol/l

1.17

282

1499

Other complications of surgical and medical care, not elsewhere classified

369

2101

1.83

24.47

3.6

3.3

4.36

4.50

pmol/l

1.41

329

1884

Emotional disorders starting during childhood or adolescence

236

1154

2.15

24.46

3.0

3.4

4.83

4.82

pmol/l

0.01

210

1050

Tinnitus

794

5424

1.50

24.40

3.1

3.3

4.48

4.44

pmol/l

0.44

694

4819

Wide developmental disorders, excluding more controls

117

416

2.96

24.32

2.8

3.7

5.15

4.98

pmol/l

0.55

100

387

Type 2 diabetes, strict (exclude DM1)

3462

17130

1.22

24.32

3.2

3.4

4.41

4.50

pmol/l

4.70

3023

15320

Elevated blood glucose level

288

1521

1.98

24.27

3.2

3.3

4.38

4.49

pmol/l

0.93

251

1348

Epilepsy

961

6774

1.44

24.24

2.8

3.4

4.34

4.53

pmol/l

6.47

858

6015

Sequelae with surgical and medical care as external cause

634

4146

1.57

24.08

3.1

3.3

4.42

4.44

pmol/l

0.16

570

3652

Other diseases of pericardium

143

575

2.63

23.83

2.9

3.3

4.20

4.59

pmol/l

2.95

126

506

Gout, strict definition

395

2302

1.76

23.63

3.1

3.3

4.10

4.36

pmol/l

5.18

350

2013

Strabismus

957

6797

1.44

23.58

3.8

3.3

4.51

4.55

pmol/l

0.47

870

6086

Type 2 diabetes, definitions combined, including avohilmo

3487

17170

1.21

23.57

3.2

3.4

4.42

4.50

pmol/l

4.87

3054

15357

Gout, idiopatic and unspecified

553

3518

1.61

23.40

2.9

3.2

4.12

4.37

pmol/l

6.30

489

3096

L04AD Calcineurin inhibitors

374

2168

1.79

23.26

3.4

4.13

4.55

pmol/l

12.46

344

1945

Extracorporeal dialysis

191

882

2.28

23.25

2.5

3.5

3.55

4.51

pmol/l

21.78

173

780

Atypical facial pain

226

1121

2.15

23.20

3.3

3.4

4.34

4.48

pmol/l

1.41

197

997

Missing teeth due to accident, extraction or parodontitis

375

2177

1.78

23.08

3.4

3.3

4.22

4.46

pmol/l

5.43

345

1927

Other disorders of eyelid

1318

9549

1.36

23.06

3.3

3.2

4.35

4.39

pmol/l

0.75

1164

8373

Other strabismus

826

5735

1.47

23.05

3.9

3.3

4.53

4.57

pmol/l

0.41

752

5132

TMD related pain

187

870

2.34

23.01

2.9

3.3

4.45

4.53

pmol/l

0.48

154

774

Internal derangement of knee

1295

9672

1.36

22.98

3.4

3.5

4.47

4.51

pmol/l

0.74

1146

8664

Benign neoplasm of other and ill-defined parts of digestive system

576

3730

1.59

22.96

3.3

3.2

4.38

4.43

pmol/l

0.54

510

3282

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

297

1611

1.90

22.75

4.3

2.9

4.23

4.43

pmol/l

1.97

266

1389

Other menopausal disorders

1166

4911

1.40

22.73

3.4

4.41

4.48

pmol/l

1.67

1045

4360

Implicit fungal Sepsis

130

515

2.71

22.59

3.1

3.3

4.06

4.57

pmol/l

4.86

107

454

Any event in hilmo or specialist outpatient

10.22

22.47

3.6

1.2

4.54

4.89

pmol/l

0.72

Disorders of refraction and accommodation

978

7020

1.42

22.43

3.3

4.54

4.58

pmol/l

0.50

872

6303

Dental caries 2 and operation codes

2970

19518

1.22

22.43

3.3

3.4

4.55

pmol/l

0.10

2630

17548

Benign neoplasm: Stomach

313

1741

1.87

22.41

3.6

2.9

4.39

4.49

pmol/l

1.06

268

1512

Injury, poisoning and certain other consequences of external causes

2395

9628

1.26

22.39

3.3

3.5

4.46

4.57

pmol/l

5.82

2132

8679

Benign neoplasm: Colon, unspecified

678

4566

1.52

22.29

2.9

3.3

4.31

4.38

pmol/l

1.04

574

4003

Speech and linguistic disorders, excluding more controls

260

1280

1.98

22.18

2.8

3.7

4.86

4.85

pmol/l

0.07

234

1174

Viral infections characterized by skin and mucous membrane lesions

1381

10491

1.34

22.16

3.3

4.43

4.52

pmol/l

2.78

1221

9335

COPD (mode)

804

4412

1.47

22.12

3.1

3.3

4.24

4.45

pmol/l

6.19

699

3875

Chronic periodontitis

432

2631

1.69

22.11

3.6

3.4

4.21

4.45

pmol/l

5.99

390

2341

Postmenopausal bleeding

1054

4174

1.42

22.04

3.2

3.3

4.40

4.44

pmol/l

0.45

916

3660

Intracranial injury

1880

14364

1.28

21.99

3.1

3.3

4.43

4.53

pmol/l

3.97

1644

12806

Bacterial intestinal infections, IBD co-morbidities

565

3676

1.58

21.93

3.1

3.2

4.25

4.45

pmol/l

5.24

497

3246

Venous thromboembolism

1645

12431

1.30

21.91

3.2

3.3

4.32

4.42

pmol/l

4.21

1435

10972

Exposure to other specified factors

2639

20318

1.23

21.89

3.0

3.4

4.48

4.54

pmol/l

2.17

2318

18230

Diseases of the myoneural junction and muscle

361

2106

1.77

21.82

2.8

3.3

4.33

4.45

pmol/l

1.37

308

1852

Arthrosis

2554

11397

1.25

21.77

3.1

3.5

4.46

4.48

pmol/l

0.32

2281

10209

Early onset COPD, excluding more controls

550

3554

1.58

21.74

3.2

3.4

4.30

4.50

pmol/l

5.12

481

3156

Vitamin deficiency

185

870

2.25

21.69

3.9

3.2

4.33

4.51

pmol/l

1.48

158

769

Vitamin deficiency, wide

185

870

2.25

21.69

3.9

3.2

4.33

4.51

pmol/l

1.48

158

769

Dissociative [conversion] disorders

183

860

2.27

21.67

3.0

3.4

4.26

4.62

pmol/l

6.27

161

773

Allergic rhinitis

1239

9228

1.36

21.62

2.9

3.4

4.65

4.59

pmol/l

0.86

1090

8343

Sicca syndrome [Sjögren]

357

2094

1.79

21.59

2.9

3.2

4.37

4.46

pmol/l

1.04

308

1869

Unspecified haematuria

1076

6748

1.39

21.58

3.1

3.3

4.33

4.45

pmol/l

2.24

942

5993

Fungal Sepsis

136

564

2.57

21.44

3.1

3.2

4.03

4.57

pmol/l

5.53

112

500

Gout, unspecified

450

2786

1.65

21.42

3.0

3.3

4.14

4.37

pmol/l

5.51

396

2446

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

325

1856

1.83

21.41

3.4

3.2

4.39

4.52

pmol/l

1.64

292

1650

Diseases of salivary glands

661

4472

1.52

21.37

3.1

3.4

4.43

4.48

pmol/l

0.70

592

3991

Other disorders of kidney and ureter

381

2273

1.73

21.25

3.0

3.3

4.19

4.44

pmol/l

5.11

346

2002

Diseases of inner ear

1748

13486

1.29

21.24

3.2

3.3

4.37

4.43

pmol/l

2.18

1539

11902

Atopic dermatitis

2233

15417

1.25

21.21

3.1

3.4

4.58

pmol/l

0.03

1957

13918

Paracetamol of NSAID medication

661

2192

1.54

21.16

3.4

3.5

4.64

4.61

pmol/l

0.21

593

1973

Myocardial infarction

1335

7243

1.34

21.15

3.2

3.3

4.24

4.45

pmol/l

9.45

1180

6364

Sarcoidosis

455

2847

1.65

21.12

3.5

3.3

4.40

4.46

pmol/l

0.50

406

2537

Ovarian dysfunction

381

2299

1.74

20.93

3.5

3.3

4.61

4.58

pmol/l

0.23

344

2074

Benign lipomatous neoplasm

893

6410

1.42

20.86

3.1

3.0

4.43

4.46

pmol/l

0.37

797

5621

Substance abuse

1786

13500

1.28

20.82

2.7

3.4

4.47

4.53

pmol/l

1.55

1511

12149

Deposits [accretions] on teeth

245

1245

1.98

20.80

3.4

3.3

4.45

4.63

pmol/l

1.66

219

1111

Erosion of teeth, including avohilmo

762

5147

1.47

20.76

3.0

3.4

4.46

4.56

pmol/l

2.18

681

4657

Mental and behavioural disorders due to psychoactive substance use

1847

13842

1.27

20.76

2.7

3.4

4.48

4.53

pmol/l

1.16

1567

12462

Adverse effects, not elsewhere classified

751

5254

1.47

20.59

3.2

3.3

4.50

4.53

pmol/l

0.43

677

4720

Other diseases of liver

590

3936

1.54

20.54

2.9

3.3

4.46

4.48

pmol/l

0.17

517

3508

Restless leg syndrome

420

2598

1.68

20.54

3.4

3.3

4.41

4.45

pmol/l

0.39

360

2295

Hypermobility syndrome

274

1517

1.92

20.48

2.8

3.3

4.56

4.57

pmol/l

0.03

251

1361

Candidiasis

494

3181

1.61

20.40

3.3

4.31

4.48

pmol/l

3.64

417

2833

Malignant melanoma, excluding all cancers (controls excluding all cancers)

472

2998

1.62

20.37

3.9

2.9

4.35

4.43

pmol/l

0.94

431

2600

Benign neoplasm of meninges

339

1988

1.77

20.34

3.0

2.9

4.26

4.46

pmol/l

2.99

304

1732

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

257

1388

1.93

20.29

2.3

3.4

4.58

4.70

pmol/l

0.91

217

1244

Dental caries 2

2990

19648

1.21

20.13

3.3

3.4

4.55

4.54

pmol/l

0.10

2642

17670

Anosmia

176

3.77

20.10

3.0

2.9

4.37

4.66

pmol/l

1.75

161

Pain associated with micturition

401

2466

1.68

20.02

3.4

3.2

4.47

4.48

pmol/l

0.08

348

2192

Use of pramipexole

677

4666

1.49

19.97

3.0

3.2

4.37

4.41

pmol/l

0.56

576

4082

Trochanteric bursitis

505

3286

1.59

19.90

2.9

3.3

4.37

4.44

pmol/l

0.95

442

2916

Coeliac disease

458

2917

1.62

19.84

3.5

3.2

4.41

4.52

pmol/l

1.62

411

2603

Autism spe, excluding more controls

326

3.02

19.82

2.7

3.8

5.27

4.97

pmol/l

0.86

301

Pulmonary embolism

822

5866

1.43

19.81

3.2

4.26

4.42

pmol/l

4.37

713

5146

Other specified/unspecified arthritis

908

6600

1.40

19.74

3.1

3.4

4.42

4.49

pmol/l

1.51

819

5892

Pulmonary heart disease

822

5874

1.43

19.66

3.2

4.26

4.41

pmol/l

4.20

713

5153

Other enthesopathies

1042

7746

1.37

19.65

3.0

3.5

4.48

4.49

pmol/l

0.10

937

6937

Misadventures to patients during surgical and medical care

465

2977

1.61

19.60

3.2

3.3

4.32

4.48

pmol/l

2.37

412

2648

Benign neoplasm: Cerebral meninges

309

1786

1.80

19.56

3.1

2.9

4.26

4.45

pmol/l

2.51

277

1551

Gonarthrosis,primary

2861

14977

1.21

19.50

3.1

3.3

4.42

4.43

pmol/l

0.11

2550

13260

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

130

551

2.48

19.43

4.9

3.1

4.26

4.46

pmol/l

0.96

120

468

Other and unspecified drugs and medicaments

301

1732

1.81

19.40

3.2

3.3

4.37

4.50

pmol/l

1.38

269

1537

Injuries to the knee and lower leg

4494

22221

1.17

19.37

3.2

3.4

4.49

4.52

pmol/l

0.88

4015

19853

Viral pneumonia

380

2323

1.68

19.28

3.2

3.3

4.37

4.54

pmol/l

1.24

340

2056

Abnormal findings on diagnostic imaging of other body structures

432

2732

1.64

19.28

3.2

4.39

4.44

pmol/l

0.50

388

2423

Other diseases of the digestive system

823

5906

1.42

19.14

3.2

4.31

4.43

pmol/l

1.94

713

5184

L01XE Protein kinase inhibitors

194

975

2.10

19.12

4.0

3.3

4.25

4.41

pmol/l

1.40

176

854

Sleep disorders, other/unspecified

153

706

2.32

19.07

3.5

3.3

4.49

4.64

pmol/l

1.15

132

629

Transient ischemic attack

1451

9359

1.30

19.03

3.1

3.3

4.29

4.40

pmol/l

3.99

1281

8222

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

474

3064

1.59

19.00

4.8

3.0

4.33

4.42

pmol/l

1.14

439

2657

Major coronary heart disease event excluding revascularizations

1769

9704

1.27

19.00

3.2

3.3

4.26

4.42

pmol/l

8.31

1558

8533

Erysipelas

1570

11276

1.29

18.98

3.2

3.3

4.25

4.49

pmol/l

16.77

1377

9964

Mental and behavioural disorders due to sedatives or hypnotics

250

1370

1.91

18.95

2.4

3.3

4.35

4.60

pmol/l

2.81

205

1234

Contraceptive management

1569

8662

1.29

18.93

3.4

4.53

4.55

pmol/l

0.26

1430

7799

Gonarthrosis [arthrosis of knee](FG)

2547

12363

1.22

18.93

3.1

3.4

4.45

4.47

pmol/l

0.26

2276

11033

Pure hyperglyceridaemia

280

3.14

18.91

2.6

3.2

4.21

4.50

pmol/l

1.66

246

Special screening examination for other diseases and disorders

273

1532

1.84

18.87

3.3

3.5

4.51

4.57

pmol/l

0.38

245

1372

Unspecified/other endometriosis

432

2757

1.63

18.77

2.9

3.4

4.56

4.60

pmol/l

0.38

397

2469

Contact with and exposure to communicable diseases

1273

9771

1.32

18.76

3.6

3.4

4.61

4.62

pmol/l

0.13

1171

8831

Noninfective enteritis and colitis

1575

12440

1.28

18.71

3.4

3.3

4.45

4.52

pmol/l

2.20

1407

11091

Malignant neoplasm of urinary organs

254

1399

1.87

18.70

4.5

3.1

4.21

4.39

pmol/l

1.45

227

1211

GI-bleeding

814

5854

1.41

18.68

3.2

4.30

4.42

pmol/l

2.17

714

5132

Radiculopathy

504

3316

1.56

18.65

3.1

3.4

4.39

4.42

pmol/l

0.25

456

2932

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1391

10832

1.30

18.59

3.1

3.4

4.57

4.59

pmol/l

0.37

1240

9769

Other and unspecified disorders of vitreous body

1257

9627

1.32

18.56

3.3

4.36

4.39

pmol/l

0.65

1094

8486

Other benign neoplasms of skin

1103

8174

1.35

18.54

3.3

3.0

4.38

4.44

pmol/l

1.66

975

7153

Diseases of liver

1021

7633

1.36

18.52

3.0

3.4

4.37

4.46

pmol/l

2.31

891

6777

Polyarthrosis

631

4173

1.48

18.43

3.2

3.4

4.34

4.42

pmol/l

0.72

563

3666

Other problems related to primary support group, including family circumstances

477

3040

1.58

18.42

3.7

3.3

4.64

4.62

pmol/l

0.10

425

2737

Need for other prophylactic measures

197

1009

2.05

18.40

3.3

3.2

4.49

4.55

pmol/l

0.41

178

886

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

394

2460

1.64

18.36

4.0

3.0

4.37

4.44

pmol/l

0.73

366

2132

DVT of lower extremities and pulmonary embolism

1189

9064

1.33

18.29

3.2

3.3

4.29

4.42

pmol/l

4.13

1041

7963

Gonarthrosis

2161

10086

1.24

18.27

3.1

3.5

4.47

pmol/l

0.05

1929

9011

Acute and transient psychotic disorders

423

2696

1.62

18.25

2.5

3.4

4.33

4.53

pmol/l

3.77

352

2435

Other and unspecified nerve root and plexus disorders, also in other diseases

610

4196

1.49

18.24

2.8

3.4

4.49

4.50

pmol/l

0.05

544

3756

Other symptoms and signs involving the urinary system

286

1645

1.79

18.22

3.3

4.34

4.47

pmol/l

1.68

264

1452

Other abnormal uterine and vaginal bleeding

914

4778

1.40

18.22

3.1

3.3

4.46

4.47

pmol/l

0.08

785

4195

Benign paroxysmal vertigo

926

6847

1.38

18.22

3.2

3.3

4.33

4.43

pmol/l

2.42

813

6031

Viral and other specified intestinal infections

745

5184

1.43

18.19

3.1

3.3

4.65

4.70

pmol/l

0.58

672

4646

Other symptoms and signs involving the circulatory and respiratory systems

209

1094

1.99

18.13

3.1

3.3

4.46

4.50

pmol/l

0.25

181

980

Malignant neoplasm of kidney, except renal pelvis

238

1298

1.90

18.13

4.5

3.1

4.24

4.39

pmol/l

1.00

213

1124

Glucagon-like peptide-1 (GLP-1) analogues

1553

10093

1.28

18.08

3.1

3.3

4.28

4.41

pmol/l

5.51

1345

8902

Primary_lymphoid and hematopoietic malignant neoplasms

640

4448

1.47

17.97

3.2

4.31

4.42

pmol/l

2.35

572

3905

Thoracic aortic aneurysm

317

1881

1.73

17.97

3.3

3.4

4.24

4.42

pmol/l

2.58

284

1662

Other diseases of jaws

248

1379

1.87

17.93

3.3

3.4

4.37

4.49

pmol/l

1.13

212

1222

Recurring oral aphthae, including avohilmo

463

3026

1.58

17.90

2.9

3.2

4.47

4.50

pmol/l

0.24

409

2670

Immunodeficiencies

191

982

2.06

17.78

3.7

3.3

4.30

4.56

pmol/l

2.84

175

867

TMD muscular pain linked with fibromyalgia

211

3.66

17.75

2.5

3.4

4.35

4.65

pmol/l

1.85

186

Oxicams

743

2975

1.44

17.63

3.1

3.6

4.42

pmol/l

0.00

670

2657

Cluster headache, wide

156

748

2.21

17.53

2.4

3.3

4.43

4.59

pmol/l

1.43

138

672

Erectile dysfunction

171

842

2.09

17.50

5.5

3.5

4.41

4.37

pmol/l

0.23

153

735

Other (not insulin) diabetes medications

3433

17667

1.18

17.47

3.1

3.4

4.40

4.49

pmol/l

5.33

2972

15796

Other disorders of glucose regulation and pancreatic internal secretion

276

1598

1.79

17.33

2.7

3.3

4.26

4.53

pmol/l

3.98

245

1416

Myocardial infarction, without ST-elevation

905

6179

1.37

17.21

3.1

3.2

4.19

4.36

pmol/l

5.37

798

5373

Astigmatism

222

1209

1.92

17.18

3.6

3.2

4.66

4.64

pmol/l

0.12

202

1082

Nonalcoholic fatty liver disease

323

1960

1.71

17.16

2.7

3.4

4.53

4.51

pmol/l

0.11

286

1759

Gestational diabetes (for exclusion)

1766

10096

1.26

17.12

3.5

3.4

4.61

4.56

pmol/l

1.28

1615

9156

Other cataract

1241

7428

1.31

17.07

3.1

3.3

4.28

4.42

pmol/l

5.05

1100

6576

Faecal incontinence

316

1911

1.72

17.01

3.0

3.2

4.50

4.43

pmol/l

0.40

266

1684

Melanocytic naevi

1019

7723

1.35

17.01

3.4

3.3

4.48

4.51

pmol/l

0.31

936

6886

Invasive ventilation

219

1191

1.91

16.97

2.7

3.3

4.20

4.50

pmol/l

3.63

191

1052

Other mental disorders due to brain damage and dysfunction and to physical disease

301

1795

1.73

16.88

2.8

3.2

4.26

4.41

pmol/l

1.92

255

1553

Pruritus

398

2553

1.61

16.83

3.1

3.3

4.31

4.48

pmol/l

2.75

343

2260

Disorders of lens

2078

10735

1.23

16.83

3.0

3.3

4.30

4.45

pmol/l

7.98

1827

9558

Haemorrhoids and perianal venous thrombosis

849

6258

1.38

16.82

3.2

3.4

4.39

4.43

pmol/l

0.34

738

5532

Other and unspecified tonsillitis

1210

7943

1.31

16.81

3.4

3.5

4.73

4.65

pmol/l

1.34

1113

7172

Benign neoplasm: Stomach

313

1895

1.71

16.75

3.6

3.2

4.39

4.40

pmol/l

0.09

268

1662

Injuries to the thorax

1260

9826

1.30

16.73

3.2

3.3

4.42

4.47

pmol/l

1.05

1097

8710

Disorders of psychological development

407

2424

1.60

16.70

2.8

3.3

4.95

4.78

pmol/l

1.07

362

2188

Oral lichen ruber planus, hypothyreosis or thyroxin

316

2.97

16.70

2.9

3.3

4.04

4.51

pmol/l

5.62

275

Seborrhoeic dermatitis

293

1742

1.74

16.70

2.9

3.4

4.35

4.49

pmol/l

1.68

257

1536

Secondary right heart disease

126

564

2.35

16.69

3.5

3.2

3.99

4.39

pmol/l

5.20

113

482

Aortic aneurysm

472

3075

1.53

16.64

3.3

4.18

4.37

pmol/l

3.77

427

2700

Hypoglycaemia, other or unspecified

221

1214

1.89

16.61

2.6

3.3

4.25

4.55

pmol/l

3.96

197

1077

Endocarditis

374

2.66

16.60

3.1

3.5

4.06

4.63

pmol/l

3.23

328

Benign neoplasm: Rectum

451

2973

1.55

16.60

3.1

3.0

4.32

4.43

pmol/l

1.59

399

2584

Benign neoplasm of meninges

339

2110

1.67

16.32

3.0

3.2

4.26

4.42

pmol/l

2.12

304

1854

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

206

1111

1.92

16.30

3.7

3.0

4.24

4.43

pmol/l

1.87

192

949

Other disorders of ear

3122

17747

1.18

16.28

3.1

3.3

4.45

4.48

pmol/l

0.55

2711

15860

Symptoms and signs involving emotional state

131

606

2.31

16.28

3.5

3.3

4.47

4.63

pmol/l

0.97

114

546

Arthropathies in other diseases classified elsewhere

133

617

2.28

16.28

3.3

3.5

4.15

4.49

pmol/l

4.01

119

548

Schizophrenia

523

3572

1.50

16.26

2.0

3.5

4.36

4.54

pmol/l

3.35

427

3212

Impingement syndrome of shoulder

754

5493

1.40

16.26

3.2

3.5

4.47

4.46

pmol/l

0.09

680

4912

Other or ill-defined heart diseases

149

718

2.15

16.26

3.6

3.5

4.28

4.69

pmol/l

4.71

131

640

Other arthritis (FG)

1020

7779

1.33

16.21

3.1

3.4

4.42

4.49

pmol/l

1.14

914

6943

Cluster headache, strict

146

706

2.19

16.11

2.5

3.3

4.44

4.59

pmol/l

1.26

132

636

Polyp of the female genital tract

1317

5996

1.30

16.11

3.5

3.4

4.47

4.50

pmol/l

0.22

1170

5312

Enterocolitis due to Clostridium difficile

305

1850

1.70

16.07

3.3

3.2

4.13

4.43

pmol/l

5.94

274

1616

Brachial plexus disorders

373

2386

1.62

16.06

2.9

3.5

4.52

4.54

pmol/l

0.14

345

2146

Other inflammation of eyelid

423

2777

1.57

16.06

3.3

3.2

4.42

4.49

pmol/l

0.88

367

2462

Other diseases of blood and blood-forming organs

214

1179

1.89

15.99

3.0

3.4

4.44

4.45

pmol/l

0.09

175

1040

L04AA Selective immunosuppressants

734

5348

1.40

15.97

3.2

3.3

4.27

4.51

pmol/l

5.74

668

4764

Other noninflammatory disorders of vulva and perineum

377

2421

1.61

15.97

3.1

3.4

4.41

4.54

pmol/l

1.73

339

2144

Lactose intolerance

125

571

2.32

15.94

3.4

3.0

4.58

4.57

pmol/l

0.06

104

504

Immunodeficiency with predominantly antibody defects

114

504

2.43

15.86

3.3

4.20

4.66

pmol/l

4.56

106

443

Diseases of male genital organs

1103

4236

1.33

15.84

3.2

3.5

4.61

4.62

pmol/l

0.02

973

3822

Unspecified kidney failure

231

1301

1.82

15.82

2.9

3.2

3.75

4.44

pmol/l

17.15

201

1133

Postmenopausal osteoporosis with pathological fracture

201

1093

1.93

15.81

2.9

4.21

4.34

pmol/l

1.12

155

929

Noninfectious colitis NAS

451

3011

1.54

15.80

3.4

3.2

4.38

4.51

pmol/l

1.87

395

2673

Vitamin D deficiency

329

2.82

15.80

3.3

4.40

4.58

pmol/l

0.66

296

Acute pharyngitis

499

3373

1.50

15.77

3.6

3.4

4.77

4.65

pmol/l

1.30

445

3055

Collagenous colitis

302

1844

1.70

15.71

3.8

3.2

4.27

4.47

pmol/l

3.32

265

1636

All influenza (not pneumonia)

444

2952

1.54

15.70

2.9

3.4

4.45

4.57

pmol/l

0.93

405

2630

Neuralgia and neuritis, unspecified

192

1032

1.95

15.63

2.8

3.3

4.38

4.49

pmol/l

0.78

170

936

Cramp and spasm

170

878

2.04

15.63

3.2

3.4

4.45

4.56

pmol/l

0.68

154

781

Benign neoplasm: Rectum, anus and anal canal

505

3450

1.49

15.62

3.0

4.35

4.42

pmol/l

0.87

445

2999

Dental caries 2, only avohilmo

2894

19482

1.18

15.52

3.3

3.4

4.56

4.55

pmol/l

0.28

2552

17529

Later onset COPD, excluding more controls

465

2419

1.53

15.47

3.1

4.20

4.38

pmol/l

2.71

399

2073

Delirium, not induced by alcohol and other psychoactive substances

262

1538

1.74

15.45

2.6

3.2

4.15

4.41

pmol/l

3.32

219

1331

Oligomenorrhoea

174

913

2.02

15.43

2.6

3.3

4.39

4.56

pmol/l

1.50

157

810

Female genital prolapse

1184

5304

1.31

15.41

3.4

3.3

4.47

pmol/l

0.01

1065

4691

Agoraphobia

142

693

2.17

15.37

3.3

3.5

4.50

4.66

pmol/l

0.66

126

626

Oter anti-inflammatory and antirheumatic agents, non-steroids

650

2543

1.44

15.28

3.2

3.6

4.42

4.37

pmol/l

0.46

568

2274

Short stature, not elsewhere classified

389

2.56

15.26

2.6

3.5

4.91

5.01

pmol/l

0.34

349

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

333

2090

1.63

15.25

2.6

2.9

4.24

4.42

pmol/l

3.24

297

1796

Disorders of sclera, cornea, iris and ciliary body

1787

14673

1.23

15.20

3.2

3.3

4.46

4.50

pmol/l

0.86

1584

13064

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

235

1351

1.80

15.18

2.7

3.2

4.20

4.42

pmol/l

2.56

201

1181

Female infertility

1372

6727

1.28

15.11

3.3

3.5

4.45

4.57

pmol/l

4.79

1248

6030

Benign neoplasm: Cerebral meninges

309

1918

1.67

15.10

3.1

3.2

4.26

4.42

pmol/l

2.07

277

1679

Other diseases of intestine

340

2152

1.62

15.09

3.6

3.3

4.42

4.47

pmol/l

0.30

288

1887

Abnormalities of gait and mobility

311

1927

1.66

15.09

2.9

3.2

4.30

4.45

pmol/l

1.59

274

1684

Other diseases of pleura

1101

7568

1.30

15.03

3.5

3.2

4.20

4.41

pmol/l

10.10

962

6668

Non-follicular lymphoma, hilmo, excluding all cancers

234

1345

1.79

15.03

2.6

3.0

4.22

4.47

pmol/l

3.89

211

1155

Disorders resulting from impaired renal tubular function

117

533

2.32

15.00

2.3

3.5

3.81

4.55

pmol/l

9.77

103

473

Mental and behavioural disorders due to opioids

147

732

2.11

14.99

2.4

3.4

4.38

4.69

pmol/l

2.20

121

665

Other pulmonary heart/vessel disease

133

637

2.18

14.91

3.7

3.3

4.00

4.39

pmol/l

4.84

118

549

Maternal care for other known or suspected fetal problems

1156

5787

1.31

14.91

3.4

3.5

4.58

4.57

pmol/l

0.06

1040

5242

Testicular dysfunction

407

2.49

14.87

3.2

3.6

4.76

4.68

pmol/l

0.42

374

Leiomyoma of uterus

2023

9441

1.23

14.75

3.5

3.1

4.47

pmol/l

0.10

1823

8373

Anorexia (incl.atypical)

268

1617

1.73

14.73

2.5

3.3

4.23

4.61

pmol/l

7.83

232

1450

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

300

1859

1.67

14.69

3.2

3.3

4.34

4.47

pmol/l

1.48

270

1647

Other disorders of veins

1335

10669

1.27

14.66

3.1

3.3

4.41

4.44

pmol/l

0.40

1156

9469

Other viral diseases

1015

7827

1.31

14.66

3.1

3.4

4.56

4.59

pmol/l

0.36

902

7053

Diseases of arteries, arterioles and capillaries

1826

11205

1.23

14.62

3.1

3.3

4.22

4.43

pmol/l

16.35

1607

9873

Cellulitis

628

4523

1.42

14.59

2.9

3.3

4.37

4.51

pmol/l

2.52

562

4005

Other respiratory disorders and diseases

484

3324

1.48

14.54

3.1

3.2

4.22

4.39

pmol/l

3.06

423

2898

Other diseases of the respiratory system

484

3324

1.48

14.54

3.1

3.2

4.22

4.39

pmol/l

3.06

423

2898

Appendectomy

2400

19582

1.19

14.50

3.4

4.48

4.52

pmol/l

1.37

2175

17521

Visual field defects

255

1520

1.73

14.50

3.3

3.2

4.28

4.44

pmol/l

1.37

232

1338

SLE (Finngen)

125

593

2.22

14.49

2.7

3.2

4.15

4.55

pmol/l

4.82

111

529

Heterophoria

301

1877

1.66

14.48

3.9

3.2

4.61

4.58

pmol/l

0.18

270

1663

Congenital malformations of the circulatory system

457

3017

1.50

14.43

3.9

3.4

4.65

4.60

pmol/l

0.34

413

2728

Other disorders starting during childhood or adolecense, excluding more controls

157

778

2.02

14.38

2.7

3.8

4.99

4.92

pmol/l

0.18

144

720

Postprocedural disorders of nervous system

310

1956

1.65

14.30

3.2

3.4

4.50

4.56

pmol/l

0.56

279

1760

Injuries to the neck

755

5624

1.37

14.27

3.7

3.3

4.49

4.55

pmol/l

0.80

686

5035

Enthesopathies of lower limb, excluding foot

731

5420

1.37

14.23

3.2

3.4

4.48

4.49

pmol/l

0.13

645

4850

Artrosis, including avohilmo

3007

14157

1.17

14.23

3.2

3.5

4.48

pmol/l

0.08

2665

12708

COPD-related respiratory insufficiency

265

1599

1.70

14.21

2.8

3.3

4.10

4.38

pmol/l

4.58

233

1368

Senile cataract

1820

9282

1.23

14.21

3.0

3.3

4.28

4.43

pmol/l

8.04

1596

8245

Other coagulation defects

266

1618

1.71

14.16

3.2

3.3

4.32

4.52

pmol/l

2.76

237

1445

Benign neoplasm: Sigmoid colon

452

3084

1.50

14.14

3.1

3.0

4.34

4.42

pmol/l

1.00

405

2682

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

396

2635

1.54

14.13

3.1

4.47

4.51

pmol/l

0.43

352

2338

Correction of physiology of bite - very demanding therapy visit

133

657

2.17

14.12

3.1

3.3

4.48

4.57

pmol/l

0.40

110

588

Flat foot [pes planus] (acquired)

330

2114

1.61

14.11

3.4

4.42

4.51

pmol/l

0.88

290

1888

Failure and rejection of transplanted organs and tissues

189

3.30

14.07

2.4

3.5

4.14

4.67

pmol/l

2.58

168

Coxarthrosis

1439

7850

1.26

14.06

3.0

3.4

4.35

4.44

pmol/l

2.85

1267

6967

Unstable angina pectoris

913

5774

1.33

14.04

3.1

3.2

4.26

4.38

pmol/l

3.22

796

5027

Pleural effusion

355

2305

1.57

14.03

3.9

3.2

4.18

4.39

pmol/l

3.68

296

2007

Clear cell adenocarcinoma of kidney

130

634

2.15

13.97

4.9

3.3

4.26

4.39

pmol/l

0.54

120

557

Pregnancy examination and test

778

3622

1.38

13.89

3.4

3.5

4.63

4.58

pmol/l

0.73

719

3252

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

242

1444

1.74

13.83

2.8

3.3

4.47

4.58

pmol/l

0.89

221

1286

Hypersomnia

276

2.87

13.77

4.3

3.7

4.26

4.63

pmol/l

2.44

249

Injuries to the abdomen, lower back, lumbar spine and pelvis

1163

9150

1.28

13.76

3.1

3.3

4.35

4.49

pmol/l

4.35

1016

8086

Spondylolisthesis/Spondylolysis

576

4136

1.42

13.73

3.1

3.4

4.43

4.45

pmol/l

0.13

507

3690

Propionic acid derivatives

991

3812

1.32

13.68

3.3

3.5

4.58

4.52

pmol/l

0.88

875

3428

Left ventricular outflow tract obstruction (LVOTO), broad definition

294

1844

1.64

13.67

3.6

3.4

4.42

4.55

pmol/l

1.04

262

1662

Coagulation defects, purpura and other haemorrhagic conditions

596

4311

1.41

13.61

3.3

4.35

4.51

pmol/l

3.20

533

3828

Congenital malformations and deformations of the musculoskeletal system

325

2083

1.60

13.58

3.2

3.3

4.75

4.66

pmol/l

0.64

289

1873

Ganglion

761

5722

1.36

13.56

3.0

3.4

4.51

pmol/l

0.06

678

5135

Aortic valve malfunction, age under 60 years

273

1689

1.67

13.46

3.6

3.4

4.41

4.53

pmol/l

0.90

245

1516

Melanocytic naevi of trunk

368

2440

1.55

13.42

3.8

3.1

4.37

4.54

pmol/l

2.66

347

2171

Major coronary heart disease event

1915

10631

1.21

13.41

3.1

3.3

4.29

4.43

pmol/l

5.61

1694

9356

Myocardial infarction, strict

1166

6730

1.28

13.33

3.1

3.3

4.24

4.44

pmol/l

8.09

1030

5908

Use of cabergoline

252

2.93

13.32

2.5

3.7

4.49

4.62

pmol/l

0.53

221

Primary gonarthrosis, bilateral

1437

10224

1.24

13.26

3.1

3.3

4.40

4.39

pmol/l

0.30

1271

8995

Persistent delusional disorders

239

1436

1.72

13.25

2.3

3.4

4.36

4.49

pmol/l

1.22

199

1275

Cluster headache, wide,, including avohilmo

199

1143

1.82

13.16

2.7

3.3

4.46

4.55

pmol/l

0.76

179

1024

Other neurotic disorders

160

857

1.94

13.16

2.8

3.3

4.39

4.50

pmol/l

0.81

141

759

Excessive vomiting in pregnancy

373

2503

1.55

13.14

2.8

3.4

4.48

4.53

pmol/l

0.41

340

2236

Trigeminal neuralgia

208

1212

1.79

13.02

3.0

3.4

4.42

4.49

pmol/l

0.41

192

1073

Persons encountering health services in circumstances related to reproduction

1979

11236

1.21

13.02

3.3

3.4

4.61

4.58

pmol/l

0.72

1825

10065

Malignant melanoma

393

2657

1.51

12.99

3.9

3.2

4.34

4.40

pmol/l

0.59

356

2337

Vitamin B12 deficiency anaemia

285

1795

1.63

12.97

3.1

3.2

4.10

4.42

pmol/l

6.22

249

1554

Other and unspecified visual disturbances

308

1983

1.60

12.94

3.5

3.3

4.44

4.46

pmol/l

0.15

284

1764

Unspecified fall

1475

11983

1.23

12.92

3.0

3.3

4.40

4.50

pmol/l

3.70

1259

10632

Other noninflammatory disorders of vagina

309

1996

1.60

12.88

3.5

3.3

4.47

4.51

pmol/l

0.26

270

1757

Zoster [herpes zoster]

500

3543

1.44

12.88

3.3

3.2

4.25

4.44

pmol/l

4.31

443

3109

Postmenopausal atrophic vaginitis

922

4279

1.32

12.83

3.0

3.3

4.38

4.45

pmol/l

1.42

817

3766

Superficial injury of lower leg

814

6230

1.33

12.80

2.7

3.3

4.48

4.53

pmol/l

0.47

724

5562

Trigger finger

465

3262

1.46

12.74

2.9

3.5

4.38

4.47

pmol/l

1.42

418

2929

Salpingitis and oophoritis

712

5367

1.36

12.71

3.3

4.40

4.45

pmol/l

0.81

615

4795

Diabetic retinopathy, strict definition

521

3271

1.43

12.66

2.9

3.2

4.27

4.42

pmol/l

2.29

449

2884

Testicular hypofunction

350

2.48

12.65

3.2

3.7

4.77

4.69

pmol/l

0.39

322

Other disorders of the musculoskeletal system and connective tissue

431

2986

1.48

12.63

3.1

3.3

4.47

4.45

pmol/l

0.15

385

2650

Bacterial pneumonia, not elsewhere classified

1101

7737

1.27

12.60

2.9

3.3

4.31

4.48

pmol/l

6.28

976

6836

Bacterial pneumoniae

1161

8212

1.27

12.59

3.0

3.3

4.32

4.49

pmol/l

5.95

1032

7263

Benign neoplasm of mouth and pharynx

308

1994

1.59

12.53

3.5

3.0

4.42

4.50

pmol/l

0.72

269

1738

Adhesive capsulitis of shoulder

519

3721

1.42

12.52

3.8

3.4

4.43

4.46

pmol/l

0.23

475

3322

Polycystic ovarian syndrome

264

1661

1.66

12.51

3.4

4.63

4.60

pmol/l

0.19

238

1497

Fracture of foot, except ankle

789

6033

1.33

12.51

3.3

3.4

4.48

4.54

pmol/l

0.77

694

5414

Vertical strabismus

128

650

2.08

12.50

4.8

3.3

4.47

4.58

pmol/l

0.48

116

573

Rash and other nonspecific skin eruption

326

2143

1.57

12.47

2.9

3.2

4.43

4.47

pmol/l

0.30

292

1907

Keratitis

1112

8876

1.27

12.47

3.3

4.49

4.50

pmol/l

0.12

979

7900

Dislocation, sprain and strain of joints and ligaments at neck level

540

3907

1.41

12.45

3.7

3.4

4.52

4.55

pmol/l

0.26

494

3508

Anaemia in chronic diseases classified elsewhere

294

2.62

12.39

3.4

3.2

3.79

4.51

pmol/l

6.26

258

Mental and behavioural disorders due to cannabinoids

113

549

2.16

12.37

2.1

3.6

4.55

4.84

pmol/l

1.60

502

Glomerular diseases

484

3434

1.44

12.36

2.9

3.3

4.08

4.49

pmol/l

11.40

430

3048

Diseases of external ear

998

7875

1.29

12.34

3.0

3.3

4.47

4.48

pmol/l

0.12

852

7005

Sequelae of injuries, of poisoning and of other consequences of external causes

716

5411

1.35

12.32

3.0

3.3

4.47

4.51

pmol/l

0.65

634

4838

Other shoulder lesions

314

2053

1.57

12.30

3.1

3.5

4.43

4.50

pmol/l

0.76

286

1856

Cluster headache, strict, including avohilmo

189

1092

1.81

12.30

2.7

3.3

4.48

4.55

pmol/l

0.65

173

981

Congenital malformations of heart and great arteries

399

2650

1.49

12.27

3.9

3.4

4.63

4.62

pmol/l

0.09

359

2396

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

160

881

1.91

12.27

3.0

3.4

4.19

4.59

pmol/l

5.25

145

795

Fracture of rib(s), sternum and thoracic spine

742

5634

1.34

12.25

3.0

3.3

4.40

4.44

pmol/l

0.41

641

4976

Dermatographic urticaria

263

1659

1.65

12.22

3.6

3.3

4.44

4.54

pmol/l

0.76

240

1477

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

692

5226

1.36

12.22

3.6

3.4

4.50

4.53

pmol/l

0.40

607

4697

Benign lipomatous neoplasm

893

6962

1.30

12.21

3.1

3.3

4.43

4.44

pmol/l

0.08

797

6171

Ptosis of eyelid

298

1929

1.59

12.17

3.3

3.1

4.33

4.42

pmol/l

0.80

267

1692

Fentanyl

250

1548

1.65

12.16

2.8

3.2

4.15

4.43

pmol/l

3.91

220

1347

Papulosquamous disorders

1207

9752

1.25

12.15

3.1

3.3

4.47

4.46

pmol/l

0.07

1069

8645

Other symptoms and signs involving general sensations and perceptions

125

634

2.06

12.15

2.7

3.2

4.32

4.56

pmol/l

1.77

109

558

Gonarthrosis, primary, with knee surgery

1535

10350

1.22

12.14

3.2

3.3

4.35

4.38

pmol/l

0.40

1354

9092

Anti-inflammatory and antirheumatic products, non-steroids

976

3813

1.30

12.07

3.3

3.5

4.57

4.52

pmol/l

0.68

869

3429

Benign neoplasm: Rectum

451

3176

1.45

12.05

3.1

3.3

4.32

4.40

pmol/l

0.96

399

2772

Cerebral palsy and other paralytic syndromes

348

2334

1.53

12.04

2.9

3.3

4.39

4.51

pmol/l

1.54

314

2076

Other and unspecified coagulation defects

185

1071

1.81

11.98

3.2

3.4

4.34

4.55

pmol/l

2.47

165

951

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

506

3521

1.42

11.98

3.7

3.3

4.55

4.59

pmol/l

0.27

461

3170

Bulimia nervosa (incl. atypical)

175

1001

1.85

11.97

3.2

3.6

4.32

4.61

pmol/l

3.93

145

898

Conjunctivitis (acute, non atopic)

911

7116

1.30

11.96

3.1

3.4

4.51

4.55

pmol/l

0.48

829

6373

Malignant melanoma of skin

304

1984

1.57

11.95

4.0

3.3

4.35

4.41

pmol/l

0.50

280

1733

Parodontitis and operation codes

2814

19013

1.16

11.95

3.2

3.4

4.45

4.47

pmol/l

0.36

2427

17043

Glucosamine medication

1411

9235

1.23

11.94

3.0

3.3

4.33

4.36

pmol/l

0.58

1214

8059

Ventral hernia

685

5170

1.35

11.90

3.2

3.4

4.33

4.43

pmol/l

2.22

597

4566

Bursitis of shoulder

459

2.27

11.90

3.0

3.4

4.37

4.55

pmol/l

1.14

408

Endometriosis ASRM stages 1,2

773

5957

1.33

11.87

3.0

3.4

4.50

pmol/l

0.09

684

5360

Haemorrhage in early pregnancy

1193

9438

1.26

11.85

3.2

3.4

4.51

pmol/l

0.05

1060

8469

Coxarthrosis [arthrosis of hip](FG)

1542

9216

1.22

11.84

3.0

3.4

4.34

4.44

pmol/l

3.20

1361

8169

Superficial injury of head

674

5077

1.35

11.84

2.8

3.3

4.49

4.51

pmol/l

0.12

587

4483

Disorders of muscles

312

2054

1.56

11.81

2.8

3.5

4.41

4.49

pmol/l

0.97

272

1852

Benign neoplasm: Caecum

249

1557

1.64

11.78

3.0

2.9

4.36

4.42

pmol/l

0.32

221

1336

Abnormal serum enzyme levels

617

4523

1.36

11.78

3.1

3.5

4.45

4.42

pmol/l

0.30

554

4046

Plantar fascial fibromatosis

336

2252

1.54

11.76

3.0

3.5

4.52

4.49

pmol/l

0.15

296

2025

Dysplasia of cervi uteri

1019

6259

1.28

11.76

3.2

3.5

4.55

4.56

pmol/l

0.21

902

5622

Pollen allergy

709

5338

1.34

11.74

2.8

3.4

4.71

4.64

pmol/l

0.63

620

4840

Disorders of breast

2010

15861

1.19

11.70

3.1

3.3

4.46

4.48

pmol/l

0.34

1793

14134

Other disorders of conjunctiva

387

2667

1.48

11.67

3.3

3.2

4.40

4.44

pmol/l

0.34

325

2346

Wide developmental disorders

117

590

2.08

11.62

2.8

3.3

5.15

4.92

pmol/l

0.80

100

536

Female infertility, cervigal, vaginal, other or unspecified origin

1210

6554

1.26

11.59

3.4

3.5

4.45

4.57

pmol/l

3.85

1107

5885

Other disorders of bone

651

4901

1.35

11.58

3.2

3.3

4.55

4.53

pmol/l

0.16

563

4399

Other disorders of white blood cells

172

984

1.82

11.51

2.8

3.5

4.57

4.51

pmol/l

0.12

145

876

conjunctival haemorrhage

213

1292

1.70

11.47

3.3

4.43

4.44

pmol/l

0.02

176

1128

Intestinal malabsorption

157

877

1.87

11.44

3.3

3.4

4.32

4.58

pmol/l

2.46

138

781

Mixed hyperlipidaemia

108

530

2.12

11.43

2.8

3.2

4.29

4.41

pmol/l

0.64

463

Gastric ulcer

433

3053

1.44

11.42

3.2

3.3

4.22

4.41

pmol/l

3.69

381

2665

Other diseases of stomach and duodenum

187

1097

1.76

11.40

3.0

3.4

4.40

4.44

pmol/l

0.13

161

958

Lactose intolerance, other/unspecified

102

493

2.18

11.39

3.7

3.0

4.52

4.54

pmol/l

0.07

433

Parodontitis or operation codes

2989

19277

1.15

11.35

3.1

3.4

4.45

4.47

pmol/l

0.41

2584

17275

Fissure and fistula of anal and rectal regions

730

5599

1.32

11.31

3.4

4.44

4.49

pmol/l

0.57

628

4993

477

2.22

11.30

3.4

3.1

4.52

4.65

pmol/l

0.51

425

Stomatitis and related lesions

265

1702

1.60

11.27

2.8

3.4

4.61

4.54

pmol/l

0.41

238

1514

Cerebrovascular diseases

2080

12706

1.18

11.25

3.2

3.3

4.28

4.43

pmol/l

9.23

1839

11226

Other abnormal findings of blood chemistry

143

781

1.91

11.22

2.5

3.5

4.29

4.54

pmol/l

2.04

129

687

Haemangioma and lymphangioma, any site

280

1826

1.58

11.16

3.2

3.0

4.44

4.53

pmol/l

0.99

253

1616

Familial hypercholesterolemia

346

2350

1.50

11.14

3.2

3.0

4.32

4.39

pmol/l

0.64

298

2032

Other diseases of lip and oral mucosa

474

3418

1.41

11.12

3.2

3.4

4.44

4.47

pmol/l

0.26

413

3035

Hyperaldosteronism

425

2.26

11.11

3.2

4.25

4.51

pmol/l

1.81

378

Other specified/unspecified soft tissue disorders

166

950

1.81

11.11

3.2

4.37

4.47

pmol/l

0.73

142

839

Parodontitis

2982

19275

1.15

11.10

3.2

3.4

4.45

4.47

pmol/l

0.41

2578

17273

Secondary parkinsonism, excluding more controls

291

2.51

11.08

2.7

3.3

4.09

4.47

pmol/l

3.02

255

Other noninflammatory disorders of uterus, except cervix

782

4121

1.32

11.06

3.0

3.3

4.36

4.44

pmol/l

1.08

689

3602

COPD

1083

7182

1.26

11.03

3.1

3.3

4.25

4.40

pmol/l

4.34

939

6325

Chronic periodontitis, including avohilmo

2967

19254

1.15

11.02

3.2

3.4

4.45

4.47

pmol/l

0.43

2564

17256

Varicose veins

2022

13036

1.18

11.00

3.2

3.3

4.39

4.42

pmol/l

0.55

1807

11546

Peritonsillar abscess

688

5258

1.33

10.99

3.5

3.4

4.59

4.54

pmol/l

0.64

623

4730

Bacterial pneumonia (organism specified)

1223

9094

1.24

10.97

3.0

3.3

4.32

4.46

pmol/l

4.95

1085

8022

Other disorders of patella

623

4705

1.35

10.91

3.3

3.5

4.58

4.53

pmol/l

0.44

552

4243

Complications of internal orthopaedic prosthetic devices, implants and grafts

582

4346

1.36

10.91

2.7

3.2

4.36

4.40

pmol/l

0.44

503

3777

Cardiac murmurs and other cardiac sounds

297

1946

1.55

10.89

3.1

3.4

4.60

4.63

pmol/l

0.21

269

1764

Iron deficiency anaemia secondary to blood loss (chronic)

442

3162

1.43

10.86

3.5

3.2

4.26

4.45

pmol/l

3.44

378

2775

Sequelae of other external causes

167

964

1.80

10.85

2.8

3.4

4.39

4.52

pmol/l

0.97

149

851

Dystonia

196

1185

1.72

10.84

3.1

3.3

4.47

4.50

pmol/l

0.14

183

1050

Focal epilepsy

603

4531

1.35

10.82

2.7

3.3

4.30

4.51

pmol/l

4.93

540

4012

Unspecified acute lower respiratory infection

411

2905

1.44

10.80

3.4

3.3

4.48

4.51

pmol/l

0.26

369

2576

Respiratory insufficiency

173

1004

1.76

10.75

2.8

3.2

4.07

4.44

pmol/l

4.54

150

862

Bruxism

462

2.22

10.71

2.4

3.6

4.44

4.64

pmol/l

1.74

414

Benign neoplasm: Rectum, anus and anal canal

505

3703

1.39

10.68

3.0

3.3

4.35

4.40

pmol/l

0.46

445

3247

Autonomic disorders

361

2.35

10.67

4.8

3.2

4.58

pmol/l

0.01

312

Melanocytic naevi, other sites/unspecified

247

1583

1.61

10.67

3.9

3.1

4.53

4.55

pmol/l

0.10

229

1401

Acute laryngitis and tracheitis

412

2875

1.44

10.67

3.3

4.69

4.68

pmol/l

0.07

358

2591

Childhood asthma (age<16), excluding more controls

489

2815

1.40

10.66

2.8

3.4

4.80

4.70

pmol/l

1.22

442

2532

Preparatory care for dialysis

117

609

2.00

10.59

2.1

3.3

3.54

4.51

pmol/l

16.93

102

546

Hyperplasia of prostate

656

2813

1.34

10.59

3.3

3.5

4.45

4.43

pmol/l

0.18

585

2540

107

544

2.08

10.54

3.1

3.5

4.44

4.57

pmol/l

0.79

490

Mixed disorders of conduct and emotions, excluding more controls

394

2.26

10.54

2.6

3.5

4.72

4.95

pmol/l

1.36

360

Other and unspecified myopathies

214

1327

1.66

10.53

2.7

3.3

4.38

4.46

pmol/l

0.51

181

1158

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

119

624

1.98

10.49

3.4

2.8

4.10

4.47

pmol/l

3.48

109

526

Alcohol use disorder, ICD-based

1108

9011

1.24

10.48

2.5

3.4

4.46

4.52

pmol/l

0.96

922

8132

Other diseases of arteries and capillaries

255

1652

1.58

10.45

2.8

3.2

4.23

4.46

pmol/l

3.64

226

1457

Pregnancy hypertension

1809

13902

1.19

10.44

3.4

4.52

4.51

pmol/l

0.14

1656

12496

COPD related to multimorbidity

871

5791

1.28

10.44

3.1

3.3

4.24

4.36

pmol/l

2.77

760

5078

Infections with a predominantly sexual mode of transmission

1184

9711

1.24

10.44

3.3

3.4

4.51

4.57

pmol/l

1.01

1043

8779

Calcific aortic valvular stenosis, including rheumatic fever

613

4532

1.34

10.43

3.0

3.2

4.21

4.31

pmol/l

1.81

534

3891

Fibroblastic disorders

619

4694

1.34

10.42

3.0

3.4

4.42

4.43

pmol/l

0.08

547

4187

Ethmoidectomy

409

2915

1.44

10.39

3.4

4.50

pmol/l

0.02

362

2619

Disorders of adrenal gland, other and/or unspecified

4.17

10.36

5.4

3.2

4.84

4.40

pmol/l

1.47

Mental and behavioural disorders due to use of other stimulants, including caffeine

111

574

2.03

10.36

2.2

3.5

4.61

4.73

pmol/l

0.40

522

Hypertrophic disorders of skin

220

1386

1.65

10.35

3.8

3.3

4.53

4.55

pmol/l

0.09

198

1240

Autism

465

2.16

10.33

2.7

3.4

5.22

4.85

pmol/l

1.21

421

Other viral diseases, not elsewhere classified

590

4444

1.35

10.32

3.2

3.3

4.57

pmol/l

0.03

530

3988

Childhood asthma (age<16)

489

2835

1.39

10.26

2.8

3.5

4.80

4.70

pmol/l

1.22

442

2552

Right bundle-branch block

430

2.17

10.25

4.2

3.2

4.38

4.55

pmol/l

0.86

379

Other bursopathies

364

2545

1.46

10.22

3.3

3.4

4.53

4.48

pmol/l

0.25

324

2263

Ulcer of lower limb, not elsewhere classified

317

2157

1.50

10.21

2.8

3.2

3.96

4.42

pmol/l

12.19

266

1871

Calcific aortic valvular stenosis, diagnosis (helper)

609

4517

1.34

10.20

3.0

3.1

4.21

4.31

pmol/l

1.72

530

3879

Operations 2 for CAVS

609

4517

1.34

10.20

3.0

3.1

4.21

4.31

pmol/l

1.72

530

3879

Other disorders of skin and subcutaneous tissue, not elsewhere classified

403

2872

1.43

10.18

3.3

3.2

4.27

4.46

pmol/l

3.21

337

2548

FESS (DNB20)

397

2827

1.44

10.15

3.5

3.4

4.50

4.51

pmol/l

0.05

352

2542

Calcific aortic valvular stenosis

610

4530

1.33

10.14

3.0

3.1

4.21

4.31

pmol/l

1.82

531

3891

Calcific aortic valvular stenosis, operated

610

4530

1.33

10.14

3.0

3.1

4.21

4.31

pmol/l

1.82

531

3891

Abnormal blood-pressure reading, without diagnosis

143

806

1.84

10.11

3.3

4.44

4.53

pmol/l

0.51

125

720

Benign lipomatous neoplasm of other sites/unspecified

230

1466

1.61

10.11

3.1

2.9

4.31

4.46

pmol/l

1.71

210

1266

Hypertrophic scar

204

1270

1.67

10.10

3.9

3.3

4.53

4.55

pmol/l

0.11

185

1135

Medical abortion

2775

13231

1.15

10.07

3.3

4.51

4.49

pmol/l

0.31

2470

11777

Non-follicular lymphoma

234

1499

1.60

10.07

2.6

3.3

4.22

4.41

pmol/l

2.60

211

1299

Other chronic obstructive pulmonary disease

1029

6915

1.25

10.06

3.1

3.3

4.25

4.39

pmol/l

4.30

890

6082

Essential (haemorrhagic) thrombocythaemia

112

586

1.99

10.04

3.1

2.8

4.33

4.53

pmol/l

1.61

501

Haemangioma, any site

258

1696

1.57

9.98

3.3

2.9

4.46

4.53

pmol/l

0.60

233

1494

Sexual dysfunction

234

2.65

9.97

3.1

3.7

4.61

4.74

pmol/l

0.33

212

Degeneration of macula and posterior pole

1128

7605

1.24

9.92

3.2

4.29

4.35

pmol/l

1.09

965

6618

Small fibre neuropathy

405

2.21

9.91

3.1

3.5

4.29

4.47

pmol/l

0.94

355

Glomerular disorders in diseases classified elsewhere

293

1977

1.51

9.91

2.6

3.4

3.93

4.48

pmol/l

11.07

252

1750

Nail disorders

258

1699

1.56

9.90

3.6

3.3

4.38

4.53

pmol/l

1.37

228

1514

Artificial joint operation, meniscal resection

2820

16506

1.14

9.90

3.2

3.3

4.42

4.45

pmol/l

1.08

2514

14627

Inflammatory diseases of prostate (prostatitis)

230

1469

1.59

9.88

3.5

3.6

4.60

4.44

pmol/l

1.31

198

1308

Endometriosis of ovary

668

5159

1.32

9.88

3.3

3.4

4.44

4.52

pmol/l

1.44

605

4582

Hodgkin lymphoma

445

2.14

9.88

3.6

3.1

4.33

4.64

pmol/l

2.40

387

Benign neoplasm: Ascending colon

299

2027

1.51

9.86

3.3

2.9

4.34

4.42

pmol/l

0.73

249

1740

Dental pulpitis 3

481

2538

1.39

9.86

3.4

3.3

4.92

4.87

pmol/l

0.34

434

2304

Unknown and unspecified causes of morbidity

221

1405

1.61

9.85

3.6

3.3

4.47

4.53

pmol/l

0.29

209

1260

Unspecified privation

317

2178

1.49

9.84

2.8

3.3

4.33

4.48

pmol/l

1.84

266

1941

Benign neoplasm of eye and adnexa

271

1804

1.54

9.84

3.3

3.0

4.38

4.49

pmol/l

1.15

242

1574

Hypertension, Pulmonary Arterial

129

3.31

9.78

4.3

3.1

4.06

4.58

pmol/l

2.55

115

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1480

8477

1.20

9.75

3.2

3.0

4.36

4.42

pmol/l

1.23

1289

7411

Hallux valgus (acquired)

1156

6867

1.23

9.74

2.8

3.4

4.39

4.45

pmol/l

1.02

992

6088

Personal history of other diseases and conditions

429

3108

1.41

9.73

3.7

3.3

4.64

4.61

pmol/l

0.16

385

2790

Myeloproliferative diseases

229

1474

1.60

9.72

2.8

3.2

4.39

4.42

pmol/l

0.16

187

1280

Unspecified misadventure during surgical and medical care

164

974

1.75

9.70

3.2

3.4

4.25

4.50

pmol/l

2.65

152

858

ILD, hospital admission 2, with pulmonary infections

207

1299

1.63

9.68

2.8

3.1

4.22

4.45

pmol/l

2.68

176

1126

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1966

9947

1.18

9.67

3.3

3.4

4.56

4.53

pmol/l

0.59

1789

8969

Autism spe

457

2.12

9.65

2.7

3.4

5.27

4.89

pmol/l

1.18

413

Benign neoplasm: Sigmoid colon

452

3313

1.39

9.64

3.1

3.3

4.34

4.41

pmol/l

0.77

405

2895

Benign neoplasm of major salivary glands

250

1642

1.56

9.64

3.6

3.0

4.28

4.48

pmol/l

3.21

228

1433

Haemorrhage, not elsewhere classified

489

2.06

9.62

3.4

3.1

4.05

4.59

pmol/l

5.00

429

Gastroduodenal ulcer

608

4638

1.32

9.62

3.2

3.3

4.26

4.41

pmol/l

2.55

537

4075

977

7446

1.25

9.58

2.8

3.3

4.28

4.34

pmol/l

1.18

816

6470

Other and unspecified local infections of skin and subcutaneous tissue

276

1857

1.52

9.55

3.3

4.36

4.52

pmol/l

2.03

253

1644

Blepharochalasis

813

6471

1.27

9.52

2.9

3.2

4.36

4.39

pmol/l

0.37

714

5669

Other benign neoplasms of skin

1103

9070

1.23

9.51

3.3

3.2

4.38

4.42

pmol/l

0.95

975

8008

Ehlers-Danlos syndrome

243

2.65

9.49

4.9

3.9

4.80

4.66

pmol/l

0.23

219

Other congenital malformations

302

2073

1.50

9.48

3.4

3.3

4.69

4.59

pmol/l

0.47

281

1860

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

109

576

1.96

9.45

2.8

3.1

4.29

4.49

pmol/l

1.42

490

Diffuse large B-cell lymphoma, helper endpoint

109

576

1.96

9.45

2.8

3.1

4.29

4.49

pmol/l

1.42

490

Agranulocytosis

332

2322

1.47

9.43

3.6

3.3

4.47

4.45

pmol/l

0.07

288

2057

Acute appendicitis, no complications

1926

16584

1.17

9.43

3.4

4.52

4.53

pmol/l

0.22

1767

14882

Other follicular disorders

235

1535

1.58

9.42

3.2

3.3

4.36

4.55

pmol/l

2.15

204

1378

Atopic conjunctivitis

163

976

1.74

9.41

3.3

3.2

4.58

4.57

pmol/l

0.04

144

865

Postpartum care and examination

659

3249

1.32

9.38

4.1

3.5

4.60

4.59

pmol/l

0.19

601

2903

Eosinophilic disease (BM)

229

2.60

9.36

2.6

3.5

4.61

pmol/l

0.01

202

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1977

14976

1.17

9.36

3.4

3.3

4.53

4.50

pmol/l

0.53

1817

13420

Transport accidents

1575

11858

1.19

9.35

3.5

3.4

4.57

4.56

pmol/l

0.16

1411

10671

Drug-induced osteoporosis with pathological fracture

236

2.59

9.35

2.3

3.0

4.02

4.44

pmol/l

1.92

204

Extreme obesity with alveolar hypoventilation

127

711

1.86

9.28

3.0

3.4

4.32

4.48

pmol/l

0.83

107

628

Other local infections of skin and subcutaneous tissue

289

1975

1.50

9.25

3.3

4.37

4.51

pmol/l

1.68

265

1753

Dermatophytosis

338

2378

1.45

9.23

3.2

3.3

4.35

4.47

pmol/l

1.22

288

2098

Supervision of high-risk pregnancy

931

4544

1.26

9.15

3.6

3.5

4.62

4.55

pmol/l

1.00

844

4097

Focal epilepsy, strict definition

535

4055

1.34

9.14

2.8

3.3

4.29

4.51

pmol/l

4.81

479

3593

Benign neoplasm: Parotid gland

205

1305

1.61

9.14

3.7

3.1

4.32

4.48

pmol/l

1.88

186

1132

Nasal polyp

481

3589

1.36

9.13

3.2

3.3

4.52

4.44

pmol/l

0.56

428

3174

Otalgia

259

1740

1.53

9.12

2.9

3.3

4.48

4.53

pmol/l

0.32

229

1549

Secondary polycythaemia

306

2.33

9.12

3.3

3.4

4.63

4.60

pmol/l

0.10

275

Other abnormal products of conception

1481

8350

1.20

9.10

3.5

3.4

4.56

4.55

pmol/l

0.18

1361

7555

Other pleural conditions

221

1430

1.58

9.09

3.4

3.3

4.04

4.41

pmol/l

5.67

188

1225

Benign leiomyoma with endometriosis

533

4054

1.34

9.06

3.2

3.0

4.43

4.44

pmol/l

0.13

478

3527

Benign neoplasm of breast

427

3145

1.39

9.05

3.1

2.9

4.46

pmol/l

0.01

376

2748

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1174

9744

1.21

9.03

2.6

3.4

4.46

4.51

pmol/l

0.98

982

8793

Speech and linguistic disorders

268

1738

1.51

9.02

2.8

3.2

4.87

4.80

pmol/l

0.38

241

1569

Anomalies of dental arch relationship, including avohilmo

663

4652

1.30

9.01

3.0

3.4

4.63

4.62

pmol/l

0.05

590

4204

Vitreous haemorrhage

262

1766

1.52

8.98

3.1

3.3

4.33

4.45

pmol/l

0.93

238

1552

Congenital malformations of cardiac septa

211

1314

1.60

8.98

3.8

3.4

4.79

4.72

pmol/l

0.26

190

1183

Hallux rigidus

406

2965

1.40

8.95

3.2

3.4

4.39

4.44

pmol/l

0.48

348

2626

Mental and behavioural disorders due to alcohol

1392

11437

1.19

8.94

2.7

3.4

4.48

4.52

pmol/l

0.70

1177

10304

Benign neoplasm: Skin of other and unspecified parts of face

283

1939

1.49

8.92

3.1

3.0

4.37

4.48

pmol/l

1.21

255

1698

Corneal ulcer

545

4161

1.33

8.91

3.3

3.4

4.51

pmol/l

0.03

475

3719

Intestinal stricture

781

6234

1.27

8.89

3.1

3.2

4.34

4.41

pmol/l

1.25

681

5464

904

0.35

8.88

2.1

3.4

3.72

4.37

pmol/l

3.30

784

Benign neoplasm of mouth and pharynx

308

2149

1.47

8.86

3.5

3.3

4.42

4.44

pmol/l

0.12

269

1906

Melanocytic naevi of other and unspecified parts of face

195

1240

1.62

8.85

3.7

3.0

4.51

4.54

pmol/l

0.19

172

1093

Impotence

104

552

1.93

8.83

3.0

3.5

4.48

4.50

pmol/l

0.03

487

Visual impairment including blindness (binocular or monocular)

177

1097

1.66

8.83

2.5

3.1

4.16

4.48

pmol/l

4.38

153

961

Otitis externa

664

5211

1.29

8.81

3.0

3.3

4.48

4.51

pmol/l

0.21

574

4660

Renal tubulo-interstitial disorders in diseases classified elsewhere

160

2.93

8.80

3.2

3.5

4.19

4.61

pmol/l

1.50

139

Abrasion of teeth

924

5516

1.25

8.78

3.4

4.42

4.51

pmol/l

2.22

805

4984

In situ neoplasms

1048

8248

1.23

8.73

3.2

3.0

4.41

4.44

pmol/l

0.42

913

7224

Mental retardation, excluding more controls

107

567

1.92

8.73

2.0

3.4

4.88

4.83

pmol/l

0.07

519

Atopic dermatitis, strict definition with reimbursement

1117

9001

1.22

8.69

3.0

3.5

4.63

4.61

pmol/l

0.17

984

8157

Myeloproliferative diseases (CML excluded)

206

1330

1.59

8.69

2.9

3.2

4.35

4.41

pmol/l

0.51

167

1156

Macular pucker

345

2464

1.43

8.68

3.3

3.2

4.35

4.36

pmol/l

0.03

301

2126

Disorders of myoneural junction and muscle in diseases classified elsewhere

128

3.19

8.68

3.3

3.6

3.95

4.50

pmol/l

2.28

108

Actinic keratosis

858

6584

1.25

8.66

2.8

3.2

4.28

4.33

pmol/l

0.78

716

5693

Melanocytic naevi of trunk

368

2663

1.41

8.65

3.8

3.3

4.37

4.51

pmol/l

2.02

347

2383

Septal defects

197

1234

1.61

8.63

3.8

3.4

4.75

4.72

pmol/l

0.12

178

1109

Unspecified urinary incontinence

274

1884

1.49

8.60

3.2

3.1

4.37

4.44

pmol/l

0.40

213

1653

Alcohol abuse, main dg, excluding more controls

365

2635

1.41

8.56

2.5

3.6

4.46

4.57

pmol/l

1.11

315

2400

Otitis media, unspecified

367

2442

1.41

8.56

3.3

4.72

pmol/l

0.00

335

2213

Benign neoplasm: Transverse colon

224

1476

1.55

8.55

3.1

2.9

4.44

4.42

pmol/l

0.09

198

1272

Artificial opening status

136

795

1.76

8.52

3.5

3.3

4.14

4.51

pmol/l

3.60

121

690

Lateral epicondylitis

425

3154

1.37

8.50

3.1

3.5

4.46

4.49

pmol/l

0.20

386

2852

Skin changes due to chronic exposure to nonionizing radiation

895

6893

1.24

8.46

2.8

3.2

4.29

4.33

pmol/l

0.69

749

5975

Retinal detachments and breaks

896

7310

1.24

8.39

3.3

4.38

4.41

pmol/l

0.38

796

6447

Other benign neoplasms of connective and other soft tissue

281

1949

1.47

8.38

3.5

3.0

4.54

4.51

pmol/l

0.12

256

1724

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

396

2915

1.39

8.38

3.1

3.3

4.47

pmol/l

0.02

352

2600

Biguanides

3204

17687

1.12

8.35

3.1

3.4

4.40

4.48

pmol/l

3.87

2790

15802

Leiomyoma of uterus

2560

12880

1.14

8.34

3.5

3.3

4.46

4.45

pmol/l

0.32

2293

11453

Malnutrition

306

2.28

8.33

4.0

3.0

4.20

4.67

pmol/l

1.94

261

Lung diseases due to external agents

293

2045

1.46

8.32

3.0

3.2

4.22

4.40

pmol/l

1.99

258

1777

Suppurative and unspecified otitis media

1271

9501

1.20

8.32

3.2

3.4

4.58

4.62

pmol/l

0.67

1130

8568

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

384

2.10

8.29

4.3

2.9

4.24

4.43

pmol/l

0.60

324

Paralytic ileus and intestinal obstruction

641

5040

1.29

8.28

3.1

3.3

4.36

4.43

pmol/l

1.11

556

4432

Prurigo nodularis

421

2.07

8.28

4.7

3.3

4.43

4.54

pmol/l

0.42

368

Budesonide

422

3142

1.37

8.28

3.2

3.4

4.42

4.54

pmol/l

1.84

365

2801

Other skin changes

447

3355

1.36

8.28

3.5

3.2

4.44

4.43

pmol/l

0.05

396

2959

Speech therapy

789

6368

1.26

8.25

2.9

3.3

4.38

4.44

pmol/l

1.01

724

5618

Early onset COPD

550

4247

1.31

8.25

3.2

3.4

4.30

4.45

pmol/l

2.97

481

3777

Ischaemic Stroke, excluding all haemorrhages

1402

8998

1.19

8.21

3.1

3.3

4.24

4.40

pmol/l

7.55

1235

7896

Polymyalgia rheumatica

312

2212

1.44

8.21

2.8

3.1

4.18

4.37

pmol/l

3.23

263

1900

Other disorders of nervous system

182

1159

1.62

8.19

2.9

3.3

4.29

4.48

pmol/l

1.81

154

1025

Covid-19 suspected case

718

5745

1.27

8.16

2.7

3.4

4.45

4.56

pmol/l

2.85

637

5146

Assault

394

2908

1.38

8.16

2.6

3.4

4.51

4.62

pmol/l

1.37

346

2624

Abnormal findings on diagnostic imaging of central nervous system

150

914

1.70

8.16

3.3

3.2

4.43

4.55

pmol/l

0.68

135

811

Use of disulfiram, acamprosate or naltrexone

236

1590

1.52

8.16

2.3

3.5

4.46

4.54

pmol/l

0.44

194

1431

Haemangioma and lymphangioma, any site

280

1955

1.47

8.13

3.2

4.44

4.50

pmol/l

0.50

253

1741

Follow-up examination after treatment for malignant neoplasms

258

1769

1.49

8.12

3.5

3.4

4.35

4.42

pmol/l

0.58

240

1550

Other postsurgical states

177

1123

1.62

8.08

2.6

3.2

4.39

4.52

pmol/l

0.87

156

985

Myopia

435

3270

1.36

8.06

3.5

3.3

4.57

4.58

pmol/l

0.09

391

2921

Other chronic obstructive pulmonary disease, including avohilmo

1298

9131

1.19

8.06

3.2

3.3

4.29

4.39

pmol/l

3.12

1122

8054

Fracture of lumbar spine and pelvis

538

4152

1.31

8.04

2.8

3.2

4.25

4.43

pmol/l

3.86

457

3599

Benign neoplasm: Caecum

249

1704

1.49

7.98

3.0

3.3

4.36

4.38

pmol/l

0.07

221

1478

Maternal care for known or suspected abnormality of pelvic organs

1099

6332

1.22

7.97

3.4

3.5

4.53

4.54

pmol/l

0.10

1010

5719

Disorder of the sleep-wake schedule

319

2.22

7.96

5.1

3.4

4.59

4.70

pmol/l

0.41

280

Opening and dilatation of root channel of tooth

209

1386

1.55

7.91

3.4

4.50

4.56

pmol/l

0.30

179

1239

Other blood glucose lowering drugs, excl. Insulins

427

3205

1.35

7.90

3.1

3.3

4.32

4.41

pmol/l

1.01

363

2791

Rosacea

369

2716

1.39

7.89

3.5

3.4

4.40

4.46

pmol/l

0.74

325

2437

COPD, hospital admissions

1032

7252

1.21

7.89

3.2

3.3

4.25

4.38

pmol/l

3.60

894

6382

Other disorders of penis

174

1102

1.61

7.88

2.8

3.5

4.55

4.56

pmol/l

0.04

158

977

Primary ovarian failure

481

2.00

7.87

3.9

3.4

4.51

4.57

pmol/l

0.23

433

Other disorders of optic [2nd] nerve and visual pathways

185

1195

1.59

7.87

2.9

3.3

4.48

4.55

pmol/l

0.17

169

1056

Idiopathic gout

174

1104

1.61

7.86

2.5

3.3

4.08

4.39

pmol/l

2.80

158

967

Lichen simplex chronicus and prurigo

188

1219

1.59

7.86

3.5

3.3

4.41

4.47

pmol/l

0.38

167

1079

Chondrocostal junction syndrome [Tietze]

128

757

1.76

7.84

3.0

3.2

4.48

4.51

pmol/l

0.12

106

663

Lesion of ulnar nerve

374

2756

1.38

7.84

2.9

3.4

4.47

4.48

pmol/l

0.07

335

2469

Vulvovaginal ulceration/inflammation in other diseases

250

1730

1.50

7.79

3.2

3.4

4.48

4.53

pmol/l

0.43

220

1558

Other/unspecified synovitis and tenosynovitis

351

2566

1.39

7.77

2.9

3.5

4.39

4.50

pmol/l

1.28

311

2305

Pre-eclampsia or eclampsia

904

7471

1.23

7.72

3.4

4.51

4.50

pmol/l

0.16

819

6693

Benign neoplasm: Skin of lower limb, including hip

481

1.96

7.72

3.8

2.9

4.40

4.56

pmol/l

0.81

416

Secondary and unspecified malignant neoplasm of lymph nodes

211

1407

1.53

7.70

3.0

3.3

4.32

4.44

pmol/l

1.30

190

1220

Hodgkin lymphoma, hilmo

488

1.95

7.70

3.6

3.4

4.33

4.63

pmol/l

2.38

426

Other necrotizing vasculopathies (FG)

158

988

1.64

7.69

2.9

3.4

4.28

4.46

pmol/l

1.23

136

866

Striking against or struck by other objects

918

7576

1.22

7.68

3.0

3.4

4.48

4.60

pmol/l

2.74

803

6800

Other diseases of oesophagus

238

1626

1.49

7.67

2.8

3.4

4.31

4.44

pmol/l

1.44

209

1427

Scoliosis

288

2044

1.44

7.66

2.9

3.2

4.57

4.56

pmol/l

0.08

252

1818

Abnormal findings on antenatal screening of mother

364

2693

1.39

7.66

3.7

3.5

4.68

4.58

pmol/l

1.12

341

2433

Diabetic retinopathy, excluding more controls

754

3412

1.26

7.65

2.9

3.3

4.24

4.47

pmol/l

7.11

660

2999

Hemiplegia

152

944

1.66

7.62

3.4

3.3

4.27

4.51

pmol/l

2.71

137

832

Benign neoplasm of urinary organs

124

731

1.75

7.60

3.2

2.9

4.39

4.47

pmol/l

0.26

104

631

Fall on and from stairs and steps

733

5926

1.25

7.59

2.9

3.3

4.41

4.48

pmol/l

1.02

631

5240

Hyperosmolality and hypernatraemia

131

2.89

7.57

2.9

2.8

4.11

4.35

pmol/l

0.64

113

Dental pulpitis 3, only avohilmo

429

2358

1.35

7.54

3.4

3.2

4.93

4.87

pmol/l

0.33

386

2146

Hypertrophy of breast

677

5444

1.27

7.53

3.4

3.3

4.47

4.48

pmol/l

0.16

608

4874

Hernia of abdominal wall

1231

10456

1.19

7.53

3.1

3.3

4.37

4.46

pmol/l

2.53

1073

9317

Diseases of tongue

186

1216

1.57

7.50

2.8

3.2

4.40

4.46

pmol/l

0.34

156

1080

Multiple myeloma and malignant plasma cell neoplasms

103

577

1.84

7.50

3.9

3.0

4.38

4.42

pmol/l

0.13

490

617

4326

1.28

7.49

3.2

3.1

4.29

pmol/l

0.07

516

3705

Calcific tendinitis of shoulder

194

1282

1.56

7.49

3.3

3.4

4.40

4.48

pmol/l

0.69

171

1162

Other and unspecified disorders of white blood cells

118

691

1.77

7.45

2.9

3.5

4.54

pmol/l

0.01

100

614

Parkinson's disease, excluding more controls

272

1864

1.44

7.43

2.5

3.6

4.39

4.41

pmol/l

0.11

227

1656

Secondary parkinsonism+Parkinsonism in other disease

353

2.09

7.43

2.7

3.2

4.07

4.44

pmol/l

2.91

304

Pustulosis palmaris et plantaris

143

884

1.68

7.42

3.9

3.4

4.55

4.51

pmol/l

0.17

132

783

COPD, early/later onset

1036

7310

1.21

7.41

3.2

3.3

4.25

4.38

pmol/l

3.81

896

6434

Pre-eclampsia or poor fetal growth

1306

11158

1.18

7.41

3.6

3.4

4.54

4.53

pmol/l

0.22

1182

10049

Hypertrophy of breast in women and men

716

5800

1.26

7.41

3.4

3.3

4.47

4.49

pmol/l

0.24

637

5197

Melanocytic naevi, other sites/unspecified

247

1717

1.48

7.40

3.9

3.4

4.53

4.52

pmol/l

0.06

229

1537

Parkinson's disease, strict definition, excluding more controls

250

1699

1.46

7.40

2.4

3.5

4.43

4.40

pmol/l

0.21

208

1505

Other/unspecified enthesopathies of lower limb, excluding foot

235

1618

1.49

7.40

3.0

3.4

4.44

4.52

pmol/l

0.59

207

1453

Deficiency of other B group vitamins

321

2.15

7.39

4.1

3.3

4.19

4.53

pmol/l

2.52

281

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

201

1331

1.53

7.38

3.3

2.9

4.21

4.37

pmol/l

1.55

177

1143

Acute pancreatitis

477

3672

1.32

7.38

3.1

3.3

4.38

4.45

pmol/l

0.72

406

3266

Phlebitis and thrombophlebitis (not including DVT)

642

5132

1.27

7.38

3.1

3.4

4.32

4.46

pmol/l

3.28

576

4533

Chronic periodontitis, complicated

238

1642

1.48

7.36

3.6

3.4

4.18

4.44

pmol/l

3.72

211

1452

Injuries to the head

3862

22920

1.10

7.34

3.2

3.4

4.45

4.53

pmol/l

4.10

3394

20541

Filling of root of tooth

103

584

1.84

7.34

3.5

3.1

4.45

4.62

pmol/l

0.69

520

Multiple myeloma, excluding all cancers (controls excluding all cancers)

103

582

1.82

7.30

4.0

3.0

4.41

4.43

pmol/l

0.07

496

Acute gastritis

207

1392

1.52

7.28

2.8

3.3

4.23

4.44

pmol/l

2.57

182

1219

Kela reimbursement Agammaglobulinemia (D80-84)

153

2.78

7.28

2.8

3.5

4.21

4.59

pmol/l

2.29

135

Glaucoma

1486

11261

1.17

7.28

3.1

3.3

4.38

pmol/l

0.01

1296

9891

Pregnancy with abortive outcome

2849

13365

1.12

7.28

3.3

4.51

4.50

pmol/l

0.33

2539

11893

Sequelae of injuries of lower limb

283

2021

1.43

7.27

3.0

3.3

4.42

4.51

pmol/l

0.79

256

1814

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

183

1184

1.56

7.26

2.6

3.5

5.00

4.83

pmol/l

0.54

168

1078

Atrophic disorders of skin

468

3614

1.32

7.23

3.4

3.2

4.42

4.47

pmol/l

0.53

417

3210

Memory loss

220

1500

1.50

7.22

2.4

3.2

4.30

4.39

pmol/l

0.73

181

1306

Diseases of appendix

2552

20818

1.12

7.18

3.4

4.51

pmol/l

0.07

2327

18628

Benign neoplasm: Skin of eyelid, including canthus

391

2943

1.35

7.17

3.2

3.0

4.39

4.45

pmol/l

0.61

343

2562

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

178

1163

1.57

7.16

3.1

2.9

4.24

4.54

pmol/l

3.24

163

1011

Fall on same level involving ice and snow

1781

15618

1.15

7.15

3.4

3.3

4.52

4.48

pmol/l

0.70

1580

13892

Lung cancer and mesothelioma

402

2587

1.34

7.14

3.8

3.2

4.25

4.42

pmol/l

2.65

364

2248

Haemangioma, any site

258

1821

1.45

7.13

3.3

4.46

4.49

pmol/l

0.24

233

1618

Fracture of skull and facial bones

570

4512

1.28

7.10

3.0

3.4

4.49

4.54

pmol/l

0.49

489

4037

Hernia

3109

19052

1.11

7.10

3.0

3.4

4.44

4.50

pmol/l

2.57

2726

17005

Other hearing loss

650

5131

1.26

7.09

3.3

3.2

4.37

4.36

pmol/l

0.03

562

4476

Other disorders of the genitourinary system

390

2947

1.35

7.06

3.0

3.1

4.43

pmol/l

0.02

348

2573

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

545

1.83

7.03

2.7

3.0

4.03

4.48

pmol/l

4.51

465

Spontaneous abortion

1941

11634

1.15

7.03

3.3

4.51

4.50

pmol/l

0.22

1744

10410

Allergic urticaria

275

1969

1.43

7.02

3.3

4.54

4.55

pmol/l

0.04

242

1762

Colonic or urogenital fistula

772

6332

1.23

7.00

3.4

3.3

4.44

4.47

pmol/l

0.28

667

5642

Other and unspecified trigeminal disorders

282

2.22

7.00

3.0

3.5

4.29

4.55

pmol/l

1.22

247

Eosinophilia

262

2.26

6.99

2.6

3.4

4.61

4.57

pmol/l

0.05

233

Anomalies of pupillary function

427

1.97

6.99

3.0

3.4

4.49

4.62

pmol/l

0.57

377

Benign neoplasm: Tongue

418

1.97

6.99

2.7

3.0

4.45

4.46

pmol/l

0.03

357

Other respiratory diseases principally affecting the interstitium

380

2857

1.35

6.98

2.7

3.2

4.21

4.38

pmol/l

2.10

330

2486

Diffuse large B-cell lymphoma

109

636

1.77

6.97

2.8

3.3

4.29

4.43

pmol/l

0.85

549

Other specified/unspecified bacterial intestinal infections

183

1213

1.55

6.97

3.0

3.4

4.40

4.48

pmol/l

0.52

160

1067

Other enthesopathy of foot (+metatarsalgia)

322

2368

1.39

6.96

2.7

3.4

4.54

4.50

pmol/l

0.26

286

2134

Appendicitis, broad definition

2529

20732

1.12

6.94

3.4

4.51

pmol/l

0.06

2306

18557

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

258

2.30

6.94

3.5

3.7

4.53

4.66

pmol/l

0.45

236

Gluteal tendinitis

129

792

1.69

6.92

3.0

3.3

4.42

4.50

pmol/l

0.48

107

699

Hypertensive Renal Disease

411

1.95

6.89

2.4

3.3

3.90

4.42

pmol/l

4.53

350

Somnolence, stupor and coma

118

706

1.72

6.88

3.1

3.4

4.32

4.48

pmol/l

0.98

101

623

Secondary parkinsonism

357

2.04

6.87

2.7

3.0

4.09

4.43

pmol/l

2.51

306

Acute suppurative otitis media

920

7176

1.21

6.86

3.0

3.4

4.61

4.66

pmol/l

0.80

825

6497

Benign neoplasm of other and unspecified sites

537

1.84

6.83

3.4

3.0

4.28

4.57

pmol/l

2.10

460

Stroke, excluding SAH

1499

9653

1.16

6.82

3.1

3.3

4.23

4.41

pmol/l

9.86

1315

8498

Entropion and trichiasis of eyelid

174

1143

1.55

6.82

3.6

3.0

4.17

4.36

pmol/l

1.66

150

985

Fracture of lower leg, including ankle

1696

14812

1.15

6.81

3.1

3.3

4.48

4.49

pmol/l

0.20

1510

13125

Benign lipomatous neoplasm of other sites/unspecified

230

1602

1.47

6.80

3.1

3.3

4.31

4.42

pmol/l

1.08

210

1394

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

305

2095

1.39

6.79

3.9

2.9

4.25

4.38

pmol/l

1.49

283

1794

Premature rupture of membranes

933

5737

1.21

6.79

3.7

3.5

4.57

4.56

pmol/l

0.18

835

5177

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

898

7499

1.21

6.78

3.3

3.4

4.55

4.56

pmol/l

0.12

788

6765

Decubitus ulcer and pressure area

125

761

1.68

6.78

2.5

3.2

3.83

4.46

pmol/l

7.96

103

663

Status epilepticus

537

1.82

6.78

2.4

3.5

4.07

4.55

pmol/l

4.13

477

Other female pelvic inflammatory diseases

602

4838

1.27

6.77

3.3

4.45

4.47

pmol/l

0.24

528

4308

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

408

1.96

6.77

2.8

3.1

4.11

4.49

pmol/l

2.85

351

Herpesviral [herpes simplex] infections

362

2723

1.36

6.77

3.3

3.4

4.42

4.48

pmol/l

0.73

321

2442

Biomechanical lesions, not elsewhere classified

139

873

1.64

6.75

3.5

3.4

4.36

4.47

pmol/l

0.87

127

761

Maltreatment syndromes

178

1183

1.55

6.75

3.0

3.4

4.63

4.67

pmol/l

0.21

153

1064

Disorders of iron metabolism

201

2.42

6.74

3.2

3.0

4.59

4.45

pmol/l

0.53

182

Other disorders of cornea

261

1864

1.43

6.74

3.4

4.50

4.48

pmol/l

0.09

222

1659

Speech disturbances, not elsewhere classified

211

1448

1.49

6.73

3.5

3.2

4.40

4.42

pmol/l

0.09

183

1267

Superficial injury of wrist and hand

620

4996

1.26

6.70

3.1

3.4

4.53

4.58

pmol/l

0.51

545

4496

Car occupant injured in other and unspecified transport accidents

594

4765

1.26

6.69

4.0

3.3

4.59

4.55

pmol/l

0.47

545

4249

Disorders of optic nerve and visual pathways

295

2156

1.40

6.67

3.0

3.4

4.52

pmol/l

0.02

267

1926

Secondary uncertain malignant neoplasm

283

2049

1.40

6.67

2.9

3.2

4.25

4.42

pmol/l

2.45

249

1784

L01XX Other antineoplastic agents

138

867

1.64

6.66

2.9

3.2

4.25

4.39

pmol/l

1.12

112

749

Examination and encounter for administrative purposes

105

614

1.76

6.65

4.1

3.6

4.50

pmol/l

0.02

540

Explicit bacterial Sepsis

238

1673

1.45

6.64

3.6

3.3

4.37

4.56

pmol/l

1.46

216

1472

Metatarsalgia

297

2176

1.39

6.61

2.7

3.4

4.54

4.50

pmol/l

0.23

263

1958

Pre-eclampsia

833

6942

1.22

6.60

3.4

3.3

4.52

4.50

pmol/l

0.19

753

6224

Melanocytic naevi of other and unspecified parts of face

195

1328

1.51

6.59

3.7

3.3

4.51

pmol/l

0.01

172

1182

Alcohol use disorder, Swedish definition

1468

11849

1.16

6.58

2.6

3.4

4.44

4.51

pmol/l

1.88

1238

10661

Radial styloid tenosynovitis [de Quervain]

198

1353

1.51

6.58

3.3

3.4

4.44

4.53

pmol/l

0.68

181

1234

Superficial injury of thorax

389

2965

1.33

6.57

3.2

3.3

4.45

4.49

pmol/l

0.31

335

2634

Conductive and sensorineural hearing loss

2343

14508

1.12

6.54

3.1

3.3

4.41

4.44

pmol/l

0.79

2029

12897

Pustular psoriasis

150

968

1.60

6.54

3.8

3.3

4.53

4.50

pmol/l

0.17

139

851

Seborrhoeic keratosis

574

4598

1.26

6.53

3.2

3.3

4.34

4.40

pmol/l

0.96

490

4031

Psoriasis

811

6736

1.22

6.51

3.1

3.3

4.50

4.48

pmol/l

0.16

719

6003

Acute pancreatitis (for exclusion)

477

3739

1.29

6.49

3.1

3.2

4.38

4.44

pmol/l

0.62

406

3322

Follicular cysts of skin and subcutaneous tissue

499

3940

1.28

6.44

3.4

3.3

4.46

4.50

pmol/l

0.37

449

3510

Benign neoplasm of urinary organs

124

766

1.67

6.44

3.2

4.39

4.44

pmol/l

0.16

104

668

All dysplastic lesions of the vulva

168

1119

1.56

6.43

3.0

3.3

4.34

4.48

pmol/l

0.72

142

993

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

127

788

1.65

6.41

3.1

4.17

4.42

pmol/l

2.10

119

668

Chondropathies

467

3662

1.30

6.41

3.2

3.4

4.58

4.51

pmol/l

0.78

401

3269

ILD, hospital admissions

310

2293

1.37

6.41

2.6

3.3

4.24

4.40

pmol/l

1.65

266

1995

Non-allergic asthma

250

1788

1.43

6.40

3.1

3.2

4.52

4.50

pmol/l

0.09

223

1588

Intentional self-harm by sharp object

542

1.81

6.40

2.5

3.4

4.50

4.68

pmol/l

1.29

487

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

217

1515

1.47

6.39

3.1

3.0

4.45

4.50

pmol/l

0.29

193

1331

Alcohol dependence

639

5188

1.24

6.38

2.5

3.5

4.45

4.50

pmol/l

0.50

527

4673

Other specified/unspecified dorsopathies

115

700

1.70

6.37

2.3

3.5

4.40

4.51

pmol/l

0.67

101

616

Respiratory conditions due to other external agents

292

2.12

6.36

2.9

2.8

4.12

4.41

pmol/l

1.15

248

Spondyloarthritis

495

3908

1.28

6.36

2.9

3.3

4.51

4.52

pmol/l

0.02

440

3488

Other disorders of binocular vision

315

2.10

6.35

3.7

3.4

4.75

4.58

pmol/l

0.51

278

Other abnormal immunological findings in serum

391

1.97

6.35

3.0

3.4

4.55

4.67

pmol/l

0.50

348

Causalgia

349

2.03

6.34

3.1

3.7

4.39

4.60

pmol/l

1.02

308

Pericarditis

445

1.87

6.34

3.0

3.3

4.32

4.65

pmol/l

1.94

391

Benign neoplasm of breast

427

3323

1.31

6.33

3.1

4.46

4.45

pmol/l

0.13

376

2936

Benign neoplasm: Duodenum

334

2.02

6.30

3.0

2.9

4.20

4.52

pmol/l

2.20

286

Sensorineural hearing loss

2156

13466

1.13

6.27

3.0

3.3

4.40

4.42

pmol/l

0.54

1862

11939

Benign neoplasm of eye and adnexa

271

1974

1.40

6.26

3.3

4.38

4.44

pmol/l

0.50

242

1738

Congenital malformations of the musculoskeletal system, not elsewhere classified

352

2.03

6.26

4.8

3.6

4.85

4.70

pmol/l

0.30

313

430

3159

1.30

6.25

3.2

3.1

4.25

4.29

pmol/l

0.31

351

2687

Schizotypal disorder

457

1.87

6.25

1.7

3.8

4.43

4.64

pmol/l

1.08

413

Arterial embolism and thrombosis

126

785

1.64

6.24

3.0

3.2

4.23

4.45

pmol/l

1.47

114

686

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2193

16024

1.13

6.23

3.2

3.4

4.52

4.49

pmol/l

0.47

1971

14381

Female infertility, associated with anovulation

336

2540

1.35

6.19

3.2

3.6

4.56

4.66

pmol/l

1.17

301

2303

Viral pneumonia (unknown virus, not influenza)

180

1220

1.51

6.19

3.7

3.5

4.33

4.56

pmol/l

2.40

163

1083

Coxarthrosis, primary

1520

11550

1.15

6.18

3.0

3.3

4.34

4.38

pmol/l

0.85

1340

10149

Idiopathic urticaria

438

1.89

6.18

2.9

3.5

4.56

4.62

pmol/l

0.23

392

Other specified disorders of muscle

487

1.83

6.18

2.8

3.5

4.46

4.56

pmol/l

0.45

440

Superficial injury of abdomen, lower back and pelvis

431

3362

1.30

6.17

3.1

3.3

4.48

4.54

pmol/l

0.56

382

3002

Other interstitial pulmonary diseases

311

2316

1.36

6.17

2.6

3.3

4.23

4.40

pmol/l

1.72

267

2013

Renal cell carcinoma of kidney

428

1.88

6.15

4.3

3.3

4.24

4.38

pmol/l

0.40

368

Interstitial lung disease

311

2317

1.36

6.15

2.6

3.3

4.23

4.40

pmol/l

1.72

267

2014

Interstitial lung disease endpoints

311

2317

1.36

6.15

2.6

3.3

4.23

4.40

pmol/l

1.72

267

2014

Benign neoplasm of other and unspecified sites

555

1.77

6.14

3.4

4.28

4.55

pmol/l

1.83

495

Calculus of kidney and ureter

709

5845

1.22

6.13

3.3

4.43

4.45

pmol/l

0.20

621

5205

Problems related to social environment

488

1.82

6.13

3.4

3.2

4.66

4.54

pmol/l

0.27

424

Benign neoplasm: salivary glands, exclude unknown (D119)

228

1619

1.44

6.13

3.5

3.3

4.30

4.44

pmol/l

1.69

208

1424

Other and unspecified rosacea

260

1891

1.41

6.12

3.7

3.3

4.40

4.46

pmol/l

0.53

226

1699

Injuries to unspecified part of trunk, limb or body region

262

1905

1.40

6.11

2.8

3.2

4.41

4.50

pmol/l

0.62

238

1685

Hypermetropia

205

1429

1.47

6.11

3.3

3.2

4.56

4.62

pmol/l

0.35

185

1265

Sacrococcygeal disorders, not elsewhere classified

110

671

1.70

6.10

3.3

3.5

4.56

4.54

pmol/l

0.06

591

Urolithiasis

754

6256

1.22

6.09

3.3

4.43

4.44

pmol/l

0.18

660

5566

Benign neoplasm: Ascending colon

299

2220

1.37

6.09

3.3

3.2

4.34

4.39

pmol/l

0.40

249

1941

Other specified/unspecified systemic involvement of connective tissue

194

1343

1.49

6.07

2.9

3.3

4.30

4.46

pmol/l

1.48

179

1194

LSIL lesion of the vulva

120

752

1.67

6.07

2.6

3.4

4.31

4.50

pmol/l

1.09

103

669

Benign neoplasm: Skin of lower limb, including hip

521

1.80

6.05

3.8

3.3

4.40

4.55

pmol/l

0.74

460

Hidradenitis suppurativa

133

853

1.62

6.03

2.8

3.3

4.40

4.58

pmol/l

1.25

111

775

Other disorders of breast

465

3682

1.29

6.03

3.4

3.3

4.45

4.49

pmol/l

0.51

405

3279

Malignant neoplasm of eye, brain and central nervous system

112

687

1.68

6.01

2.9

3.3

4.21

4.57

pmol/l

2.57

100

603

Other misadventures during surgical and medical care

355

1.98

6.00

3.1

3.3

4.31

4.58

pmol/l

1.19

311

Chronic tubulo-interstitial nephritis

120

750

1.65

6.00

3.0

3.3

4.07

4.48

pmol/l

4.68

108

654

Postprocedural disorders of digestive system, not elsewhere classified

529

1.78

5.99

3.9

3.5

4.41

4.55

pmol/l

0.72

465

Superficial injury of ankle and foot

368

2826

1.32

5.98

2.9

3.3

4.60

4.58

pmol/l

0.17

318

2557

Ulcer of oesophagus

154

1017

1.54

5.97

2.9

3.4

4.28

4.42

pmol/l

0.95

124

886

Benign neoplasm of bone and articular cartilage

237

1703

1.42

5.97

2.8

3.0

4.51

4.54

pmol/l

0.17

213

1510

Other disorders of amniotic fluid and membranes

577

4645

1.25

5.96

3.3

3.5

4.59

4.56

pmol/l

0.28

521

4193

Other disorders of gingiva or/and edentulous alveolar ridge

136

876

1.59

5.96

3.4

3.2

4.33

4.53

pmol/l

1.94

129

774

Pneumonia due to other infectious organisms, not elsewhere classified

500

1.80

5.95

3.2

3.5

4.17

4.60

pmol/l

3.77

439

Vasomotor rhinitis (mode)

221

1572

1.44

5.94

3.1

3.3

4.36

4.47

pmol/l

1.18

195

1398

Benign neoplasm: Tongue

442

1.86

5.94

2.7

3.4

4.45

4.48

pmol/l

0.09

379

Benign neoplasm: Parotid gland

205

1437

1.46

5.94

3.7

3.4

4.32

4.45

pmol/l

1.32

186

1262

Glomerulonephritis

253

1838

1.40

5.94

3.2

3.4

4.23

4.49

pmol/l

3.58

231

1634

Specific development disorders of scholastic skills

138

883

1.59

5.93

2.7

3.3

4.97

4.84

pmol/l

0.56

125

800

Benign neoplasm: Kidney

531

1.77

5.92

3.2

3.0

4.50

4.45

pmol/l

0.15

458

Otitis externa, unspecified

324

2449

1.35

5.91

3.2

3.4

4.52

4.53

pmol/l

0.04

288

2194

Acute appendicitis

2353

20020

1.12

5.91

3.5

3.4

4.51

4.52

pmol/l

0.20

2153

17934

Viral warts

302

2260

1.36

5.91

3.2

3.3

4.54

pmol/l

0.01

272

2025

Acne

345

2631

1.33

5.89

3.1

3.4

4.61

4.70

pmol/l

1.04

307

2379

Traumatic subdural haemorrhage

237

1672

1.41

5.89

2.9

3.3

4.15

4.39

pmol/l

2.55

190

1459

Vascular disorders of the intestines

139

900

1.57

5.88

3.1

4.10

4.45

pmol/l

3.21

125

769

Abnormal findings on examination of urine, without diagnosis

119

746

1.64

5.87

3.4

4.37

4.56

pmol/l

1.02

106

655

Cyst of kidney

159

1063

1.53

5.86

3.2

3.3

4.37

4.41

pmol/l

0.21

142

914

Postprocedural musculoskeletal disorders, not elsewhere classified

182

1252

1.49

5.85

2.6

3.3

4.57

4.43

pmol/l

0.80

155

1099

Injuries to the elbow and forearm

2285

18605

1.12

5.84

3.1

3.3

4.46

4.52

pmol/l

1.72

2004

16571

Embolic stroke with flimmer

206

2.24

5.83

3.0

3.2

4.23

4.45

pmol/l

0.81

175

Ingrowing nail

156

1042

1.54

5.81

3.2

3.3

4.47

4.59

pmol/l

0.63

138

929

Single delivery by caesarean section

811

3922

1.21

5.81

3.3

3.4

4.56

4.55

pmol/l

0.05

744

3501

DVT of lower extremities

477

3795

1.27

5.81

3.1

3.3

4.33

4.43

pmol/l

1.44

425

3340

Bronchiectasis

192

1335

1.47

5.80

3.4

3.3

4.27

4.40

pmol/l

0.63

162

1143

Other degenerative diseases of the nervous system

684

4270

1.23

5.80

2.9

3.5

4.33

4.46

pmol/l

2.78

574

3777

Other specified and unspecified retinal disorders

534

1.76

5.79

2.8

3.4

4.31

4.52

pmol/l

1.04

462

Mixed connective tissue disease

214

1523

1.44

5.79

2.8

3.2

4.30

4.47

pmol/l

1.41

192

1345

Other and unspecified glaucoma

154

1025

1.53

5.78

2.7

3.2

4.23

4.38

pmol/l

1.08

133

884

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

365

1.92

5.77

3.2

2.9

4.41

4.59

pmol/l

0.72

317

Melanocytic naevi of lower limb, including hip

133

861

1.59

5.77

3.8

3.1

4.53

4.56

pmol/l

0.12

122

759

Superficial injury of forearm

288

2149

1.37

5.75

3.3

3.2

4.50

4.56

pmol/l

0.56

252

1914

Congenital malformations of eye, ear, face and neck

209

1481

1.44

5.75

3.8

3.3

4.67

pmol/l

0.00

185

1314

Use of biperiden

148

980

1.55

5.75

2.3

3.4

4.34

4.51

pmol/l

1.25

124

865

1557

12606

1.14

5.74

2.7

3.4

4.46

4.52

pmol/l

1.15

1321

11328

Focal epilepsy, mode (most common among epilepsy diagnosis)

488

3900

1.27

5.72

2.8

3.2

4.27

4.52

pmol/l

5.04

438

3459

Charcot foot

236

2.17

5.71

3.3

3.8

3.98

4.60

pmol/l

4.21

207

Open wound of head

1357

11694

1.15

5.68

3.2

3.3

4.41

4.51

pmol/l

2.83

1172

10403

Atopic dermatitis, strict definition

1065

8990

1.17

5.67

3.0

3.4

4.64

4.61

pmol/l

0.42

943

8126

Convalescence

165

1122

1.51

5.66

3.7

3.3

4.46

4.50

pmol/l

0.15

139

996

Giant cell arteritis

103

629

1.69

5.66

3.0

3.1

4.28

4.38

pmol/l

0.36

540

Toxic liver disease

258

2.12

5.65

3.3

3.7

4.30

4.50

pmol/l

0.63

226

Paranoid personality disorder

356

1.94

5.64

3.3

3.6

4.48

4.61

pmol/l

0.54

313

Benign neoplasm of major salivary glands

250

1831

1.39

5.62

3.6

3.3

4.28

4.42

pmol/l

2.03

228

1603

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

153

1024

1.53

5.61

4.1

3.0

4.44

4.53

pmol/l

0.56

139

882

Atrial septal defect

115

719

1.64

5.61

3.2

3.1

4.50

4.77

pmol/l

1.65

103

648

Stroke, including SAH

1599

10454

1.14

5.59

3.1

3.3

4.24

4.42

pmol/l

9.72

1408

9227

Inflammatory diseases of the central nervous system

232

1681

1.41

5.59

3.2

3.3

4.36

4.49

pmol/l

1.05

202

1498

Other necrotizing vasculopathies

180

1247

1.48

5.58

3.0

3.3

4.25

4.44

pmol/l

1.57

152

1099

Benign neoplasm of middle ear and respiratory system

175

1204

1.48

5.58

2.9

3.0

4.35

4.53

pmol/l

1.27

160

1048

Hypotension due to drugs

160

2.42

5.58

3.0

3.1

4.04

4.44

pmol/l

2.12

141

Other benign neoplasm of uterus: Other parts/unspecified

114

718

1.64

5.56

3.1

2.7

4.59

4.40

pmol/l

0.37

102

593

Left ventricular outflow tract obstruction, narrow definition

127

819

1.59

5.56

3.6

3.5

4.50

4.71

pmol/l

1.37

112

737

Suggestive for eosinophilic asthma

238

1733

1.40

5.55

3.1

3.3

4.52

4.45

pmol/l

0.32

210

1532

Malignant neoplasm of small intestine

294

2.02

5.52

2.9

3.2

4.16

4.42

pmol/l

1.42

253

Other inflammatory liver diseases

182

1268

1.47

5.50

3.9

3.3

4.40

4.49

pmol/l

0.56

169

1116

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

482

3230

1.26

5.49

3.7

2.9

4.27

4.39

pmol/l

1.80

439

2793

Other congenital malformations of face and neck

605

1.70

5.49

4.7

3.2

4.72

4.65

pmol/l

0.28

538

Dialysis

603

1.69

5.49

2.1

3.4

3.76

4.64

pmol/l

12.75

538

Other embolism and thrombosis

333

2553

1.32

5.49

3.4

3.3

4.30

4.45

pmol/l

1.17

291

2249

Temporal arteritis

558

1.72

5.49

3.0

3.1

4.34

4.36

pmol/l

0.05

478

Degenerative macular diseases

274

2042

1.36

5.49

3.5

3.1

4.28

4.37

pmol/l

0.77

238

1750

Familial hypercholesterolemia, with ischemic heart disease

181

1257

1.46

5.48

3.3

3.2

4.12

4.35

pmol/l

2.37

151

1081

Injuries to the hip and thigh

1209

9629

1.16

5.46

2.9

3.3

4.38

4.44

pmol/l

1.29

1046

8474

Benign neoplasm: Pancreas

359

1.91

5.45

3.0

2.9

4.55

4.49

pmol/l

0.11

310

Behavioural disorders, excluding more controls

337

1.93

5.44

3.5

3.6

4.61

4.92

pmol/l

1.60

309

Open bite

181

1267

1.47

5.40

2.9

3.3

4.65

4.67

pmol/l

0.13

163

1135

Giant cell arteritis with polymyalgia rheumatica

561

1.71

5.39

3.0

3.1

4.34

4.36

pmol/l

0.06

479

Systemic lupus erythematosus

125

813

1.59

5.38

2.7

3.3

4.15

4.51

pmol/l

4.19

111

713

Findings of drugs and other substances, not normally found in blood

3.53

5.37

2.1

3.1

4.40

4.57

pmol/l

0.29

Hirsutism in women

520

1.76

5.37

3.1

3.3

4.50

4.62

pmol/l

0.65

471

Algoneurodystrophy

118

758

1.61

5.37

3.2

3.4

4.48

4.52

pmol/l

0.19

104

668

Non-small cell lung cancer

305

2314

1.33

5.37

3.9

3.2

4.25

4.35

pmol/l

0.93

283

1989

Glaucoma suspect

944

8089

1.18

5.37

3.2

3.3

4.42

4.38

pmol/l

0.38

822

7109

Assault by bodily force

223

1618

1.41

5.35

2.6

3.4

4.48

4.65

pmol/l

1.74

196

1455

1657

13199

1.13

5.34

2.7

3.4

4.47

4.52

pmol/l

1.10

1410

11874

Other specified and unspecified strabismus

210

2.22

5.33

4.0

3.3

4.18

4.62

pmol/l

2.39

188

Chronic pancreatitis

268

2000

1.36

5.32

3.0

3.4

4.17

4.45

pmol/l

4.93

231

1782

Other benign neoplasms of uterus

152

1031

1.51

5.32

3.2

2.8

4.55

4.41

pmol/l

0.32

135

867

Nephrotic syndrome

510

1.74

5.31

2.8

3.4

4.14

4.66

pmol/l

3.11

458

Other adrenocortical overactivity

116

2.73

5.30

3.4

3.3

4.99

4.88

pmol/l

0.24

103

Sequelae of injuries of upper limb

271

2031

1.36

5.29

3.1

3.3

4.53

4.49

pmol/l

0.20

241

1822

Multiple myeloma and malignant plasma cell neoplasms

103

640

1.65

5.28

3.9

3.3

4.38

4.35

pmol/l

0.09

545

Onycholysis

110

2.76

5.28

4.5

3.3

4.48

4.51

pmol/l

0.06

103

Scar conditions and fibrosis of skin

136

905

1.55

5.26

4.0

3.2

4.42

4.54

pmol/l

0.65

121

805

Other lesions of median nerve

459

1.78

5.26

2.8

3.0

4.24

4.49

pmol/l

1.12

389

Benign neoplasm: Small intestine

611

1.67

5.25

2.9

4.17

4.47

pmol/l

2.86

520

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

197

2.22

5.24

3.3

3.4

4.18

4.63

pmol/l

1.85

171

Disorders of oesophagus in diseases classified elsewhere

286

2.00

5.22

3.0

3.1

3.95

4.54

pmol/l

3.63

247

Benign neoplasm: Transverse colon

224

1633

1.40

5.21

3.1

3.2

4.44

4.39

pmol/l

0.30

198

1415

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

555

4476

1.24

5.19

4.3

3.0

4.45

4.42

pmol/l

0.21

499

3877

Benign leiomyoma with endometriosis

533

4361

1.24

5.19

3.2

4.43

4.42

pmol/l

0.02

478

3822

Corns and callosities

186

1316

1.44

5.19

2.8

3.3

4.35

4.47

pmol/l

0.88

156

1166

Other predominantly sexually transmitted diseases, not elsewhere classified

627

5211

1.22

5.19

3.5

4.56

4.58

pmol/l

0.19

556

4721

Other and unspecified types of non-Hodgkin lymphoma, hilmo

597

1.67

5.18

2.7

3.3

4.03

4.43

pmol/l

3.83

515

Benign neoplasm: Other parts of oropharynx

154

2.43

5.17

3.7

3.6

4.48

4.59

pmol/l

0.22

136

Polycystic ovarian syndrome, broad definition

461

3719

1.26

5.17

3.3

3.4

4.58

4.59

pmol/l

0.09

411

3363

Complications of the puerperium, not elsewhere classified

180

1275

1.46

5.15

4.2

3.4

4.58

4.56

pmol/l

0.06

171

1146

Bicipital tendinitis

131

867

1.55

5.15

2.9

3.5

4.48

4.45

pmol/l

0.15

115

784

Cytomegalovirus infection, IBD co-morbidity

367

1.87

5.14

3.4

3.2

4.21

4.69

pmol/l

2.52

323

Other benign neoplasm of uterus: Other parts/unspecified

114

733

1.60

5.13

3.1

2.8

4.59

4.36

pmol/l

0.46

102

620

Beningn neoplasm: Meninges, unspecified

261

2.05

5.12

3.7

2.8

4.02

4.53

pmol/l

3.47

227

Injuries to the wrist and hand

3409

22798

1.09

5.11

3.2

3.4

4.51

4.52

pmol/l

0.20

3004

20453

Convergence insufficiency and excess

326

1.95

5.11

3.0

3.4

4.73

4.67

pmol/l

0.19

289

Other benign neoplasms of connective and other soft tissue

281

2130

1.34

5.10

3.5

3.3

4.54

4.47

pmol/l

0.29

256

1895

Mandibular retrognathia

221

1613

1.40

5.09

2.9

3.2

4.73

4.64

pmol/l

0.50

200

1456

Bell's palsy

317

2443

1.32

5.08

3.0

3.3

4.44

4.48

pmol/l

0.32

279

2178

Diabetic nephropathy, excluding more controls

372

2436

1.29

5.07

2.8

3.3

3.97

4.48

pmol/l

12.58

324

2140

Sequelae of cerebrovascular disease

766

5680

1.19

5.07

3.0

3.2

4.25

4.37

pmol/l

2.59

666

4950

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

247

2.06

5.07

3.0

3.5

4.09

4.66

pmol/l

3.09

213

Diseases of middle ear and mastoid

1963

14484

1.12

5.06

3.2

3.4

4.56

4.57

pmol/l

0.23

1739

12995

Kidney transplant status

128

846

1.55

5.06

2.3

3.5

3.86

4.64

pmol/l

14.17

122

751

Benign neoplasm of brain and other parts of central nervous system

165

1148

1.47

5.05

3.1

3.0

4.40

4.54

pmol/l

0.84

150

1004

Benign neoplasm: Descending colon

141

951

1.51

5.03

2.9

3.0

4.24

4.44

pmol/l

1.42

130

821

Other superficial mycoses

377

1.85

5.03

2.5

3.6

4.37

4.61

pmol/l

1.50

340

Inguinal or femoral hernia, bilateral

185

1311

1.43

5.03

3.4

3.6

4.45

4.41

pmol/l

0.15

164

1163

Beningn neoplasm: Meninges, unspecified

263

2.03

5.01

3.7

2.9

4.02

4.51

pmol/l

3.35

221

Scleritis and episcleritis

192

1378

1.43

5.00

3.2

3.3

4.48

4.51

pmol/l

0.23

168

1237

Sudden idiopathic hearing loss

252

1885

1.36

5.00

3.3

4.29

4.42

pmol/l

1.29

215

1658

Lichen planus

345

2697

1.30

4.98

3.3

3.2

4.37

4.44

pmol/l

0.70

304

2375

Muscle strain

605

1.65

4.97

2.1

3.4

4.42

4.56

pmol/l

0.84

547

Other specified and unspecified disorders of eye and adnexa

114

739

1.59

4.96

2.6

3.3

4.18

4.49

pmol/l

2.96

647

Impacted cerumen

221

1621

1.39

4.96

3.1

3.3

4.34

4.47

pmol/l

0.99

174

1412

Tobacco use

150

1030

1.49

4.96

3.8

3.4

4.56

4.55

pmol/l

0.06

132

915

Acute lymphadenitis

183

1304

1.44

4.94

3.2

3.4

4.55

4.59

pmol/l

0.30

167

1165

Anogenital herpesviral [herpes simplex] infection

228

1688

1.38

4.94

3.5

3.4

4.41

4.58

pmol/l

2.06

202

1523

Von Willebrand disease

294

1.98

4.93

3.3

3.7

4.45

4.66

pmol/l

0.87

261

Benign neoplasm: Skin of other and unspecified parts of face

283

2157

1.33

4.93

3.1

3.2

4.37

4.43

pmol/l

0.53

255

1898

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

149

1023

1.49

4.93

3.0

3.5

4.54

4.56

pmol/l

0.09

139

922

Dermatitis due to substances taken internally

160

1113

1.47

4.93

3.0

3.3

4.44

4.55

pmol/l

0.62

143

989

Chronic Coagulation defects

562

1.69

4.93

3.3

3.5

4.48

4.57

pmol/l

0.35

492

Polycythaemia vera

460

1.74

4.92

2.7

2.9

4.31

4.45

pmol/l

0.81

390

Infectious mononucleosis

286

2187

1.33

4.91

2.9

3.4

4.70

4.68

pmol/l

0.07

255

1975

Other/unspecified enthesopathies, not elsewhere classified

232

1719

1.37

4.90

3.4

4.37

4.46

pmol/l

0.79

213

1536

Other and unspecified disorders of orbit

3.20

4.90

4.0

3.6

4.27

4.49

pmol/l

0.60

Diabetic nephropathy

374

2920

1.28

4.89

2.8

3.3

3.97

4.40

pmol/l

9.52

326

2567

Benign neoplasm: Anus and anal canal

394

1.81

4.89

2.8

4.47

4.52

pmol/l

0.10

334

Fracture at wrist and hand level

936

8072

1.17

4.88

3.2

3.4

4.55

4.56

pmol/l

0.18

818

7241

Optic atrophy

301

1.94

4.87

2.4

3.5

4.35

4.63

pmol/l

0.77

269

Complications predominantly related to the puerperium

1045

9111

1.16

4.87

3.6

3.4

4.47

4.53

pmol/l

0.98

947

8174

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

323

2521

1.31

4.86

3.4

4.61

4.52

pmol/l

0.76

304

2266

Other diseases of peritoneum

134

904

1.52

4.86

3.4

3.2

4.49

4.46

pmol/l

0.10

110

795

Other peripheral vascular diseases

228

1690

1.38

4.84

2.6

3.3

4.35

4.48

pmol/l

1.17

199

1494

Dislocation, sprain and strain of joints and ligaments of thorax

586

1.65

4.84

3.7

3.5

4.53

4.63

pmol/l

0.59

521

Pneumonitis due to solids and liquids

153

1056

1.47

4.84

2.8

3.2

4.16

4.41

pmol/l

1.97

130

908

Viral infections of the central nervous system

211

1546

1.39

4.83

3.0

3.2

4.34

4.53

pmol/l

2.54

188

1383

Benign neoplasm: Other parts of oropharynx

159

2.35

4.83

3.7

3.9

4.48

4.60

pmol/l

0.27

142

Benign neoplasm: Kidney

563

1.67

4.83

3.2

3.5

4.50

4.42

pmol/l

0.26

495

Fracture of femur

562

4238

1.22

4.81

2.8

3.1

4.28

4.36

pmol/l

0.93

480

3642

Intestinal adhesions without obstruction

196

1418

1.41

4.81

3.3

3.2

4.45

4.46

pmol/l

0.05

171

1238

Mental and behavioural disorders associated with the puerperium

298

1.97

4.80

3.5

3.7

4.53

4.68

pmol/l

0.56

265

Benign neoplasm: Duodenum

368

1.83

4.77

3.0

3.2

4.20

4.46

pmol/l

1.69

314

Lichen planus, including avohilmo

495

4053

1.24

4.77

3.2

3.3

4.41

4.43

pmol/l

0.29

430

3586

Diseases of peritoneum

258

1951

1.34

4.77

3.2

3.3

4.22

4.43

pmol/l

2.40

221

1726

Osteonecrosis

150

1038

1.48

4.77

2.7

3.3

4.39

4.47

pmol/l

0.49

136

911

Perioral dermatitis

506

1.71

4.76

3.1

3.3

4.39

4.55

pmol/l

0.94

449

Presbycusis

251

1877

1.34

4.76

3.6

3.0

4.37

4.26

pmol/l

0.98

211

1594

Spondylopathies (FG)

416

3344

1.26

4.75

2.8

3.4

4.57

4.54

pmol/l

0.12

368

3006

Episcleritis

166

1173

1.45

4.75

3.1

3.4

4.53

4.52

pmol/l

0.06

147

1051

Other and unspecified corneal deformities and disorders

597

1.64

4.75

3.8

3.3

4.47

4.55

pmol/l

0.16

529

Other drug-induced secondary parkinsonism

128

2.49

4.75

1.7

3.1

3.83

4.49

pmol/l

2.95

107

Herpesviral keratitis and keratoconjunctivitis

116

763

1.56

4.73

3.1

3.4

4.48

4.53

pmol/l

0.17

107

673

Intentional self-harm by unspecified means

277

1.99

4.73

2.9

3.5

4.55

4.71

pmol/l

0.41

244

Carcinoma in situ of skin of other and unspecified parts of face

137

930

1.50

4.73

2.8

2.9

4.32

4.35

pmol/l

0.12

115

770

Wet age-related macular degeneration

328

2513

1.30

4.73

3.3

3.0

4.28

4.26

pmol/l

0.11

280

2130

In situ neoplasms

1048

9147

1.16

4.73

3.2

4.41

4.43

pmol/l

0.22

913

8053

Streptococcal septicaemia

182

1304

1.42

4.72

3.6

3.4

4.35

4.56

pmol/l

1.32

162

1134

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

190

1370

1.41

4.71

2.9

3.0

4.08

4.46

pmol/l

5.19

169

1181

ILD, hospital admissions 1, main diag only

269

2049

1.33

4.70

2.5

3.3

4.26

4.39

pmol/l

1.03

230

1780

Other acquired deformities of musculoskeletal system and connective tissue

126

845

1.53

4.69

3.2

3.4

4.39

4.56

pmol/l

1.16

119

747

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

117

774

1.56

4.69

2.9

3.4

4.58

4.60

pmol/l

0.06

109

697

Stenosis and insufficiency of lacrimal passages

256

1940

1.34

4.69

3.2

3.1

4.38

4.46

pmol/l

0.72

232

1712

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

222

1649

1.37

4.68

3.3

4.35

4.47

pmol/l

0.63

190

1450

Disorders of tooth development and eruption

150

1013

1.47

4.68

2.8

3.3

4.75

4.71

pmol/l

0.14

133

909

Other and unspecified disorders of skin and subcutaneous tissue

179

1284

1.42

4.67

3.1

3.2

4.38

4.46

pmol/l

0.49

148

1139

Open wound of lower leg

371

2949

1.27

4.67

3.5

3.2

4.35

4.50

pmol/l

1.96

329

2613

Dental caries 2 and operation codes, only avohilmo

2566

14576

1.10

4.67

3.3

4.55

4.52

pmol/l

0.60

2257

13083

Achilles tendinitis

276

2115

1.33

4.65

3.2

3.4

4.58

4.48

pmol/l

0.77

243

1899

Additional codes for the location of defect, injury or illness

157

1102

1.46

4.65

2.9

3.3

4.48

4.53

pmol/l

0.19

142

971

Lichen ruber planus, wide definition including periferal and oral lichen planus

581

4846

1.21

4.64

3.2

3.3

4.38

4.43

pmol/l

0.69

507

4284

Benign neoplasm: Choroid

142

978

1.48

4.63

4.1

3.0

4.36

4.49

pmol/l

0.97

126

849

Disease of hard tissues of teeth, NOS

202

2.15

4.63

3.4

4.20

4.61

pmol/l

1.82

185

Acute nasopharyngitis (common cold)

287

2197

1.31

4.62

3.4

3.3

4.61

4.62

pmol/l

0.01

263

1962

Purpura and other haemorrhagic conditions

337

2653

1.29

4.61

3.5

3.3

4.37

4.49

pmol/l

1.23

303

2348

Hypertrichosis

598

1.64

4.59

3.0

3.3

4.52

4.59

pmol/l

0.28

543

Prolapse and hernia of ovary and fallopian tube

100

634

1.60

4.58

2.3

2.8

4.24

4.31

pmol/l

0.33

519

Mental and behavioural disorders of puerperium, not classified elsewhere

303

1.94

4.57

3.5

3.7

4.53

4.67

pmol/l

0.51

269

Other and unspecified diseases of blood and blood-forming organs

403

1.77

4.57

3.0

3.2

4.32

4.48

pmol/l

0.72

351

Asthma and opportunity respiratory infection

118

786

1.54

4.56

3.4

3.2

4.19

4.39

pmol/l

1.83

103

682

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

120

801

1.53

4.55

2.8

3.0

4.20

4.58

pmol/l

3.16

112

698

Crossbite

202

1375

1.39

4.54

3.3

3.2

4.81

4.79

pmol/l

0.08

181

1250

Other infectious diseases

190

1383

1.40

4.53

3.2

3.3

4.25

4.45

pmol/l

2.04

165

1209

Benign neoplasm: Pancreas

382

1.79

4.52

3.0

4.55

4.48

pmol/l

0.14

329

Schizoid personality disorder

287

1.92

4.52

2.1

3.6

4.50

4.65

pmol/l

0.56

254

Retinal vascular occlusion

242

1828

1.34

4.50

3.1

3.3

4.20

4.38

pmol/l

2.14

212

1584

Other/unspecified cytomegaloviral diseases

317

1.87

4.49

3.5

3.3

4.17

4.64

pmol/l

2.12

283

Carrier of infectious disease

459

1.72

4.49

3.4

4.30

4.58

pmol/l

1.34

403

Tubulo-interstitial nephritis, not specified as acute or chronic

186

1352

1.40

4.48

2.8

3.2

4.31

4.49

pmol/l

0.95

168

1182

Intermittent heterotropia

180

1303

1.41

4.48

3.5

3.2

4.73

4.70

pmol/l

0.11

161

1158

Melanocytic naevi of lower limb, including hip

133

913

1.50

4.47

3.8

3.3

4.53

pmol/l

0.01

122

806

ILD, hospital admissions 3, with pneumonia sepsis

159

1124

1.44

4.47

2.7

3.2

4.19

4.45

pmol/l

2.66

133

968

Acute posthaemorrhagic anaemia

473

1.69

4.46

3.7

3.2

4.15

4.49

pmol/l

2.08

410

Orchitis and epididymitis

145

1007

1.46

4.44

3.3

3.6

4.50

4.52

pmol/l

0.07

125

885

Urethritis and urethral syndrome

430

1.74

4.43

4.1

3.2

4.48

4.63

pmol/l

0.55

376

Ménière disease

255

1949

1.33

4.43

3.3

4.38

4.42

pmol/l

0.30

226

1712

Myasthenia gravis

268

1.95

4.42

2.7

3.4

4.24

4.61

pmol/l

1.37

241

Other or unspecified ileus, impaction or obstruction

406

3278

1.25

4.42

3.1

3.3

4.32

4.44

pmol/l

1.99

349

2866

Other congenital malformations of the digestive system

118

786

1.53

4.42

2.7

3.3

4.71

4.76

pmol/l

0.17

105

709

Attention to artificial openings

505

1.66

4.42

3.8

3.5

4.15

4.50

pmol/l

1.82

449

Dipeptidyl peptidase 4 (DPP-4) inhibitors

252

1921

1.33

4.41

3.1

3.2

4.27

4.41

pmol/l

1.40

218

1691

Cytomegaloviral disease

393

1.77

4.40

3.3

3.4

4.23

4.66

pmol/l

2.22

349

Other erythematous conditions

617

1.60

4.39

2.7

3.4

4.32

4.53

pmol/l

1.15

542

Benign neoplasm: Liver/bile ducts

470

1.70

4.38

3.2

4.50

4.58

pmol/l

0.31

410

Retinal breaks without detachment

396

3198

1.25

4.38

3.4

3.3

4.48

4.45

pmol/l

0.33

355

2827

Retinal vascular disorders

244

1853

1.33

4.38

3.1

3.2

4.19

4.38

pmol/l

2.39

214

1606

Other otitis externa (chronic)

177

1283

1.41

4.37

3.5

3.4

4.45

4.52

pmol/l

0.49

144

1139

Redundant prepuce, phimosis and paraphimosis

339

2670

1.27

4.37

3.2

3.6

4.69

4.66

pmol/l

0.11

302

2389

Spinal osteochondrosis

172

2.19

4.37

3.4

3.5

4.44

4.60

pmol/l

0.40

151

Malignant neoplasm of skin

1538

10376

1.12

4.36

3.1

3.3

4.33

4.37

pmol/l

0.77

1337

9105

Other benign neoplasms of uterus

152

1075

1.45

4.36

3.2

3.1

4.55

4.37

pmol/l

0.44

135

917

Exposure to other and unspecified inanimate mechanical forces

183

1334

1.40

4.36

3.2

3.4

4.53

4.59

pmol/l

0.29

166

1191

Other disorders starting during childhood or adolescence

158

1115

1.44

4.35

2.6

3.3

5.00

4.87

pmol/l

0.36

145

1011

Protozoal diseases

440

1.71

4.33

2.7

3.2

4.11

4.60

pmol/l

3.14

378

Erosion of teeth

314

1.86

4.33

3.7

3.1

4.40

4.59

pmol/l

0.56

285

Other disorders of binocular movement

519

1.66

4.32

3.1

3.5

4.59

4.63

pmol/l

0.14

467

Benign neoplasm: Other/unspecified site

242

1.98

4.30

4.1

3.1

4.41

4.60

pmol/l

0.69

210

Myeloid leukaemia

335

1.81

4.30

3.2

3.0

4.51

4.47

pmol/l

0.09

287

Other aneurysm

107

706

1.54

4.29

2.9

3.3

4.41

4.40

pmol/l

0.01

617

Amblyopia ex anopsia

117

789

1.52

4.29

3.4

3.2

4.55

4.72

pmol/l

0.93

103

701

Other and unspecified erythematous conditions

542

1.63

4.28

2.5

3.3

4.30

4.50

pmol/l

1.02

473

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

566

1.62

4.28

2.8

3.4

4.38

4.65

pmol/l

1.97

497

Early lumbar disc prolapse, operated

310

2442

1.29

4.28

3.3

3.6

4.67

4.57

pmol/l

0.88

282

2215

Other dialysis

457

1.69

4.26

1.6

3.4

3.54

4.58

pmol/l

13.99

404

Mental retardation, wide definition

115

773

1.52

4.26

2.1

3.4

4.84

4.80

pmol/l

0.06

107

693

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

605

1.59

4.25

4.1

3.0

4.52

4.55

pmol/l

0.08

513

Malignant neoplasm of oropharynx

201

2.07

4.25

3.0

3.5

4.16

4.57

pmol/l

1.58

176

Chronic ulcer of skin, not elsewhere classified

150

1061

1.44

4.24

3.0

3.3

4.14

4.45

pmol/l

2.63

128

922

Diabetic retinopathy

869

4746

1.17

4.24

3.0

3.2

4.25

4.38

pmol/l

3.20

752

4191

Contusion of other and unspecified parts of foot

148

1047

1.45

4.24

2.8

3.3

4.54

4.60

pmol/l

0.47

129

939

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

245

1875

1.33

4.23

3.1

3.5

4.45

4.58

pmol/l

1.29

211

1701

Arterial embolism and thrombosis of lower extremity artery

426

1.70

4.23

3.4

3.2

4.15

4.42

pmol/l

1.17

368

Total colectomy operation

112

751

1.53

4.22

4.2

3.6

4.37

4.61

pmol/l

1.68

103

674

Total colectomy

112

751

1.53

4.22

4.2

3.6

4.37

4.61

pmol/l

1.68

103

674

Artificial joint re-operation

162

1164

1.42

4.22

3.2

3.1

4.30

4.38

pmol/l

0.46

136

1018

Diseases of spleen

265

1.92

4.22

4.2

3.6

4.25

4.54

pmol/l

1.59

235

Unspecified lump in breast

544

4563

1.21

4.20

2.9

3.3

4.45

4.46

pmol/l

0.05

482

4051

Dependent personality disorder

415

1.73

4.18

2.4

3.5

4.07

4.62

pmol/l

3.98

370

Congenital malformations of aortic and mitral valves

101

664

1.56

4.17

3.7

3.5

4.55

4.70

pmol/l

0.74

597

Sequelae of injuries of neck and trunk

499

1.65

4.16

3.0

3.4

4.49

4.58

pmol/l

0.38

440

Enteropathic arthropathies

446

1.69

4.15

2.9

3.6

4.36

4.54

pmol/l

0.69

405

Benign intracranial hypertension

233

2.01

4.14

3.6

3.7

4.67

4.68

pmol/l

0.02

210

Olecranon bursitis

120

817

1.49

4.14

3.3

3.6

4.58

4.46

pmol/l

0.51

110

737

Coronary revascularization (ANGIO or CABG)

1006

6144

1.15

4.14

2.9

3.3

4.29

4.43

pmol/l

3.68

905

5385

Torsion of ovary, ovarian pedicle and fallopian tube

581

1.61

4.13

3.4

3.3

4.55

4.57

pmol/l

0.06

522

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1175

7152

1.14

4.13

3.0

4.37

4.40

pmol/l

0.43

1001

6245

Dissocial personality disorder

246

1.94

4.10

3.0

3.7

4.50

4.77

pmol/l

1.10

224

Dislocation, sprain and strain of joints and ligaments of knee

1998

16940

1.10

4.10

3.2

3.4

4.55

4.54

pmol/l

0.05

1798

15224

Other diseases of gallbladder

117

797

1.50

4.09

3.1

3.2

4.38

4.46

pmol/l

0.43

106

697

Carcinoma in situ of skin of trunk

303

1.83

4.09

3.1

2.8

4.24

4.38

pmol/l

0.57

252

Rare circulating lymphoid malignancy

408

1.71

4.09

3.2

3.3

4.41

4.56

pmol/l

0.60

366

Asthma mixed form (mode), excluding more controls

137

960

1.45

4.09

3.0

3.4

4.38

4.53

pmol/l

1.39

129

842

Conotruncal defects

240

1.96

4.08

5.4

3.6

4.80

4.85

pmol/l

0.07

219

Mixed disorders of conduct and emotions

542

1.62

4.07

2.6

3.5

4.72

4.85

pmol/l

0.58

483

malignant neoplasm of female genital organs

445

3674

1.23

4.06

4.5

3.1

4.43

4.40

pmol/l

0.18

406

3193

Factitial dermatitis

2.70

4.05

2.7

3.2

4.36

4.60

pmol/l

0.22

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1148

7005

1.14

4.05

3.0

4.36

4.40

pmol/l

0.47

978

6116

Inguinal hernia, bilateral

174

1271

1.38

4.05

3.5

3.6

4.45

4.41

pmol/l

0.20

154

1128

Paralytic strabismus

165

1198

1.40

4.05

3.2

3.3

4.39

4.47

pmol/l

0.45

148

1043

Carcinoma in situ of other and unspecified sites

326

1.79

4.04

2.9

3.2

4.33

4.44

pmol/l

0.37

273

Personal history of malignant neoplasm

112

760

1.52

4.03

3.6

3.2

4.47

4.50

pmol/l

0.10

658

Benign neoplasm: Small intestine

654

1.55

4.03

2.9

3.1

4.17

4.43

pmol/l

2.26

566

Carcinoma in situ, bladder

297

1.83

4.02

2.8

3.2

4.28

4.43

pmol/l

0.55

248

Diabetic neuropathy

250

1922

1.31

4.01

2.6

3.3

4.08

4.36

pmol/l

3.20

218

1691

Autoimmune hepatitis

2.58

4.00

3.6

3.1

4.30

4.48

pmol/l

0.35

Adrenomedullary hyperfunction

3.42

3.99

4.7

3.7

4.23

4.56

pmol/l

0.55

Other/unspecified disorders of vestibular function

656

1.55

3.98

3.2

3.3

4.25

4.46

pmol/l

1.44

573

Brain meningioma, excluding all cancers (controls excluding all cancers)

134

943

1.45

3.97

3.2

2.9

4.27

4.45

pmol/l

1.12

123

811

Rheumatoid arthritis

931

7417

1.15

3.97

2.8

3.4

4.31

4.45

pmol/l

2.83

821

6573

Chronic suppurative otitis media, including avohilmo

207

1563

1.35

3.95

3.6

3.2

4.45

4.56

pmol/l

0.87

177

1384

Injury of unspecified body region

190

1417

1.36

3.95

2.9

3.3

4.41

4.52

pmol/l

0.69

172

1253

Melanoma in situ

537

1.60

3.94

3.3

3.0

4.22

4.49

pmol/l

2.17

461

Acne vulgaris

261

2037

1.30

3.93

3.2

3.4

4.59

4.70

pmol/l

1.12

233

1845

Other noninfective disorders of lymphatic vessels and lymph nodes

104

699

1.53

3.93

3.5

3.4

4.16

4.52

pmol/l

2.94

605

Cholera

124

863

1.47

3.93

3.7

3.0

4.33

4.38

pmol/l

0.26

117

755

Gestational [pregnancy-induced] hypertension

1055

9331

1.14

3.92

3.4

4.52

4.53

pmol/l

0.04

968

8391

Achalasia of cardia

257

1.89

3.92

2.6

3.7

4.47

4.51

pmol/l

0.09

224

SLE, ICD10

115

791

1.50

3.91

2.7

3.3

4.13

4.50

pmol/l

4.00

101

692

SLE, strict definition

115

791

1.50

3.91

2.7

3.3

4.13

4.50

pmol/l

4.00

101

692

Recurrent dislocation of patella

187

1397

1.37

3.90

3.7

3.4

4.53

4.59

pmol/l

0.47

166

1260

Dental caries 3 and operation codes, only avohilmo

1149

5109

1.14

3.89

3.1

3.2

4.53

pmol/l

0.07

1021

4616

Foreign body in respiratory tract

140

997

1.43

3.89

3.7

3.3

4.50

4.58

pmol/l

0.42

125

879

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1192

7268

1.13

3.88

3.0

4.36

4.40

pmol/l

0.62

1010

6340

Other obstructive and reflux uropathy

126

881

1.46

3.87

3.4

3.3

4.47

4.58

pmol/l

0.54

112

779

Other disorders involving the immune mechanism, not elsewhere classified

493

1.63

3.86

3.8

3.6

4.41

4.67

pmol/l

0.79

436

Benign neoplasm: Anus and anal canal

423

1.68

3.86

2.8

3.2

4.47

4.41

pmol/l

0.13

365

Allergic colitis

439

1.67

3.84

3.1

3.4

4.99

4.91

pmol/l

0.19

396

Encephalitis

518

1.61

3.84

3.2

3.4

4.30

4.56

pmol/l

1.41

457

Acquired absence of organs, not elsewhere classified

154

2.17

3.83

3.7

3.6

4.30

4.48

pmol/l

0.29

136

Benign neoplasm of bone and articular cartilage

237

1834

1.31

3.83

2.8

3.3

4.51

4.53

pmol/l

0.13

213

1650

LSIL lesion of the cervix uteri, vagina or vulva

544

4608

1.20

3.82

3.1

3.4

4.49

4.51

pmol/l

0.15

475

4160

Family history of malignant neoplasm

349

2832

1.25

3.81

3.4

3.3

4.46

4.54

pmol/l

0.83

321

2526

Primary coxarthrosis, bilateral

651

5583

1.18

3.80

3.1

3.2

4.32

4.37

pmol/l

0.61

568

4879

Vascular dementia (mixed)

121

2.30

3.80

1.8

2.8

4.15

4.06

pmol/l

0.21

105

Disorders of continuity of bone

269

2118

1.29

3.79

3.2

3.3

4.41

4.52

pmol/l

0.73

249

1896

Other and unspecified intracranial injuries

464

1.64

3.79

3.5

3.2

4.34

4.63

pmol/l

1.85

414

Peripheral artery operations in Hilmo

219

1673

1.32

3.79

3.4

3.2

3.98

4.37

pmol/l

7.22

197

1445

Peripheral artery disease

912

6437

1.15

3.78

3.1

3.2

4.08

4.38

pmol/l

16.60

794

5620

Volvulus

387

1.70

3.78

3.8

3.3

4.28

4.54

pmol/l

1.37

332

Cholecystitis

305

2435

1.27

3.77

3.1

3.2

4.32

4.43

pmol/l

1.11

274

2141

Chronic suppurative otitis media

176

1308

1.37

3.76

3.7

3.3

4.46

4.54

pmol/l

0.47

146

1165

Other disorders affecting eyelid function

136

2.26

3.76

6.3

3.1

4.17

4.50

pmol/l

1.28

119

Meralgia paraesthetica

625

1.55

3.75

3.1

3.4

4.53

pmol/l

0.00

552

Specific development disorders of speech and language

146

1013

1.41

3.74

3.1

3.2

4.83

4.78

pmol/l

0.15

130

904

Viral pneumonia (known virus, not influenza)

328

1.76

3.73

2.9

3.1

4.81

4.62

pmol/l

0.14

291

Burns and corrosions

355

2889

1.24

3.72

3.5

3.3

4.56

pmol/l

0.03

317

2568

Other and unspecified mononeuropathies of upper limb

562

1.57

3.72

2.6

3.7

4.44

4.55

pmol/l

0.52

504

Benign neoplasm: Liver

429

1.67

3.72

3.2

4.42

4.58

pmol/l

0.81

376

Drug-induced cataract

421

1.67

3.71

2.3

3.0

4.22

4.61

pmol/l

2.06

369

Papilloedema, unspecified

437

1.66

3.70

2.5

3.5

4.50

4.60

pmol/l

0.27

388

Suppurative and necrotic conditions of lower respiratory tract

105

714

1.50

3.70

3.2

3.3

4.18

4.49

pmol/l

2.21

626

Drug-induced obesity

185

2.06

3.70

3.7

3.8

4.45

4.58

pmol/l

0.30

165

Organic, including symptomatic, mental disorders

1087

6963

1.13

3.70

2.7

3.3

4.30

4.36

pmol/l

1.19

908

6059

Benign neoplasm: Skin of eyelid, including canthus

391

3217

1.23

3.70

3.2

4.39

4.43

pmol/l

0.34

343

2835

Alzheimer disease, excluding more controls

333

1785

1.26

3.69

2.6

3.4

4.29

4.37

pmol/l

0.85

271

1566

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2003

14449

1.10

3.68

3.2

3.4

4.54

4.51

pmol/l

0.48

1802

12998

Osteomyelitis

131

931

1.43

3.66

2.7

3.4

4.00

4.50

pmol/l

4.39

111

824

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

217

1671

1.32

3.66

3.1

3.4

4.45

4.44

pmol/l

0.09

193

1482

Hereditary hypogammaglobulinemia

2.87

3.65

3.0

3.4

3.96

4.39

pmol/l

1.03

Synovial cyst of popliteal space [Baker]

186

1401

1.35

3.65

3.5

3.3

4.59

4.45

pmol/l

0.42

167

1243

Anxious personality disorder

400

1.68

3.65

2.3

3.6

4.49

4.67

pmol/l

0.89

363

Viral hepatitis

199

1514

1.34

3.65

2.6

3.4

4.54

4.57

pmol/l

0.17

169

1364

Emphysema

129

914

1.43

3.65

2.9

3.4

4.21

4.40

pmol/l

1.22

107

782

Status post-ami

110

616

1.48

3.64

3.0

4.06

4.24

pmol/l

1.16

518

Open wound of forearm

222

1714

1.31

3.64

3.0

3.3

4.41

4.54

pmol/l

1.39

189

1512

Congenital deformities of feet

526

1.59

3.63

2.4

3.3

4.65

4.70

pmol/l

0.14

469

D07AA Corticosteroids, weak (group I)

471

3948

1.20

3.63

2.8

3.3

4.52

4.57

pmol/l

0.38

416

3541

Meningitis

134

960

1.42

3.62

3.2

3.3

4.44

4.55

pmol/l

0.57

114

844

Viral encephalitis, not elsewhere classified/unspecified

324

1.75

3.61

2.5

3.2

4.12

4.59

pmol/l

3.13

287

Other peripheral vertigo

237

1849

1.30

3.61

3.2

3.3

4.35

4.44

pmol/l

0.71

205

1635

Overexertion and strenuous or repetitive movements

265

2096

1.28

3.61

3.5

3.4

4.41

4.52

pmol/l

1.32

236

1878

Vascular dementia

122

827

1.44

3.60

2.5

2.8

4.20

4.24

pmol/l

0.19

697

Later onset COPD

492

3243

1.20

3.60

3.1

4.19

4.27

pmol/l

0.76

419

2777

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

138

991

1.41

3.59

2.8

3.2

4.09

4.42

pmol/l

3.98

121

853

Spermatocele

115

800

1.45

3.58

3.2

3.6

4.45

4.43

pmol/l

0.10

102

696

Convergent concomitant strabismus

178

1338

1.36

3.58

3.7

3.2

4.38

4.62

pmol/l

3.37

166

1194

Mental retardation

107

737

1.48

3.58

2.0

3.4

4.88

4.82

pmol/l

0.08

662

Other and unspecified follicular disorders

103

705

1.50

3.58

3.8

3.4

4.28

4.58

pmol/l

2.34

630

Erythema nodosum

633

1.53

3.57

2.6

3.5

4.41

4.53

pmol/l

0.41

558

Benign neoplasm: Conjunctiva

544

1.57

3.55

2.4

3.1

4.28

4.60

pmol/l

2.28

469

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

152

2.11

3.55

3.0

3.1

4.06

4.45

pmol/l

1.19

132

Failed induction of labour

237

1860

1.30

3.55

3.3

3.4

4.62

4.58

pmol/l

0.29

206

1691

Preterm labour and delivery

985

8753

1.14

3.54

3.2

3.4

4.42

4.50

pmol/l

1.83

879

7886

Open wound of ankle and foot

245

1924

1.29

3.53

2.8

3.4

4.39

4.53

pmol/l

1.08

219

1705

ILD-related respiratory insufficiency

379

1.67

3.52

2.0

3.3

4.07

4.32

pmol/l

1.13

328

Non-small cell lung cancer, adenocarcinoma, helper endpoint

127

905

1.43

3.52

3.1

3.2

4.17

4.36

pmol/l

1.36

119

776

Non-small cell lung cancer, adenocarcinoma

127

905

1.43

3.52

3.1

3.2

4.17

4.36

pmol/l

1.36

119

776

Malignant neoplasm of brain

537

1.56

3.51

2.5

3.4

4.16

4.60

pmol/l

2.58

476

Hydronephrosis

257

2031

1.28

3.51

3.2

3.3

4.19

4.50

pmol/l

5.95

235

1784

Benign neoplasm: Other/unspecified site

260

1.84

3.51

4.1

3.4

4.41

4.54

pmol/l

0.41

228

Endometriosis of rectovaginal septum and vagina

261

2072

1.28

3.50

3.0

3.3

4.42

4.50

pmol/l

0.81

219

1816

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

102

702

1.50

3.49

6.9

2.9

4.31

4.46

pmol/l

1.14

597

Mental and behavioural disorders due to tobacco

217

1682

1.31

3.49

3.3

3.4

4.47

4.46

pmol/l

0.02

192

1507

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

524

1.58

3.48

5.3

2.8

4.44

4.51

pmol/l

0.19

445

Down's syndrome

2.71

3.48

2.9

3.5

4.91

4.98

pmol/l

0.06

Seronegative rheumatoid arthritis

325

2643

1.25

3.48

2.8

3.4

4.27

4.47

pmol/l

3.82

289

2351

Myeloid leukaemia

358

1.69

3.47

3.2

3.3

4.51

4.50

pmol/l

0.03

310

Other specified/unspecified inflammatory spondylopathies

152

1122

1.38

3.46

2.9

3.4

4.54

4.53

pmol/l

0.08

135

1008

Other diseases of pancreas

166

1240

1.36

3.46

2.7

3.2

4.22

4.41

pmol/l

1.91

145

1092

Other salmonella infections

102

702

1.49

3.46

2.2

3.3

4.34

4.52

pmol/l

0.73

611

Benign neoplasm: Peripheral nerves and autonomic nervous system

232

1.88

3.45

2.3

3.4

4.07

4.61

pmol/l

2.49

203

Barrett oesophagus

100

685

1.49

3.44

3.3

3.5

4.60

4.43

pmol/l

1.07

601

Other/unspecified rheumatoid arthritis

326

2655

1.24

3.44

3.0

3.1

4.30

4.41

pmol/l

0.66

298

2327

Other and unspecified injuries of head

152

1122

1.38

3.44

2.6

3.3

4.33

4.53

pmol/l

1.99

129

992

Presence of other devices

495

4188

1.19

3.42

3.0

3.1

4.40

pmol/l

0.03

440

3632

Generalized skin eruption due to drugs and medicaments

109

762

1.46

3.42

3.0

3.3

4.42

4.55

pmol/l

0.54

670

Acute bronchiolitis

162

1084

1.36

3.42

3.4

3.2

4.99

4.95

pmol/l

0.13

149

974

Exposure to other and unspecified animate mechanical forces

615

1.52

3.41

2.8

3.3

4.54

4.68

pmol/l

0.67

545

Trichomoniasis

142

2.16

3.40

3.7

3.0

4.11

4.48

pmol/l

1.48

121

Diffuse brain injury

532

1.55

3.40

2.4

3.5

4.51

4.61

pmol/l

0.47

471

Macular cyst

345

1.70

3.40

2.6

3.3

4.13

4.38

pmol/l

1.58

298

Other disorders of male genital organs

390

1.64

3.39

4.0

3.9

4.86

4.66

pmol/l

0.40

353

Smoking dependency

217

1690

1.30

3.38

3.3

3.4

4.47

4.46

pmol/l

0.04

192

1514

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

145

1065

1.38

3.38

3.1

3.2

4.56

4.50

pmol/l

0.29

127

932

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

197

1510

1.32

3.38

2.4

2.8

4.20

4.35

pmol/l

1.01

162

1263

Open wound of wrist and hand

1181

10516

1.12

3.37

3.2

3.4

4.52

4.56

pmol/l

0.76

1051

9478

Chronic nephritic syndrome

640

1.50

3.36

2.3

3.5

4.11

4.57

pmol/l

4.96

564

Umbilical hernia

635

5494

1.16

3.36

3.2

3.4

4.42

4.50

pmol/l

1.15

555

4921

COPD, hospital admission 2, with asthma infections

640

4717

1.16

3.35

3.1

3.3

4.16

4.37

pmol/l

6.49

546

4135

Other interventions on the root canals of the tooth

363

1.69

3.35

3.7

3.4

4.46

4.60

pmol/l

0.31

325

Injuries involving multiple body regions

102

707

1.48

3.35

2.2

3.3

4.51

4.57

pmol/l

0.29

629

Recurring oral aphthae

127

917

1.42

3.33

3.0

3.2

4.62

4.56

pmol/l

0.26

114

809

Frontotemporal dementia

2.83

3.33

2.1

2.9

4.02

4.27

pmol/l

—

Type of accident

771

6771

1.15

3.32

2.9

3.3

4.43

4.52

pmol/l

1.73

684

6025

Uterine polyps

304

2472

1.25

3.31

3.3

4.59

4.49

pmol/l

0.55

275

2173

Use of levodopa decarboxylase inhibitor

243

1922

1.28

3.30

2.5

3.2

4.35

4.33

pmol/l

0.13

201

1649

Myocardial infarction, with ST-elevation

296

2393

1.25

3.30

3.3

3.2

4.32

4.36

pmol/l

0.17

263

2075

Acute generalized exanthematous pustulosis

121

869

1.42

3.28

3.0

3.3

4.43

4.54

pmol/l

0.45

106

762

Drug-induced neutropenia

187

1436

1.33

3.27

3.6

3.4

4.48

4.46

pmol/l

0.05

166

1271

Coxarthrosis, primary, with hip surgery

1097

9330

1.12

3.27

3.0

3.3

4.34

4.37

pmol/l

0.51

968

8167

Asthma mixed form (mode)

137

1003

1.39

3.26

3.0

3.4

4.38

4.51

pmol/l

1.19

129

883

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

459

1.59

3.25

3.8

3.6

4.36

4.66

pmol/l

1.10

409

Other disorders of bone density and structure

516

1.56

3.25

3.8

3.3

4.49

4.64

pmol/l

0.56

459

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

288

1.75

3.25

3.0

3.4

4.14

4.58

pmol/l

2.28

249

Other and unspecified haemorrhagic conditions

259

1.80

3.25

4.0

3.4

4.46

4.54

pmol/l

0.15

231

Benign neoplasm: Liver/bile ducts

509

1.56

3.24

3.2

3.4

4.50

4.57

pmol/l

0.25

448

Effects of foreign body entering through natural orifice

581

5011

1.17

3.22

3.3

4.58

4.55

pmol/l

0.24

518

4480

ILD medications: azathioprine

415

3484

1.20

3.22

2.8

3.4

4.36

4.58

pmol/l

4.79

370

3104

Other disorders of iris and ciliary body

389

1.63

3.22

3.2

3.3

4.25

4.56

pmol/l

1.57

334

Benign neoplasm: Skin, unspecified

101

705

1.46

3.21

3.1

4.37

4.52

pmol/l

1.03

611

Acute drug-induced interstitial lung disorder

105

2.31

3.20

2.4

2.6

4.29

4.30

pmol/l

0.01

Lesion of plantar nerve

177

1354

1.33

3.20

2.8

3.3

4.46

pmol/l

0.00

158

1199

Coronary artery bypass grafting

477

3073

1.19

3.20

2.9

3.3

4.09

4.39

pmol/l

9.76

416

2680

Carcinoma in situ of skin of other and unspecified parts of face

137

1006

1.38

3.20

2.8

3.0

4.32

pmol/l

0.02

115

849

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

606

1.50

3.19

2.6

3.0

4.28

4.56

pmol/l

1.60

519

Keratoconus

406

1.62

3.19

3.1

3.6

4.75

4.72

pmol/l

0.09

366

Intussusception

415

1.62

3.18

4.0

3.2

4.40

4.55

pmol/l

0.81

359

Benign neoplasm: Long bones of lower limb

591

1.51

3.18

3.0

3.2

4.55

4.63

pmol/l

0.38

520

Benign neoplasm of brain and other parts of central nervous system

165

1250

1.34

3.18

3.1

3.3

4.40

4.48

pmol/l

0.40

150

1099

Carcinoma in situ of skin of ear and external auricular canal

2.31

3.18

2.6

2.5

4.09

4.20

pmol/l

0.27

Erythema intertrigo

360

1.66

3.17

2.8

3.4

4.18

4.62

pmol/l

2.11

316

Lichen simplex chronicus

608

1.50

3.17

2.7

3.4

4.47

4.55

pmol/l

0.32

538

Nummular dermatitis

186

1433

1.32

3.16

3.3

4.40

4.47

pmol/l

0.46

171

1262

Anisometropia and aniseikonia

609

1.50

3.16

3.4

3.0

4.44

4.61

pmol/l

0.90

533

Personal history of allergy to drugs, medicaments and biological substances

203

1.91

3.15

3.9

3.3

4.14

4.63

pmol/l

3.56

181

Endometriosis ASRM stages 3,4

851

7563

1.14

3.13

3.2

3.3

4.45

4.48

pmol/l

0.42

756

6714

Habit and impulse disorders

308

1.71

3.12

2.6

3.7

4.63

4.72

pmol/l

0.27

281

Ulcer of vagina/vulva

596

1.51

3.12

3.4

3.3

4.36

4.53

pmol/l

1.07

533

Other and unspecified psoriasis

158

1193

1.35

3.12

2.7

3.5

4.40

4.47

pmol/l

0.38

140

1058

Abdominal aortic aneurysm (AAA)

132

958

1.38

3.11

3.0

3.2

3.96

4.27

pmol/l

2.68

119

817

Dementia in other diseases classified elsewhere

626

1.48

3.10

2.9

3.2

4.44

4.40

pmol/l

0.08

542

Bronchitis, not specified as acute or chronic

208

1630

1.29

3.09

3.0

3.4

4.43

4.48

pmol/l

0.29

184

1430

Traumatic subarachnoid haemorrhage

424

1.58

3.09

2.6

3.2

4.25

4.55

pmol/l

1.46

370

Palmar fascial fibromatosis [Dupuytren]

281

2278

1.24

3.09

3.0

3.4

4.32

4.38

pmol/l

0.45

249

2025

Primary open-angle glaucoma, strict

568

4899

1.17

3.08

3.0

3.2

4.28

4.33

pmol/l

0.55

487

4224

Drug-induced tremor

2.37

3.08

1.7

3.0

4.22

4.32

pmol/l

0.17

Infective dermatitis

288

2346

1.24

3.08

3.0

3.4

4.29

4.50

pmol/l

3.33

253

2084

Benign neoplasm: Skin of ear and external auricular canal

570

1.50

3.08

3.0

2.9

4.27

4.51

pmol/l

1.27

491

Iridocyclitis

606

5267

1.16

3.07

3.1

3.3

4.43

4.48

pmol/l

0.61

539

4692

Amputation

165

1253

1.33

3.07

3.0

3.2

3.85

4.41

pmol/l

10.40

148

1081

Other bursal cyst

264

1.77

3.06

2.7

3.1

4.27

4.50

pmol/l

1.07

234

Dislocation, sprain and strain of joints and ligaments of head

122

889

1.40

3.06

3.4

4.60

4.64

pmol/l

0.15

103

791

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

341

1.67

3.06

3.7

3.4

4.43

4.83

pmol/l

2.63

309

Progressive vascular leukoencephalopathy

386

1.61

3.06

3.0

2.7

4.13

4.27

pmol/l

0.65

323

Burns and corrosions confined to eye and internal organs

507

1.54

3.06

4.0

3.6

4.58

4.68

pmol/l

0.38

456

Alzheimer’s disease (Atypical or mixed), excluding more controls

119

741

1.40

3.06

2.9

3.2

4.16

4.30

pmol/l

0.70

637

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

702

5926

1.15

3.05

3.0

2.9

4.38

4.42

pmol/l

0.34

625

5139

Peripheral arterial reconstruction

282

2291

1.24

3.04

3.0

3.1

4.04

4.33

pmol/l

4.83

253

1951

Glaucoma-related operations

116

838

1.41

3.04

3.7

3.2

4.33

4.38

pmol/l

0.19

102

718

Chromosomal abnormalities, not elsewhere classified

419

1.60

3.04

3.0

3.5

4.78

4.82

pmol/l

0.09

371

Supplementary factors related to causes of morbidity and mortality classified elsewhere

832

7389

1.13

3.04

3.0

3.3

4.46

4.52

pmol/l

1.14

737

6570

Benign neoplasm: Choroid

142

1061

1.36

3.03

4.1

3.3

4.35

4.44

pmol/l

0.50

126

930

Superficial injury of hip and thigh

334

2764

1.22

3.02

2.9

3.2

4.42

4.47

pmol/l

0.42

281

2423

Vertigo of central origin

220

1.83

3.02

2.8

3.1

4.23

4.42

pmol/l

0.53

186

Antepartum haemorrhage, not elsewhere classified

345

2875

1.22

3.02

3.6

3.5

4.64

4.53

pmol/l

0.72

320

2581

Benign neoplasm: Skin of trunk

104

739

1.44

3.01

4.0

3.1

4.33

4.50

pmol/l

1.17

644

Nonspecific lymphadenitis

183

1420

1.31

3.00

3.3

4.56

4.52

pmol/l

0.20

170

1272

Other congenital malformations of peripheral vascular system

274

1.75

3.00

2.8

3.3

4.52

4.65

pmol/l

0.43

241

Systemic lupus erythematosus, unspecified

692

1.46

2.99

2.7

3.3

4.11

4.51

pmol/l

4.12

606

Benign neoplasm of middle ear and respiratory system

175

1348

1.32

2.99

2.9

3.3

4.35

4.45

pmol/l

0.58

160

1188

Circumscribed brain atrophy

235

1.79

2.99

2.3

3.1

4.14

4.43

pmol/l

0.83

204

Certain conditions originating in the perinatal period

254

1813

1.26

2.99

3.1

3.3

4.95

4.83

pmol/l

0.47

232

1646

Other diseases of biliary tract

187

1454

1.30

2.98

3.1

3.2

4.23

4.42

pmol/l

2.37

165

1271

Late syphilis

192

1.89

2.98

3.1

3.3

3.99

4.62

pmol/l

3.73

170

Presbyopia

174

1343

1.32

2.97

3.4

3.3

4.40

4.49

pmol/l

0.64

148

1195

Azathioprine

415

3513

1.19

2.97

2.8

3.3

4.36

4.58

pmol/l

4.71

370

3133

Family history of certain disabilities and chronic diseases leading to disablement

148

1118

1.35

2.97

2.7

3.3

4.52

4.62

pmol/l

0.78

135

996

Psoriasis vulgaris

468

4001

1.18

2.96

2.9

3.3

4.45

4.48

pmol/l

0.26

415

3573

Social disorders starting during childhood or adolecense, excluding more controls

122

2.14

2.96

5.4

3.1

4.74

5.19

pmol/l

1.35

113

Allergic contact dermatitis

434

3693

1.19

2.95

3.2

3.4

4.48

4.52

pmol/l

0.38

370

3330

Dental caries 1 and operation codes, only avohilmo

961

4312

1.13

2.95

3.1

3.2

4.52

pmol/l

0.03

854

3890

Coronary angioplasty

767

5200

1.14

2.95

3.0

3.3

4.34

4.42

pmol/l

1.10

700

4551

Disorders of brain, other and unspecified

136

2.07

2.94

2.4

3.4

4.05

4.49

pmol/l

1.16

120

Fasciculation

223

1.83

2.94

3.0

3.7

4.47

4.60

pmol/l

0.41

199

Drug-induced hypoglycaemia without coma

237

1.78

2.93

3.0

3.4

4.01

4.63

pmol/l

2.65

209

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

389

1.59

2.93

5.5

3.0

4.38

4.34

pmol/l

0.13

333

Spinal instabilities

586

1.49

2.93

2.9

3.5

4.37

4.52

pmol/l

0.72

517

Primary open-angle glaucoma

693

5941

1.14

2.92

2.9

3.2

4.31

4.33

pmol/l

0.16

596

5126

Carcinoma in situ of skin

145

1092

1.35

2.91

3.0

4.26

4.42

pmol/l

1.32

128

923

Divergent concomitant strabismus

227

1817

1.27

2.90

3.6

3.3

4.45

4.52

pmol/l

0.64

209

1618

Hepatic failure, not elsewhere classified

570

1.49

2.90

2.6

3.4

4.15

4.52

pmol/l

1.53

506

Parkinson's disease, including avohilmo

288

2360

1.23

2.90

2.6

3.2

4.38

4.33

pmol/l

0.44

242

2040

Inflammatory bowel disease

915

8198

1.12

2.89

3.4

4.50

4.53

pmol/l

0.39

818

7316

Lesion of sciatic nerve

652

1.45

2.89

3.0

3.2

4.16

4.36

pmol/l

1.13

561

Lack of expected normal physiological development

354

1.59

2.89

2.4

3.3

4.89

5.05

pmol/l

0.53

324

Other localized connective tissue disorders

386

1.61

2.89

3.2

3.3

4.50

4.53

pmol/l

0.03

344

Other and unspecified paralytic syndromes

254

1.76

2.88

1.8

3.4

4.35

4.59

pmol/l

1.01

221

Frontotemporal dementia, wide, incl. Pick's disease

2.51

2.88

2.1

3.1

4.02

4.30

pmol/l

—

Polypectomy (DHB20)

144

1086

1.34

2.88

2.9

3.5

4.66

4.47

pmol/l

0.65

133

966

Alopecia areata

590

1.48

2.86

3.5

3.2

4.49

4.62

pmol/l

0.65

521

Intrahepatic Cholestasis of Pregnancy (ICP)

279

2293

1.24

2.85

2.8

3.4

4.58

4.54

pmol/l

0.27

258

2069

Other epidermal thickening

106

764

1.41

2.85

3.0

3.3

4.38

4.53

pmol/l

0.95

679

Corneal scars and opacities

410

1.57

2.85

4.3

3.4

4.49

4.62

pmol/l

0.22

360

Injuries to the shoulder and upper arm

2469

19358

1.07

2.85

3.0

3.3

4.46

4.50

pmol/l

0.91

2152

17258

Mild mental retardation

459

1.54

2.84

2.0

3.5

5.24

4.78

pmol/l

0.64

411

Other protozoal intestinal diseases

263

1.74

2.83

3.1

3.3

4.47

4.57

pmol/l

0.34

231

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

388

2727

1.19

2.83

3.7

2.9

4.25

4.37

pmol/l

1.46

351

2349

Basal cell carcinoma, including avohilmo

1345

9669

1.10

2.83

3.0

3.3

4.35

4.36

pmol/l

0.19

1153

8475

Pyothorax

531

1.49

2.83

3.2

3.3

4.18

4.46

pmol/l

1.42

471

Postpartum haemorrhage

1032

8117

1.12

2.82

3.7

3.4

4.57

4.55

pmol/l

0.23

929

7343

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

279

2297

1.24

2.81

2.8

3.5

4.58

4.57

pmol/l

0.01

258

2086

Moderate visual impairment, binocular

395

1.58

2.80

2.3

3.1

4.06

4.41

pmol/l

2.11

334

Primary biliary cholangitis (PBC)

325

1.64

2.80

2.3

2.9

4.42

4.53

pmol/l

0.25

290

Benign neoplasm: Liver

462

1.54

2.79

3.2

3.4

4.42

4.54

pmol/l

0.55

405

Eustachian salpingitis and obstruction

242

1961

1.25

2.78

3.6

3.5

4.50

4.62

pmol/l

1.17

222

1769

Monoplegia

249

1.74

2.78

2.5

3.4

4.48

4.60

pmol/l

0.34

216

Tongue abnormality

155

1190

1.33

2.78

2.8

3.3

4.40

4.46

pmol/l

0.42

131

1043

5-aminosalicylic acid

598

5235

1.15

2.77

3.3

3.4

4.47

4.57

pmol/l

1.71

531

4684

Other diseases of spinal cord

502

1.51

2.77

2.6

3.3

4.43

4.62

pmol/l

0.83

438

Basal cell carcinoma

1301

9461

1.10

2.77

3.0

3.3

4.34

4.36

pmol/l

0.23

1116

8282

Carcinoma in situ of skin of trunk

341

1.62

2.77

3.1

3.0

4.24

4.26

pmol/l

0.08

291

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

115

846

1.39

2.75

3.4

3.0

4.47

4.54

pmol/l

0.35

105

736

Recurrent dislocation and subluxation of joint

203

1614

1.28

2.75

3.3

3.5

4.44

4.58

pmol/l

1.27

175

1457

Other vitreous opacities

677

1.43

2.75

2.4

3.3

4.37

4.45

pmol/l

0.36

594

Isolated proteinuria

495

1.51

2.75

3.3

3.6

4.26

4.60

pmol/l

1.92

431

Carcinoma in situ of other and unspecified digestive organs

303

1.66

2.74

3.3

2.9

4.34

4.51

pmol/l

0.44

255

Bitten or struck by other mammals

331

2772

1.21

2.74

3.7

3.3

4.68

4.53

pmol/l

1.46

292

2483

Brain meningioma

131

985

1.36

2.73

3.2

4.27

4.43

pmol/l

0.81

120

852

Other facial nerve disorders

537

1.49

2.73

2.1

3.5

4.18

4.52

pmol/l

2.33

475

Other encephalitis

496

1.51

2.73

3.3

3.5

4.26

4.56

pmol/l

1.49

439

Lichen sclerosus et atrophicus

283

2337

1.23

2.73

3.0

3.1

4.34

4.47

pmol/l

1.55

252

2067

Oesophagitis

123

916

1.36

2.71

2.5

3.6

4.31

4.50

pmol/l

1.09

104

803

Oral leukoplakia and related diseases, including avohilmo

210

1680

1.27

2.71

3.4

3.3

4.37

4.42

pmol/l

0.37

185

1492

Unspecified nephritic syndrome

344

1.61

2.70

4.2

3.4

4.06

4.51

pmol/l

3.12

301

Haemolytic anaemias

571

1.47

2.69

2.7

3.2

4.19

4.62

pmol/l

2.46

499

Follow-up care involving plastic surgery

117

868

1.38

2.69

4.2

3.2

4.34

4.49

pmol/l

0.91

771

Other congenital malformations of skin

116

859

1.38

2.69

3.5

3.4

4.75

4.63

pmol/l

0.25

108

768

Ascites

156

1204

1.31

2.68

3.3

3.2

4.06

4.41

pmol/l

3.64

142

1070

Other melanin hyperpigmentation

361

1.60

2.68

2.7

3.0

4.35

4.49

pmol/l

0.57

315

Inflammation of lacrimal passages (acute and unspecified)

314

1.64

2.67

4.5

3.1

4.38

4.60

pmol/l

0.93

274

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

740

6584

1.13

2.67

2.9

3.4

4.51

4.52

pmol/l

0.06

654

5882

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

323

2711

1.21

2.67

2.7

3.4

4.56

4.54

pmol/l

0.14

297

2449

Ulcerative ileocolitis

113

834

1.38

2.66

2.9

3.3

4.44

4.58

pmol/l

0.88

751

Spontaneous rupture of synovium and tendon

193

1532

1.28

2.66

3.1

3.4

4.37

4.44

pmol/l

0.32

174

1372

Other and unspecified acne

284

1.68

2.65

2.9

3.6

4.61

4.67

pmol/l

0.17

257

Infective bursitis

409

1.55

2.65

3.5

3.7

4.69

4.50

pmol/l

0.73

371

443

1.53

2.65

3.7

3.2

4.75

4.82

pmol/l

0.22

401

Other deformities of toe(s)

700

1.42

2.63

2.9

3.2

4.36

4.50

pmol/l

0.75

621

Benign neoplasm: Rectosigmoid junction

565

1.46

2.63

3.0

2.9

4.43

4.47

pmol/l

0.14

483

Syphilis

370

1.58

2.63

3.0

3.5

4.27

4.63

pmol/l

2.19

333

Benign neoplasm: Descending colon

141

1077

1.33

2.63

2.9

3.2

4.24

4.39

pmol/l

0.90

130

932

Other juvenile arthritis

125

940

1.35

2.62

3.4

4.39

4.69

pmol/l

3.12

117

847

Other viral hepatitis

166

1297

1.30

2.62

2.5

3.4

4.52

4.60

pmol/l

0.40

138

1172

Hydrocele

169

1319

1.29

2.62

3.3

3.5

4.36

4.40

pmol/l

0.17

147

1161

Melanoma in situ

591

1.45

2.62

3.3

4.22

4.42

pmol/l

1.42

517

Perichondritis of external ear

261

1.70

2.62

3.2

2.8

4.28

4.51

pmol/l

0.71

221

Crystal arthropathies, rheuma endpoint

215

1.77

2.62

3.2

3.1

3.96

4.38

pmol/l

1.70

184

Other and unspecified abdominal hernia

658

1.42

2.61

3.6

3.5

4.34

4.42

pmol/l

0.47

575

Postpartum hemorraghe, all women as controls

1032

9333

1.11

2.61

3.7

3.4

4.57

4.56

pmol/l

0.14

929

8460

Benign neoplasm: Peripheral nerves and autonomic nervous system

254

1.71

2.61

2.3

3.5

4.07

4.54

pmol/l

2.19

222

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

323

2718

1.21

2.60

2.7

3.4

4.56

4.52

pmol/l

0.32

297

2445

Maternal care for known or suspected malpresentation of fetus

756

5028

1.13

2.60

3.4

3.5

4.58

4.56

pmol/l

0.19

698

4541

Major anomalies of jaw size

569

1.46

2.58

3.1

3.3

4.40

4.65

pmol/l

1.58

503

Other specified/unspecified spondylopathies

364

1.57

2.57

3.6

3.3

3.99

4.47

pmol/l

3.35

313

Benign neoplasm: Skin of ear and external auricular canal

593

1.44

2.57

3.0

3.3

4.27

4.46

pmol/l

0.92

513

Contusion of ankle

106

780

1.39

2.56

3.1

3.3

4.58

4.62

pmol/l

0.17

708

Other secondary gonarthrosis

122

917

1.35

2.56

2.9

3.4

4.59

4.44

pmol/l

0.52

113

808

Panniculitis affecting regions of neck and back

103

755

1.39

2.55

3.4

4.18

4.51

pmol/l

3.70

664

Pneumocystosis

225

1.74

2.55

2.5

3.3

4.00

4.53

pmol/l

2.06

189

Unspecified visual impairment (binocular)

225

1.74

2.54

2.4

3.2

4.14

4.55

pmol/l

2.04

200

Vestibular neuronitis

214

1730

1.25

2.54

3.5

3.3

4.40

4.44

pmol/l

0.25

189

1538

Serous carcinoma of ovary

102

749

1.40

2.54

6.9

3.0

4.31

4.43

pmol/l

0.84

644

Mature T/NK-cell lymphomas, hilmo

173

1.85

2.53

3.0

3.2

4.06

4.42

pmol/l

1.07

154

Burn and corrosion confined to eye and adnexa

431

1.52

2.52

4.3

3.5

4.56

4.71

pmol/l

0.67

387

Chronic conjunctivitis

605

1.44

2.52

2.5

3.2

4.18

4.62

pmol/l

4.61

524

Other orthopaedic follow-up care

138

1058

1.32

2.52

3.5

3.3

4.43

4.51

pmol/l

0.39

125

943

Other and unspecified vascular occlusions

179

1418

1.28

2.51

3.0

3.2

4.29

4.37

pmol/l

0.56

152

1213

LSIL lesion of the cervix uteri

424

3660

1.17

2.51

3.0

3.4

4.56

4.52

pmol/l

0.28

371

3303

COPD, hospital admissions 3, with asthma pneumonia sepsis

488

3603

1.16

2.51

3.0

3.2

4.15

4.34

pmol/l

4.10

412

3134

Carcinoma in situ of skin of ear and external auricular canal

109

2.07

2.50

2.6

2.9

4.09

4.20

pmol/l

0.26

Atlantoaxial subluxation

117

2.07

2.50

4.2

3.6

4.32

4.55

pmol/l

0.62

103

Procedures for purposes other than remedying health state

565

1.45

2.50

2.6

3.3

4.38

4.56

pmol/l

1.22

494

Erosion and ectropion of cervix uteri

607

1.43

2.48

3.5

2.9

4.43

4.45

pmol/l

0.04

531

Malignant neoplasm of head and neck

149

1155

1.30

2.48

2.8

3.2

4.02

4.43

pmol/l

4.37

133

1004

Injury of muscle and tendon at shoulder and upper arm level

805

7231

1.12

2.48

2.9

3.4

4.47

4.45

pmol/l

0.25

715

6453

Dyshidrosis [pompholyx]

321

1.61

2.47

2.5

3.4

4.52

4.63

pmol/l

0.29

284

Psoriatic and enteropathic arthropathies

313

2635

1.20

2.47

2.7

3.5

4.47

4.51

pmol/l

0.21

279

2375

Leisure time condition

448

3881

1.16

2.47

3.0

3.3

4.38

4.51

pmol/l

2.25

384

3451

Other renal tubulo-interstitial diseases

500

1.48

2.45

3.0

3.4

4.49

4.55

pmol/l

0.09

443

Parkinson's disease

272

2259

1.21

2.45

2.5

3.2

4.39

4.34

pmol/l

0.37

227

1949

Parkinson's disease, strict definition

250

2060

1.22

2.45

2.4

3.2

4.43

4.35

pmol/l

0.71

208

1776

!Aliquae complicationes praecoces traumatis

701

1.39

2.44

3.4

3.5

4.24

4.62

pmol/l

3.70

623

Early complications of trauma

701

1.39

2.44

3.4

3.5

4.24

4.62

pmol/l

3.70

623

Superficial injury of shoulder and upper arm

278

2318

1.21

2.44

2.8

3.4

4.52

pmol/l

0.03

240

2076

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

108

805

1.37

2.43

2.8

3.4

4.80

4.72

pmol/l

0.31

727

Retinal detachment with retinal break

263

2181

1.22

2.43

3.2

3.3

4.45

4.42

pmol/l

0.11

236

1905

Outcome of delivery

688

3794

1.13

2.41

3.3

3.6

4.58

4.56

pmol/l

0.16

630

3413

Malignant neoplasm of respiratory system and intrathoracic organs

368

2890

1.18

2.41

3.8

3.1

4.23

4.33

pmol/l

1.09

334

2493

Conduct disorder

436

1.50

2.40

3.4

4.61

4.76

pmol/l

0.61

393

Other congenital malformations of circulatory system

461

1.49

2.40

3.8

3.5

4.45

4.62

pmol/l

0.68

413

Pathological resorption of teeth

535

1.45

2.40

3.0

3.4

4.42

4.57

pmol/l

0.77

470

Somnolence

253

1.68

2.39

3.0

3.3

4.40

4.64

pmol/l

0.90

225

Superficial injuries involving multiple body regions

486

1.47

2.39

2.3

3.3

4.63

4.59

pmol/l

0.14

426

Other conjunctival vascular disorders and cysts

396

1.53

2.38

3.3

3.2

4.34

4.55

pmol/l

1.13

347

Benign neoplasm: Conjunctiva

595

1.43

2.38

2.4

3.3

4.28

4.56

pmol/l

1.86

519

Complications following abortion and ectopic and molar pregnancy

114

862

1.35

2.37

3.9

3.3

4.33

4.43

pmol/l

0.57

102

759

Bicuspidal aortic valve syndrome

561

1.43

2.37

3.9

3.5

4.56

4.66

pmol/l

0.32

503

All dysplastic lesions of the vagina

631

1.42

2.37

3.3

4.50

4.55

pmol/l

0.18

556

Congenital malformations of genital organs

324

2735

1.19

2.36

3.7

3.3

4.64

4.59

pmol/l

0.34

291

2445

Other inflammation of vagina/vulva

133

1029

1.32

2.36

3.1

3.4

4.56

4.54

pmol/l

0.04

118

927

Alcoholic liver disease

110

1455

0.75

2.35

2.3

3.4

4.07

4.46

pmol/l

2.84

1287

Other and unspecified injuries of lower leg

204

1657

1.25

2.35

2.7

3.3

4.52

4.58

pmol/l

0.35

186

1487

Benign neoplasm: Skin, unspecified

101

749

1.37

2.35

3.1

3.4

4.37

4.52

pmol/l

0.98

655

Second line medication for Crohn's disease

1747

16285

1.08

2.35

3.0

3.4

4.43

4.51

pmol/l

1.86

1561

14549

Poisoning by medicine, drug-induced

262

1.66

2.35

3.3

3.8

4.25

4.66

pmol/l

1.99

231

Lichen ruber moniliformis

6.87

2.35

2.6

1.4

4.37

4.27

pmol/l

—

Supervision of normal pregnancy

906

4685

1.11

2.35

3.4

3.5

4.58

4.56

pmol/l

0.29

822

4227

Other infective otitis externa

151

1185

1.29

2.34

2.6

3.3

4.44

4.52

pmol/l

0.47

127

1056

Inflammatory disorders of breast

227

1869

1.24

2.34

2.9

3.3

4.48

4.51

pmol/l

0.25

204

1665

Distal bite

106

788

1.36

2.33

2.6

3.3

4.84

4.83

pmol/l

0.03

718

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

180

1445

1.27

2.33

5.9

3.0

4.43

4.47

pmol/l

0.26

167

1259

Viral meningitis

109

820

1.36

2.33

3.1

3.3

4.49

4.59

pmol/l

0.61

735

Alzheimer’s disease (Atypical or mixed)

125

952

1.32

2.33

2.9

2.8

4.18

4.26

pmol/l

0.38

102

790

Other and unspecified acute skin changes due to ultraviolet radiation

365

1.54

2.33

2.3

3.4

4.23

4.50

pmol/l

0.86

318

Retinoschisis and retinal cysts

317

1.58

2.33

4.3

3.4

4.37

4.48

pmol/l

0.42

275

Rheumatic fever incl heart disease

438

1.49

2.32

3.3

3.1

4.24

4.55

pmol/l

1.84

381

Neovascular glaucoma

622

1.41

2.32

4.1

3.5

4.37

4.49

pmol/l

0.53

545

Cholangitis (primary sclerosing, PSC)

131

1010

1.31

2.32

2.9

3.2

4.22

4.51

pmol/l

3.00

114

890

Benign neoplasm: Other and unspecified parts of mouth

564

1.43

2.31

3.8

3.1

4.33

4.56

pmol/l

1.39

483

Lesion of lateral popliteal nerve

110

828

1.35

2.31

2.8

3.5

4.49

4.48

pmol/l

0.08

100

733

Other disorders of pigmentation

110

829

1.35

2.31

3.1

3.2

4.45

4.50

pmol/l

0.20

730

L04AX Other immunosuppressants

1698

15825

1.08

2.31

3.0

3.4

4.42

4.50

pmol/l

1.91

1517

14131

Crohn disease (strict definition, all UC cases excluded)

137

1065

1.31

2.30

3.0

3.2

4.51

4.60

pmol/l

0.54

124

954

Carcinoma in situ of other and unspecified sites

382

1.52

2.29

2.9

3.6

4.33

pmol/l

0.00

331

Alcohol abuse, main dg

365

3133

1.17

2.29

2.5

3.4

4.46

4.55

pmol/l

0.93

315

2815

Indeterminate sex and pseudohermaphroditism

4.33

2.28

2.9

2.6

4.44

4.50

pmol/l

—

Background retinopathy and retinal vascular changes

287

1.60

2.28

3.2

3.3

3.97

4.52

pmol/l

3.79

252

Glaucoma secondary to other eye disorders

634

1.39

2.26

4.2

3.4

4.37

4.49

pmol/l

0.48

552

Malignant neoplasm of corpus uteri

212

1739

1.24

2.26

3.3

2.9

4.46

4.37

pmol/l

0.28

185

1493

Abnormal findings in nipple discharge synovial fluid wound secretions

289

1.61

2.25

3.9

3.3

4.51

4.63

pmol/l

0.35

255

Pediculosis, acariasis and other infestations

137

1068

1.30

2.25

2.7

3.4

4.46

4.59

pmol/l

0.70

117

962

Amputation of toe

119

910

1.32

2.23

3.5

3.2

3.82

4.41

pmol/l

8.60

107

788

Car occupant injured in noncollision transport accident

722

1.37

2.23

2.7

3.4

4.56

4.63

pmol/l

0.30

651

Other and specified injuries of hip and thigh

329

1.55

2.22

3.1

3.2

4.28

4.58

pmol/l

1.24

288

Ankylosing spondylitis

228

1885

1.22

2.22

2.6

3.5

4.59

4.51

pmol/l

0.25

200

1689

Other disorders of Eustachian tube

604

1.41

2.21

2.6

3.4

4.44

4.57

pmol/l

0.69

532

Postpartum hemorraghe, parous women as controls

1032

8278

1.10

2.21

3.7

3.4

4.57

4.56

pmol/l

0.09

929

7560

Nonsuppurative otitis media

704

5462

1.12

2.21

3.2

3.3

4.73

4.67

pmol/l

0.57

624

4916

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

418

1.48

2.21

2.9

4.25

4.44

pmol/l

0.69

358

Idiopathic thrombocytopenic purpura

511

1.44

2.20

3.9

3.4

4.33

4.62

pmol/l

1.42

453

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

655

1.38

2.19

2.6

3.4

4.28

4.50

pmol/l

1.16

572

Carcinoma in situ of other and unspecified digestive organs

322

1.55

2.19

3.3

3.0

4.34

4.42

pmol/l

0.17

272

Dermatopolymyositis (FG)

220

1.68

2.19

3.2

3.1

4.20

4.53

pmol/l

1.61

191

Other maltreatment syndromes

579

1.41

2.18

2.6

3.6

4.53

4.73

pmol/l

0.80

522

Scabies

108

819

1.34

2.18

2.7

3.4

4.42

4.64

pmol/l

1.31

741

Spirochaetal infections, other/unspecified

201

1645

1.24

2.18

2.4

3.3

4.45

4.46

pmol/l

0.05

177

1470

Hyphaema and other vascular disorders of iris and ciliary body

267

1.61

2.17

1.9

3.3

4.11

4.51

pmol/l

1.71

232

Carcinoma in situ of skin of lower limb, including hip

220

1.67

2.17

4.5

2.8

4.06

4.40

pmol/l

1.52

186

Localized scleroderma [morphea]

292

1.59

2.17

3.1

3.3

4.62

4.58

pmol/l

0.03

260

Vascular dementia (other)

2.46

2.17

2.5

2.7

3.82

4.11

pmol/l

—

Benign neoplasm: Long bones of lower limb

640

1.39

2.17

3.0

3.4

4.55

4.60

pmol/l

0.26

570

Other crystal arthropathies

228

1.66

2.16

3.2

3.96

4.42

pmol/l

1.98

198

Ulcerative colitis

678

6090

1.12

2.16

3.4

3.3

4.51

4.54

pmol/l

0.30

603

5459

L02BA Anti-estrogens

406

4651

0.86

2.16

3.0

3.2

4.47

4.44

pmol/l

0.28

358

4088

Cerebral aneurysm, nonruptured

220

1820

1.22

2.15

3.3

4.45

pmol/l

0.00

192

1612

Myositis

430

1.47

2.15

3.2

3.5

4.33

4.59

pmol/l

1.54

382

Other and unspecified mononeuropathies, also in other diseases

505

1.43

2.15

3.4

4.25

4.54

pmol/l

1.71

436

Other (seronegative) rheumatoid arthritis, wide

504

4452

1.14

2.15

2.7

3.3

4.28

4.43

pmol/l

1.69

450

3927

Bacterial meningoencephalitis and meningomyelitis

3.55

2.14

2.9

2.1

4.14

4.37

pmol/l

—

Unspecified contracted kidney

2.12

2.13

4.1

3.0

4.11

4.48

pmol/l

0.88

Anterior Iridocyclitis

532

4717

1.14

2.13

3.1

3.3

4.45

4.48

pmol/l

0.24

475

4199

Acute inflammation of orbit

110

2.00

2.13

1.6

3.4

4.57

4.81

pmol/l

0.55

Maternal care for known or suspected fetal abnormality and damage

616

4904

1.13

2.13

3.4

3.5

4.61

4.56

pmol/l

0.65

557

4433

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

249

2088

1.21

2.12

3.8

2.8

4.42

4.41

pmol/l

0.04

220

1787

Squamous cell neoplasms and carcinomas of the skin

197

1611

1.23

2.12

2.4

3.1

4.20

4.32

pmol/l

0.77

162

1378

Other surgical follow-up care

617

1.39

2.11

3.6

3.4

4.53

4.61

pmol/l

0.25

553

Campylobacter enteritis

482

1.44

2.11

2.4

3.4

4.29

4.63

pmol/l

2.05

418

Medial epicondylitis

108

825

1.33

2.10

2.6

3.5

4.66

4.50

pmol/l

0.82

751

Pilonidal cyst

224

1861

1.22

2.10

3.2

3.5

4.50

4.64

pmol/l

1.37

208

1673

Congenital malformations of great arteries

352

1.51

2.09

3.4

3.6

4.62

4.94

pmol/l

1.69

321

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

199

1.69

2.09

3.7

2.9

4.23

4.47

pmol/l

0.75

169

Benign neoplasm of ovary

516

4577

1.14

2.09

3.1

3.0

4.46

4.44

pmol/l

0.16

457

3983

Unspecified abortion

174

1414

1.25

2.08

3.3

3.5

4.45

4.47

pmol/l

0.08

151

1285

Malignant neoplasm of ovary

128

1003

1.30

2.08

6.5

3.1

4.37

4.44

pmol/l

0.47

122

871

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

145

1152

1.27

2.07

3.1

3.4

4.56

4.48

pmol/l

0.38

127

1014

Behçet disease

2.45

2.07

2.5

4.8

4.14

4.53

pmol/l

0.73

Other and unspecified injuries of shoulder and upper arm

526

1.41

2.07

2.8

3.2

4.26

4.65

pmol/l

3.14

468

Hereditary corneal dystrophies

552

1.40

2.06

3.3

3.1

4.50

4.47

pmol/l

0.10

478

Oral leukoplakia and related diseases

126

985

1.30

2.06

3.3

3.1

4.44

4.43

pmol/l

0.01

111

863

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

248

1.62

2.06

2.2

3.0

4.61

4.47

pmol/l

0.18

211

Haemorrhagic disorder due to circulating anticoagulants

118

1.91

2.06

3.8

2.9

3.59

4.26

pmol/l

2.25

104

Generalized epilepsy

121

942

1.31

2.05

2.5

3.4

4.47

4.66

pmol/l

1.57

107

844

Inflammatory disease of cervix uteri

196

1614

1.23

2.05

3.2

3.1

4.43

4.44

pmol/l

0.07

171

1432

Bacterial, viral and other infectious agents

209

1729

1.22

2.05

3.0

3.4

4.47

4.57

pmol/l

1.06

192

1551

Foreign body in alimentary tract

122

950

1.30

2.05

2.8

3.3

4.56

pmol/l

0.03

109

843

Other overlap syndromes

361

1.51

2.05

2.6

3.3

4.19

4.56

pmol/l

1.32

314

Fistulae involving female genital tract

337

1.53

2.04

2.4

3.1

4.55

4.52

pmol/l

0.06

297

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

115

890

1.31

2.04

3.4

3.2

4.47

4.51

pmol/l

0.15

105

782

Carcinoma in situ, bladder

360

1.50

2.04

2.8

3.5

4.28

4.31

pmol/l

0.11

310

Delivery, wide proxy

1229

6039

1.09

2.04

3.3

3.2

4.55

4.48

pmol/l

1.52

1085

5257

Macular hole

114

881

1.31

2.04

3.4

3.2

4.37

pmol/l

0.02

101

763

Event of undetermined intent

150

1200

1.27

2.03

2.6

3.4

4.63

4.62

pmol/l

0.04

126

1067

Anoxic brain damage

163

1.76

2.03

3.7

3.5

4.10

4.52

pmol/l

1.16

140

Peripheral retinal degeneration

571

1.39

2.02

3.0

3.4

4.46

4.54

pmol/l

0.28

501

Benign neoplasm: Skin of trunk

104

796

1.33

2.01

4.0

3.5

4.33

4.49

pmol/l

1.07

697

Pneumothorax

129

1014

1.29

2.00

3.7

3.4

4.15

4.49

pmol/l

3.64

112

889

Benign neoplasm: Rectosigmoid junction

597

1.38

2.00

3.0

3.1

4.43

4.45

pmol/l

0.06

514

Colectomy operation

357

3098

1.16

1.99

3.5

3.2

4.30

4.41

pmol/l

1.47

316

2707

Erythema multiforme

421

1.46

1.99

2.9

3.2

4.49

4.55

pmol/l

0.17

373

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.99

2.7

2.8

4.74

4.72

pmol/l

0.03

Chronic viral hepatitis

135

1070

1.28

1.99

2.1

3.4

4.44

4.63

pmol/l

1.22

108

974

Combinations of oral blood glucose lowering drugs

604

5419

1.12

1.99

2.8

3.4

4.31

4.45

pmol/l

3.03

538

4831

Dissection of aorta

362

1.49

1.98

4.0

3.2

4.03

4.52

pmol/l

3.36

311

Granulomatous disorders of skin and subcutaneous tissue

557

1.40

1.98

3.4

3.3

4.61

4.57

pmol/l

0.08

498

Traumatic ischaemia of muscle

203

1.67

1.98

3.4

3.7

4.17

4.63

pmol/l

2.08

179

Congenital malformations of the urinary system

141

1125

1.27

1.97

3.4

3.3

4.28

4.61

pmol/l

2.92

134

998

Parodontitis, under 40 years and operation codes

293

2512

1.18

1.95

3.3

3.4

4.82

4.67

pmol/l

0.83

265

2277

Other specified/unspecified hearing loss

170

1385

1.24

1.95

2.8

3.3

4.47

4.43

pmol/l

0.19

153

1211

Burn and corrosion of trunk

498

1.41

1.95

3.5

4.57

4.69

pmol/l

0.49

442

Labour and delivery complicated by umbilical cord complications

121

1529

0.78

1.95

3.4

3.3

4.46

4.52

pmol/l

0.32

104

1377

Measles

252

1.60

1.95

3.1

3.9

4.51

4.58

pmol/l

0.18

221

Ectropion of eyelid

413

1.45

1.95

2.8

3.0

4.53

4.25

pmol/l

1.13

355

Parodontitis, operation under 40 years and operation codes

293

2513

1.18

1.95

3.3

3.4

4.82

4.67

pmol/l

0.83

265

2278

Pedestrian injured in transport accident

168

1370

1.24

1.93

3.1

3.2

4.36

4.54

pmol/l

1.58

141

1208

Myocardial infarction, unclassifiable

368

2856

1.15

1.93

3.3

3.1

4.07

4.32

pmol/l

5.59

325

2432

Unspecified chronic bronchitis

532

1.39

1.93

3.2

3.3

4.19

4.49

pmol/l

2.17

460

379

3321

1.15

1.92

3.2

3.4

4.59

4.57

pmol/l

0.18

346

2997

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

1.92

0.0

2.8

—

4.34

—

Alzheimer’s disease (Early onset)

543

0.64

1.91

3.2

3.0

4.48

4.39

pmol/l

0.26

458

Normotensive glaucoma

173

1417

1.23

1.90

2.7

3.0

4.23

4.34

pmol/l

0.76

150

1211

All dysplastic lesions of the cervix uteri, vagina or vulva

1131

10419

1.09

1.90

3.3

3.4

4.53

pmol/l

0.03

1001

9410

Other acute skin changes due to ultraviolet radiation

612

1.36

1.89

3.1

3.5

4.30

4.50

pmol/l

0.97

538

Other specific arthropathies, wide

392

1.46

1.89

3.2

3.3

4.21

4.54

pmol/l

1.77

348

Chorioretinal inflammation

510

1.40

1.89

2.5

3.6

4.46

4.55

pmol/l

0.32

450

Hypothermia

245

1.59

1.89

2.9

3.4

4.14

4.61

pmol/l

1.41

214

Alcohol-induced chronic pancreatitis

115

899

1.29

1.89

2.9

3.6

4.24

4.50

pmol/l

2.01

100

811

Glaucoma, exfoliation

199

1653

1.21

1.88

2.9

3.0

4.42

4.29

pmol/l

0.74

174

1388

Other and unspecified bullous disorders

160

1.75

1.88

2.2

3.5

4.17

4.58

pmol/l

1.04

141

Other noninflammatory disorders of cervix uteri

137

1098

1.27

1.87

3.9

3.2

4.40

4.47

pmol/l

0.36

117

965

Antenatal screening

929

4801

1.10

1.86

3.3

3.5

4.60

4.57

pmol/l

0.48

855

4335

Endometriosis diagnosis and infertility diagnosis occurring together

397

3498

1.15

1.86

3.4

3.3

4.44

4.52

pmol/l

0.94

349

3144

Other and unspecified injuries of abdomen, lower back and pelvis

279

1.55

1.85

3.6

4.40

4.63

pmol/l

0.70

248

Disorders of speech understanding and production

713

1.33

1.85

3.1

3.3

4.67

4.83

pmol/l

0.59

631

Injury of muscle and tendon at hip and thigh level

228

1924

1.20

1.85

2.7

3.3

4.45

4.49

pmol/l

0.28

203

1717

Vascular dementia (subcortical)

286

1.52

1.84

2.9

2.6

4.16

4.26

pmol/l

0.26

247

Non-Hodgkin lymphoma, all

452

1.41

1.84

2.1

3.2

3.70

4.34

pmol/l

5.35

387

LSIL lesion of the vagina

338

1.50

1.83

4.4

3.5

4.43

4.62

pmol/l

0.85

300

Conductive hearing loss, unspecified

208

1743

1.21

1.83

3.5

3.3

4.47

4.49

pmol/l

0.10

187

1552

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

322

1.51

1.83

2.6

3.6

4.58

4.61

pmol/l

0.07

287

Other and unspecified aplastic anaemias

169

1.71

1.82

6.1

3.1

4.57

4.65

pmol/l

0.10

150

Abnormal findings on diagnostic imaging of breast

273

1.55

1.81

3.3

2.8

4.15

4.49

pmol/l

1.98

238

Acute and subacute iridocyclitis

493

4403

1.13

1.81

3.1

3.3

4.46

4.49

pmol/l

0.23

442

3924

Toxic effect of ethanol

101

783

1.31

1.80

2.6

3.5

4.58

4.67

pmol/l

0.40

708

Lupus erythematosus

464

1.41

1.80

2.5

3.3

4.27

4.54

pmol/l

1.72

404

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1238

9095

1.08

1.79

2.9

3.3

4.33

4.36

pmol/l

0.46

1060

7959

Optic neuritis

128

1025

1.27

1.79

3.3

3.4

4.55

pmol/l

0.04

114

919

Other fall from one level to another

541

4859

1.12

1.78

3.3

3.4

4.69

4.56

pmol/l

1.75

487

4341

Other bursitis of hip

373

1.45

1.77

3.4

3.2

4.35

4.43

pmol/l

0.28

327

Dermatitis due to ingested food

714

1.31

1.76

3.0

3.4

4.83

4.97

pmol/l

0.70

652

Pedestrian injured in collision with pedal cycle

568

1.36

1.76

3.3

3.4

4.33

4.61

pmol/l

1.67

504

Dermatopolymyositis

250

1.56

1.76

3.4

2.9

4.24

4.55

pmol/l

1.52

216

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

304

2642

1.16

1.76

3.2

4.51

4.47

pmol/l

0.30

283

2366

Sacroiliitis, not elsewhere classified

142

1152

1.25

1.76

2.8

3.5

4.64

4.59

pmol/l

0.12

129

1037

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

673

1.33

1.75

3.3

3.2

4.26

4.49

pmol/l

1.39

596

Other hammer toe(s) (acquired)

433

3605

1.13

1.75

2.7

3.4

4.34

4.41

pmol/l

0.52

365

3157

COPD, hospital admissions 1, only main diagnosis

677

5239

1.10

1.75

3.1

3.3

4.24

4.36

pmol/l

2.03

576

4595

Parodontitis, under 40 years

305

2650

1.16

1.74

3.3

3.4

4.87

4.67

pmol/l

1.08

275

2401

Psoriatic arthropathies

250

2139

1.18

1.74

2.6

3.5

4.50

4.51

pmol/l

0.05

220

1926

Injury of muscle and tendon at forearm level

316

1.49

1.74

3.5

4.30

4.54

pmol/l

1.06

278

Deep bite

299

2267

1.16

1.73

3.1

3.2

4.73

4.69

pmol/l

0.19

267

2049

Urethral stricture

646

1.33

1.73

3.2

3.5

4.66

4.46

pmol/l

0.31

565

Parodontitis, under 40 years, or operation codes

305

2652

1.16

1.73

3.3

3.4

4.87

4.67

pmol/l

1.09

275

2403

Early lumbar disc prolapse operation

316

2755

1.16

1.73

3.3

3.4

4.66

4.57

pmol/l

0.72

288

2496

Melanocytic naevi of upper limb, including shoulder

434

1.41

1.72

2.9

3.1

4.40

4.65

pmol/l

1.34

381

Oral leukoplakia, including avohilmo

425

1.41

1.72

4.1

3.1

4.47

4.56

pmol/l

0.23

369

Other and unspecified primary disorders of muscles

119

1.83

1.72

4.3

3.4

4.75

4.65

pmol/l

0.21

106

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

187

1.63

1.71

2.2

3.2

5.13

4.76

pmol/l

0.50

170

Reimbursement for rheumatic diseases

1770

16677

1.06

1.71

2.9

3.3

4.40

4.48

pmol/l

2.18

1570

14840

Other spirochaetal diseases

672

6123

1.10

1.71

2.9

3.4

4.48

4.45

pmol/l

0.23

581

5438

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

591

1.35

1.71

2.6

3.4

4.53

4.55

pmol/l

0.08

526

Other infections specific to the perinatal period

1.97

1.70

2.5

2.7

4.86

5.13

pmol/l

0.71

Fracture of forearm

1672

14762

1.06

1.70

3.1

3.3

4.47

4.49

pmol/l

0.39

1472

13067

Deep endometriosis

316

2761

1.16

1.70

3.0

3.3

4.47

4.49

pmol/l

0.12

269

2445

Tooth eruption problems

435

3836

1.13

1.70

3.2

3.3

4.72

pmol/l

0.04

391

3480

Cysts of oral region, not elsewhere classified

737

1.31

1.70

4.0

3.4

4.61

4.55

pmol/l

0.22

655

Any dementia, excluding more controls

627

3941

1.11

1.69

2.8

3.2

4.27

4.32

pmol/l

0.61

504

3428

Embedded teeth, including avohilmo

275

2379

1.17

1.68

3.5

3.3

4.62

4.66

pmol/l

0.28

251

2142

Placenta praevia

174

1452

1.22

1.68

3.1

3.4

4.58

4.52

pmol/l

0.46

158

1305

Embedded and impacted teeth

849

6647

1.09

1.67

3.2

3.4

4.71

4.68

pmol/l

0.37

772

6006

Calculus of lower urinary tract

616

1.33

1.66

2.8

3.3

4.43

4.42

pmol/l

0.06

539

Polyhydramnios

172

1435

1.22

1.66

3.2

3.4

4.51

4.54

pmol/l

0.14

157

1276

Scleritis

246

1.55

1.66

2.8

3.5

4.28

4.63

pmol/l

1.49

217

Other bullous disorders

471

1.38

1.66

3.1

3.3

4.33

4.59

pmol/l

1.34

415

Contact with heat and hot substances

123

989

1.26

1.66

3.2

4.59

4.65

pmol/l

0.17

107

878

Ankylosing spondylitis, ICD10

220

1874

1.18

1.64

2.5

3.4

4.59

4.53

pmol/l

0.17

193

1684

Use of antiglaucoma preparations and miotics

151

1242

1.23

1.63

3.2

3.1

4.39

4.38

pmol/l

0.04

130

1061

Pneumonia due to Streptococcus pneumoniae

671

1.31

1.63

4.1

3.5

4.51

4.59

pmol/l

0.27

591

Malignant neoplasm of bladder

731

1.30

1.63

3.7

3.3

4.28

4.30

pmol/l

0.08

621

Iridocyclitis in diseases classified elsewhere

313

1.47

1.62

2.6

3.5

4.47

4.61

pmol/l

0.22

274

Embolic stroke

575

1.33

1.61

3.2

3.0

4.21

4.39

pmol/l

0.98

491

Xerosis cutis

223

1.56

1.61

2.9

4.05

4.45

pmol/l

1.31

200

Benign neoplasm: Ill-defined sites within the digestive system

1.92

1.61

3.8

3.6

4.11

4.43

pmol/l

1.50

Other, unspecified and serous retinal detachments

439

1.39

1.61

4.3

3.4

4.34

4.48

pmol/l

0.68

382

Other and unspecified iridocyclitis

102

806

1.28

1.61

3.2

3.4

4.58

4.55

pmol/l

0.10

710

Emergency coronary revascularization (for ACS)

1097

7335

1.08

1.60

2.9

3.3

4.27

4.38

pmol/l

2.60

987

6396

Burns and corrosions of external body surface, specified by site

253

2183

1.17

1.60

3.3

4.56

4.57

pmol/l

0.05

225

1952

Benign neoplasm: Other and unspecified parts of mouth

604

1.33

1.60

3.8

3.3

4.33

4.51

pmol/l

0.98

525

Behavioural disorders

466

1.38

1.60

3.5

3.4

4.61

4.81

pmol/l

0.85

417

Follicular lymphoma

621

1.32

1.60

2.4

3.1

4.38

4.50

pmol/l

0.69

536

Malignant neoplasm of testis

191

1.60

2.2

3.4

5.13

4.81

pmol/l

0.41

175

Chronic myringitis

2.01

1.60

3.1

3.8

4.60

4.52

pmol/l

0.18

HSIL lesion of the vulva

365

1.44

1.60

3.9

3.3

4.53

4.55

pmol/l

0.03

320

Acute alcohol intoxication

551

4992

1.11

1.58

2.7

3.4

4.44

4.50

pmol/l

0.67

473

4486

Hirsprung

3.63

1.57

2.6

2.4

4.31

5.20

pmol/l

—

Disturbances of smell and taste

105

836

1.27

1.57

3.1

3.3

4.31

4.48

pmol/l

1.28

730

Post-traumatic wound infection, not elsewhere classified

416

1.39

1.57

3.5

4.33

4.66

pmol/l

1.84

370

Atherosclerosis, excluding cerebral and coronary sclerosis

793

5833

1.09

1.57

3.0

3.2

4.06

4.36

pmol/l

13.69

685

5078

Benign neoplasm: Ill-defined sites within the digestive system

1.90

1.57

3.8

3.9

4.11

4.40

pmol/l

1.30

Open wound of hip and thigh

545

1.34

1.56

2.0

3.5

4.46

4.65

pmol/l

0.84

489

Sixth [abducent] nerve palsy

502

1.35

1.56

3.7

3.2

4.46

4.52

pmol/l

0.16

435

Polyarthritis, unspecified

677

1.30

1.55

2.7

3.3

4.30

4.53

pmol/l

1.76

609

Duodenal ulcer

183

1541

1.19

1.55

3.1

3.3

4.28

4.40

pmol/l

0.56

162

1340

Other specified/unspecified nutritional deficiencies

131

1.74

1.55

3.8

3.0

4.25

4.57

pmol/l

1.13

116

Amputation of foot

274

1.48

1.54

2.4

3.6

3.62

4.38

pmol/l

3.97

237

Other bacterial agents as the cause of diseases classified to other chapters

170

1.64

1.54

3.3

3.5

4.39

4.64

pmol/l

0.68

148

Pigmented purpuric dermatosis

139

1.70

1.53

2.7

3.3

4.67

4.47

pmol/l

0.35

127

Other appendicitis

221

1897

1.18

1.53

3.2

3.4

4.51

4.50

pmol/l

0.04

193

1693

Lymphoid leukaemia

722

1.29

1.53

3.3

3.0

4.43

4.56

pmol/l

0.59

629

Other keratitis

284

2483

1.15

1.52

2.8

3.4

4.47

4.53

pmol/l

0.54

259

2228

Vascular syndromes of brain in cerebrovascular disorders

608

1.31

1.52

2.3

3.1

4.09

4.35

pmol/l

1.77

525

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

163

1.65

1.52

4.2

2.9

4.42

4.49

pmol/l

0.15

139

Other and unspecified epidermal thickening

462

1.36

1.51

3.2

3.3

4.50

4.59

pmol/l

0.35

407

Malignant neoplasm of pancreas

848

0.75

1.51

2.1

3.1

4.17

4.34

pmol/l

0.54

732

Carcinoma in situ of skin of lower limb, including hip

243

1.51

4.5

2.7

4.06

4.36

pmol/l

1.32

210

Juvenile arthritis (FINNGEN)

137

1129

1.23

1.51

3.3

4.42

4.68

pmol/l

2.51

126

1015

Other specified disorders of external ear

479

1.35

1.50

2.7

3.5

4.44

4.51

pmol/l

0.15

425

Galactorrhea

278

1.49

1.50

3.6

3.8

4.58

4.64

pmol/l

0.19

250

Other acute disseminated demyelination

228

1.54

1.50

3.1

3.5

4.51

4.64

pmol/l

0.41

203

Malignant neoplasm of breast, HER-positive

934

9890

0.93

1.49

3.1

3.2

4.47

4.40

pmol/l

1.03

831

8666

Fracture of shoulder and upper arm

897

8324

1.08

1.49

3.3

4.37

4.49

pmol/l

2.61

766

7356

Use of rasagiline

352

1.42

1.49

1.9

3.2

4.43

4.46

pmol/l

0.09

304

Impacted teeth

578

4905

1.10

1.48

3.2

3.4

4.74

4.71

pmol/l

0.28

530

4441

Other and unspecified injuries of ankle and foot

108

870

1.26

1.47

2.9

3.3

4.65

4.61

pmol/l

0.10

781

Pregnancy, childbirth and the puerperium

1046

5101

1.08

1.47

3.3

3.2

4.59

4.48

pmol/l

2.48

920

4423

Fall on and from ladder

131

1076

1.23

1.47

3.0

3.5

4.79

4.45

pmol/l

1.57

118

945

Lyme disease

660

6062

1.09

1.46

2.9

3.4

4.48

4.45

pmol/l

0.25

570

5388

Corneal degeneration

237

1.51

1.46

3.0

3.5

4.27

4.52

pmol/l

0.87

206

Other specified/unspecified disorders of bone/cartilage

465

1.35

1.46

3.7

3.2

4.39

4.56

pmol/l

0.79

403

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

709

1.28

1.46

3.5

2.9

4.09

4.48

pmol/l

3.29

610

Disorder of external ear, unspecified

561

1.32

1.45

2.5

3.3

4.42

4.56

pmol/l

0.58

499

Acute peritonitis

125

1024

1.23

1.45

2.9

3.4

3.94

4.46

pmol/l

5.95

111

900

Acute alcohol intoxication, ICD10

446

4021

1.11

1.45

2.7

3.3

4.51

4.54

pmol/l

0.23

386

3605

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

686

1.29

1.44

3.5

3.4

4.39

4.57

pmol/l

1.00

614

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

120

1464

0.81

1.44

3.1

3.2

4.31

4.39

pmol/l

0.36

113

1271

Chronic lymphocytic leukaemia, helper endpoint

295

1.44

2.3

3.0

4.10

4.41

pmol/l

1.55

246

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

295

1.44

2.3

3.0

4.10

4.41

pmol/l

1.55

246

Crohn disease (strict definition, require KELA)

168

1419

1.20

1.43

3.2

3.3

4.55

4.59

pmol/l

0.21

150

1271

Fall involving bed

363

1.40

1.43

3.2

3.93

4.47

pmol/l

4.01

309

Maternal care for cervical incompetence

123

1011

1.24

1.42

2.6

3.1

4.44

4.51

pmol/l

0.35

114

894

Other puerperal infections

287

2530

1.15

1.42

3.7

3.4

4.47

4.58

pmol/l

1.59

266

2275

Adenocarcinoma and papilloma adenocarcinoma of rectum

115

1406

0.81

1.42

3.0

3.2

4.30

4.39

pmol/l

0.47

108

1217

Carcinoma in situ of middle ear and respiratory system

2.15

1.42

3.8

2.8

4.13

4.14

pmol/l

0.02

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

180

1531

1.19

1.42

3.2

3.4

4.62

4.58

pmol/l

0.16

160

1366

Ulcerative proctitis

159

1338

1.20

1.42

3.6

3.4

4.51

4.56

pmol/l

0.37

146

1195

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

246

1.48

1.42

3.7

3.1

4.13

4.39

pmol/l

0.84

214

Contracture of joint

198

1.55

1.41

2.4

3.2

4.63

4.49

pmol/l

0.34

180

Carcinoma in situ of skin

145

1210

1.21

1.40

3.0

3.2

4.26

4.37

pmol/l

0.79

128

1037

Seropositive rheumatoid arthritis, strict definition

323

3633

0.88

1.40

2.5

3.3

4.25

4.44

pmol/l

3.13

284

3219

Benign mammary dysplasia

430

3882

1.12

1.40

2.8

3.2

4.43

pmol/l

0.05

386

3412

Poor fetal growth

474

4306

1.11

1.38

4.0

3.4

4.62

4.55

pmol/l

0.94

430

3883

Toxic effects of substances chiefly nonmedicinal as to source

274

2409

1.15

1.38

2.7

3.3

4.55

pmol/l

0.02

251

2157

Female infertility, tubal origin

160

1352

1.20

1.38

3.4

3.5

4.40

4.57

pmol/l

1.69

146

1220

Childhood allergy (age < 16)

470

3507

1.11

1.38

2.9

3.3

4.89

4.82

pmol/l

0.68

425

3175

Chronic iridocyclitis

120

986

1.23

1.38

3.8

3.2

4.38

4.53

pmol/l

1.01

107

869

Crohn disease (strict definition, require KELA, min 2 HDR)

164

1388

1.19

1.38

3.3

4.56

4.60

pmol/l

0.25

146

1242

Other osteochondropathies

172

1463

1.19

1.36

3.6

3.5

4.61

4.53

pmol/l

0.50

151

1320

Hordeolum and other deep inflammation of eyelid

134

1115

1.22

1.36

3.8

3.2

4.58

4.53

pmol/l

0.18

118

995

Sequelae of injuries of head

111

906

1.24

1.36

2.9

3.5

4.44

4.57

pmol/l

0.72

809

Congenital deformities of hip

385

1.38

1.35

3.8

3.1

4.88

4.75

pmol/l

0.36

337

Femoral hernia

736

1.26

1.35

2.6

3.4

4.32

4.42

pmol/l

0.50

636

Crushed, pushed or stepped on by crowd or human stampede

175

1492

1.18

1.35

3.1

3.3

4.71

4.68

pmol/l

0.10

154

1332

Injury of muscle and tendon at lower leg level

321

2856

1.13

1.34

3.2

3.3

4.47

4.48

pmol/l

0.09

292

2572

Infections of genitourinary tract in pregnancy

322

2872

1.13

1.33

3.4

4.50

pmol/l

0.02

293

2556

Congenital malformations of uterus and cervix

598

1.30

1.32

3.8

3.4

4.75

4.58

pmol/l

0.74

534

Other other unspecified disorders of the circulatory system

605

1.29

1.32

3.0

3.3

4.31

4.49

pmol/l

0.88

524

Contusion of toe(s) without damage to nail

509

1.32

2.5

3.3

4.65

4.64

pmol/l

0.05

457

Other proliferative retinopathy

2.02

1.32

2.1

3.6

3.87

4.50

pmol/l

1.46

Dementia due to Parkinsons disease, excluding more controls

193

1.52

1.31

2.7

3.2

4.32

4.28

pmol/l

0.10

164

Carcinoma in situ of middle ear and respiratory system

2.07

1.30

3.8

2.9

4.13

4.33

pmol/l

0.31

Seropositive rheumatoid arthritis

677

6247

1.09

1.30

2.9

3.4

4.27

4.45

pmol/l

4.92

598

5535

Congenital malformations of ovaries, fallopian tubes and broad ligaments

199

1724

1.17

1.29

3.7

3.3

4.45

4.52

pmol/l

0.66

180

1534

Oesophageal obstruction

492

1.32

1.29

4.0

3.4

4.17

4.44

pmol/l

1.26

428

Malignant neoplasm of digestive organs

649

6913

0.92

1.29

3.1

3.2

4.23

4.37

pmol/l

3.00

569

6036

Personal history of certain other diseases

433

1.34

1.28

3.5

3.3

4.54

4.60

pmol/l

0.15

386

Wilms' tumor

1.91

1.27

5.1

3.0

4.19

4.57

pmol/l

0.56

Wilms' tumor, excluding all cancers (controls excluding all cancers)

1.91

1.27

5.1

3.1

4.19

4.66

pmol/l

0.74

Fibrosis of liver

108

1.73

1.26

2.7

2.8

3.96

4.48

pmol/l

1.81

Special screening examination for neoplasms

626

1.27

1.26

2.6

3.6

4.18

4.43

pmol/l

1.87

551

Foreign body entering into or through eye or natural orifice

169

1446

1.18

1.26

3.1

3.4

4.40

4.59

pmol/l

2.19

148

1294

Nonpyogenic thrombosis of intracranial venous system

188

1.53

1.26

2.4

3.6

4.19

4.62

pmol/l

1.06

165

Contact with hypodermic needle

143

0.47

1.26

1.7

4.1

4.44

4.80

pmol/l

—

131

severe traumatic brain injury, does not include concussion

403

3646

1.11

1.25

2.7

3.2

4.24

4.41

pmol/l

2.54

336

3203

Mucosal proctocolitis

332

2976

1.12

1.25

3.2

3.4

4.49

4.55

pmol/l

0.43

298

2663

Simple and mucopurulent chronic bronchitis

627

1.27

1.25

3.5

3.3

4.57

4.42

pmol/l

0.71

538

Melanocytic naevi of scalp and neck

443

1.33

1.25

2.7

3.1

4.67

4.64

pmol/l

0.05

393

Ectopic pregnancy

615

5684

1.09

1.25

3.3

4.44

4.48

pmol/l

0.56

550

5093

Pyogenic arthritis

128

1070

1.21

1.25

3.4

4.35

4.49

pmol/l

0.70

111

947

Contact with machinery

184

1586

1.17

1.24

3.5

3.4

4.60

4.54

pmol/l

0.21

170

1411

Injury of muscle and tendon at wrist and hand level

306

2731

1.13

1.24

3.1

3.4

4.55

4.52

pmol/l

0.17

267

2456

Reactive arthropathies, FINNGEN

175

1505

1.17

1.24

3.4

3.5

4.46

4.52

pmol/l

0.42

153

1353

Other and unspecified injuries of wrist and hand

746

1.25

1.23

2.6

3.4

4.56

4.64

pmol/l

0.32

667

Melanocytic naevi of upper limb, including shoulder

462

1.32

1.23

2.9

3.3

4.40

4.58

pmol/l

0.89

409

Cardiomyopathy due to drugs and other external agents

2.24

1.23

2.5

3.9

4.05

4.55

pmol/l

—

Crohn's disease of small intestine

174

1498

1.17

1.22

3.5

3.3

4.53

4.57

pmol/l

0.20

157

1334

Alzheimer’s disease (Late onset), excluding more controls

245

1434

1.14

1.22

2.4

3.3

4.33

4.36

pmol/l

0.16

195

1250

Other/unspecified soft tissue disorders related to use, overuse and pressure

604

1.28

1.22

3.1

3.3

4.41

4.57

pmol/l

0.75

540

Fetus and newborn affected by complications of placenta, cord and membranes

2.44

1.21

4.3

2.7

5.42

5.12

pmol/l

—

Crohn disease

343

3088

1.12

1.21

3.6

3.3

4.47

4.55

pmol/l

0.80

307

2765

Infections of breast associated with childbirth

131

1105

1.20

1.21

3.7

3.3

4.40

4.57

pmol/l

1.27

118

987

Left hemicolectomy

298

1.40

1.21

2.8

3.2

4.28

4.46

pmol/l

0.75

258

Vascular diseases of the intestine

480

1.30

1.20

2.7

3.2

4.21

4.42

pmol/l

0.79

413

Varicose veins of other sites

127

1066

1.20

2.9

3.5

4.63

4.55

pmol/l

0.23

108

947

Other forms of systemic lupus erythematosus

191

1.51

1.19

2.9

3.8

4.17

4.65

pmol/l

1.37

169

Colorectal adenocarcinoma

290

3245

0.89

1.19

3.0

3.2

4.25

4.35

pmol/l

1.15

258

2803

Focal brain injury

109

902

1.22

1.18

2.6

3.3

4.25

4.51

pmol/l

1.92

800

Polydactyly

2.68

1.18

2.4

3.0

5.18

4.71

pmol/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

199

1.49

1.18

3.5

3.7

4.62

4.63

pmol/l

0.03

176

Follicular lymphoma, hilmo

651

1.26

1.18

2.4

3.3

4.38

4.45

pmol/l

0.32

568

Bullous disorders

114

950

1.21

1.17

2.9

3.3

4.21

4.48

pmol/l

2.40

827

Femoral hernia, unilateral

430

1.32

1.17

2.3

3.3

4.37

4.43

pmol/l

0.20

374

Inguinal of femoral hernia, unilateral

430

1.32

1.17

2.3

3.3

4.37

4.43

pmol/l

0.20

374

Inguinal hernia, unilateral

430

1.32

1.17

2.3

3.3

4.37

4.43

pmol/l

0.20

374

Endometroid carcinoma of ovary

175

1.53

1.17

4.2

2.6

4.42

4.46

pmol/l

0.08

148

Non-small cell lung cancer, squamous, helper endpoint

473

1.30

1.16

5.5

3.2

4.38

4.28

pmol/l

0.31

405

Non-small cell lung cancer, squamous

473

1.30

1.16

5.5

3.2

4.38

4.28

pmol/l

0.31

405

Disorders of eyelid in diseases classified elsewhere

626

1.26

1.16

4.2

3.2

4.34

4.59

pmol/l

1.80

550

Malignant neoplasm of mesothelium and soft tissue

617

1.26

1.15

4.5

3.2

4.47

pmol/l

0.01

537

Benign neoplasm: Mediastinum

2.05

1.15

5.4

3.1

3.95

4.71

pmol/l

—

Other condition

334

3014

1.11

1.14

2.7

3.3

4.48

4.51

pmol/l

0.22

313

2690

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

698

1.24

1.14

3.5

3.0

4.23

4.44

pmol/l

1.03

589

Tooth agenesis EXCLUDE clefts and syndromes

103

854

1.22

1.13

3.5

3.4

4.81

4.75

pmol/l

0.19

769

Bilateral sagittal split ramus osteotomy operation

102

847

1.22

1.12

3.4

3.5

4.46

4.60

pmol/l

0.97

764

Disorders of vagus nerve

2.56

1.12

2.6

4.3

4.50

4.55

pmol/l

—

Varicella [chickenpox]

782

1.23

1.12

3.6

3.4

4.56

4.68

pmol/l

0.65

712

Complications of other internal prosthetic devices, implants and grafts

656

1.25

1.12

2.6

3.2

4.22

4.44

pmol/l

1.39

575

Cardiomyopathies, Secondary/extrinsic

1.86

1.11

3.4

3.7

4.29

4.87

pmol/l

0.91

Toxic effect of organic solvents

1.94

1.10

2.5

4.4

4.67

4.71

pmol/l

0.05

Transient synovitis

161

1.53

1.10

4.8

3.3

4.90

4.72

pmol/l

0.45

147

Benign neoplasm: Mediastinum

2.01

1.10

5.4

3.1

3.95

4.58

pmol/l

—

Thrombocytopenia, unspecified

140

1197

1.18

1.09

3.6

3.3

4.18

4.49

pmol/l

2.68

125

1047

278

1.38

1.09

3.2

3.0

4.14

4.31

pmol/l

0.49

236

Carcinoma in situ of cervix uteri

306

2760

1.12

1.09

3.4

3.1

4.63

4.55

pmol/l

0.55

269

2465

Ulcerative colitis, NAS

358

3252

1.11

1.09

3.3

4.48

4.53

pmol/l

0.39

317

2901

Telogen effluvium

2.10

1.09

5.3

3.8

4.41

4.63

pmol/l

—

Reduction defects of upper limb

2.11

1.08

2.1

3.9

4.43

5.14

pmol/l

—

Carcinoma in situ of breast, intraductal

222

1966

1.14

1.08

2.7

3.0

4.32

4.46

pmol/l

1.57

192

1722

Carcinoma in situ of skin of lip

2.21

1.08

3.3

3.2

4.04

4.27

pmol/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

413

2298

1.10

1.08

3.1

3.2

4.51

4.44

pmol/l

0.56

364

2056

Seminoma of testis

121

1.60

1.08

2.7

3.3

4.74

4.63

pmol/l

0.20

109

Exposure to other and unspecified forces of nature

1.69

1.07

2.8

3.6

4.33

4.78

pmol/l

1.15

Idiopathic pulmonary fibrosis

117

988

1.19

1.06

2.8

3.1

4.21

4.37

pmol/l

0.58

107

842

Pneumonia derived septicemia

526

1.27

1.06

3.3

4.58

4.60

pmol/l

0.04

464

Crystalline deposits in vitreous body

114

1.62

1.05

1.4

3.4

4.15

4.37

pmol/l

0.39

102

Juvenile rheumatoid arthirtis

510

1.27

1.04

2.8

3.5

4.22

4.59

pmol/l

2.81

462

Alzheimer’s disease (Early onset), excluding more controls

448

0.73

1.04

3.2

4.48

4.45

pmol/l

0.08

391

Carcinoma in situ of other and unspecified genital organs

369

1.33

1.04

3.4

3.0

4.48

4.50

pmol/l

0.02

316

Congenital malformations of breast

467

1.29

1.04

2.9

3.6

4.50

4.63

pmol/l

0.54

418

Unspecified dementia

144

1116

1.17

1.03

2.4

3.0

4.12

4.27

pmol/l

0.89

117

933

Social disorders starting during childhood or adolescence

172

1.49

1.03

5.4

3.5

4.74

5.04

pmol/l

0.80

159

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

123

1437

0.85

1.03

3.1

3.2

4.45

4.49

pmol/l

0.23

114

1279

Allergic purpura

601

1.25

1.02

3.7

3.3

4.51

4.61

pmol/l

0.31

534

Labyrinthitis

1.89

1.02

3.3

3.8

4.54

4.52

pmol/l

0.03

Mandibular retrognathia AND surgery (BSSRO)

638

1.24

1.02

3.4

3.6

4.50

4.62

pmol/l

0.64

574

Carcinoma in situ of skin of lip

2.08

1.02

3.3

2.9

4.04

4.35

pmol/l

—

Mitochondrial myopathy

1.74

1.02

2.6

3.9

4.01

4.78

pmol/l

1.62

Other contact dermatitis

214

1899

1.14

1.02

3.1

3.3

4.40

4.51

pmol/l

1.17

185

1695

Assault by blunt object

231

1.41

1.02

2.7

3.9

4.43

4.74

pmol/l

0.79

211

Chalazion

274

2466

1.12

1.02

3.3

3.2

4.46

4.49

pmol/l

0.25

247

2196

Asymmetry of jaw

344

1.33

1.02

1.8

3.3

4.42

4.65

pmol/l

0.89

307

Injury of other and unspecified intrathoracic organs

112

947

1.19

1.01

3.2

3.4

4.48

4.51

pmol/l

0.10

838

6-mercaptopurine

647

1.24

1.01

3.2

3.3

4.60

4.69

pmol/l

0.34

588

Perforation of tympanic membrane

229

2041

1.13

1.01

2.9

3.3

4.33

4.50

pmol/l

2.26

200

1821

Chondromalacia

566

1.25

1.01

2.7

3.6

4.61

4.56

pmol/l

0.19

499

Contact with other hot fluids

584

1.25

1.01

3.0

3.3

4.71

4.73

pmol/l

0.03

523

Vasculitis limited to skin, not elsewhere classified

423

1.29

1.01

2.3

3.1

4.05

4.51

pmol/l

3.10

377

Mixed conductive and sensorineural hearing loss

255

2287

1.12

1.01

3.0

3.3

4.43

4.42

pmol/l

0.05

221

1996

Malignant neoplasm of bronchus and lung

293

2474

1.11

1.01

3.8

3.1

4.23

4.33

pmol/l

0.93

264

2118

Precocious puberty

108

1.63

1.00

3.4

2.7

5.34

4.88

pmol/l

1.28

Assault by hanging, strangulation and suffocation

1.89

1.00

2.4

4.0

4.88

4.85

pmol/l

—

Oral lichen ruber planus

469

1.28

0.99

3.6

3.0

4.29

4.47

pmol/l

1.04

406

Impaction of intestines

1.67

0.99

1.3

3.0

4.37

4.45

pmol/l

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

1.92

0.99

6.0

3.4

5.03

5.06

pmol/l

—

Reactive arthropathies

208

1846

1.13

0.99

3.3

3.4

4.45

4.51

pmol/l

0.46

183

1656

Hypertensive encephalopathy

1.86

0.99

2.4

4.03

4.27

pmol/l

—

Monoarthritis, not elsewhere classified

822

1.20

0.99

2.8

3.4

4.53

4.52

pmol/l

0.02

743

Oral lichen ruber planus, including avohilmo

149

1295

1.16

0.98

2.8

3.3

4.21

4.46

pmol/l

4.29

133

1147

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

407

1.30

0.98

4.3

3.2

4.33

4.56

pmol/l

0.95

350

Puerperal sepsis

422

3891

1.09

0.98

3.5

3.3

4.43

4.47

pmol/l

0.31

372

3469

Purulent endophthalmitis

1.74

0.98

2.9

2.6

3.95

4.22

pmol/l

0.76

Burn and corrosion of shoulder and upper limb, except wrist and hand

337

1.32

0.97

3.8

3.4

4.33

4.76

pmol/l

2.02

299

Congenital malformation syndromes predominantly affecting facial appearance

1.84

0.97

2.0

3.5

4.99

4.92

pmol/l

—

Acne keloid

2.36

0.96

5.2

4.3

4.40

4.76

pmol/l

—

Other/unspecified reactive arthropathies

158

1381

1.15

0.96

3.5

3.3

4.40

4.51

pmol/l

0.91

137

1228

Congenital myopathies

2.34

0.96

2.3

3.7

4.75

4.16

pmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases

135

1167

1.17

0.96

3.5

3.4

4.42

4.55

pmol/l

0.82

124

1045

Twin gestation

325

2967

1.10

0.95

3.7

3.5

4.54

4.53

pmol/l

0.06

303

2669

Pyogenic granuloma

295

1.34

0.95

4.2

3.3

4.19

4.62

pmol/l

2.10

265

Female infertility, uterine origin

102

1.63

0.95

2.9

3.9

4.41

4.65

pmol/l

0.72

Benign neoplasm: Cranial nerves

445

1.27

0.95

2.5

3.1

4.55

4.51

pmol/l

0.08

383

Other acute viral hepatitis

235

1.39

0.94

2.9

3.6

4.73

4.64

pmol/l

0.26

208

All dysplastic lesions of the cervix uteri

976

9249

1.06

0.94

3.3

3.4

4.56

4.53

pmol/l

0.35

867

8370

Increased muscle tone

118

1.57

0.94

4.3

3.5

4.28

4.59

pmol/l

1.20

102

Demyelinating diseases of the central nervous system

256

2311

1.12

0.93

3.3

3.4

4.44

4.54

pmol/l

0.84

224

2069

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

205

2299

0.89

0.93

2.5

3.4

3.92

4.45

pmol/l

9.76

173

2028

Other and unspecified mononeuropathies of lower limb

527

1.25

0.93

3.5

3.2

4.45

4.48

pmol/l

0.10

457

Undefined dementia

146

1167

1.15

0.93

2.4

2.9

4.10

4.26

pmol/l

0.97

119

961

Fetal death of unspecified cause

1.99

0.92

3.3

3.9

4.37

4.73

pmol/l

—

Lesion of radial nerve

646

1.22

0.91

4.3

3.4

4.52

4.53

pmol/l

0.03

561

Environmental-pollution-related condition

2.16

0.91

4.2

3.9

4.47

4.74

pmol/l

—

Chronic mastoiditis

394

1.28

0.91

3.4

3.1

4.54

4.48

pmol/l

0.12

339

Labour and delivery complicated by fetal stress [distress]

996

6314

1.06

0.91

3.4

3.5

4.60

4.58

pmol/l

0.17

890

5731

Injury of eye and orbit

322

2943

1.10

0.91

3.0

3.3

4.60

4.56

pmol/l

0.29

287

2623

Marfan's syndrome

103

1.60

0.91

5.6

3.4

4.58

4.79

pmol/l

0.51

Fibrosis and cirrhosis of liver

147

1285

1.15

0.91

2.3

3.3

4.01

4.44

pmol/l

4.49

129

1128

Crushing injury of wrist and hand

218

0.63

0.90

5.1

4.0

4.39

4.69

pmol/l

0.77

204

Acquired haemolytic anaemia

368

1.29

0.90

2.3

3.3

3.92

4.56

pmol/l

3.41

321

Juvenile osteochondrosis

684

1.21

0.90

3.0

3.4

4.76

4.72

pmol/l

0.11

616

Carcinoma in situ of other and unspecified genital organs

378

1.29

0.90

3.4

3.2

4.48

4.52

pmol/l

0.06

328

Complications of labour and delivery

2489

13436

1.04

0.89

3.4

3.3

4.50

pmol/l

0.02

2211

12015

Osteomyelitis of vertebra

1.92

0.89

2.4

2.8

4.22

4.46

pmol/l

—

Retained placenta and membranes, without haemorrhage

356

3866

0.91

0.89

3.1

3.3

4.44

4.49

pmol/l

0.47

313

3480

Open wound of abdomen, lower back and pelvis

521

1.24

0.89

3.0

3.3

4.22

4.68

pmol/l

3.01

464

Etanercept

165

1457

1.14

0.89

2.4

3.2

4.32

4.57

pmol/l

2.63

151

1309

Haematosalpinx/Haematoma of broad ligament

1.87

0.88

2.4

3.0

4.54

pmol/l

—

IBD patients in KELA-register

622

5843

1.07

0.87

3.3

4.53

4.56

pmol/l

0.28

557

5265

Complications of genitourinary prosthetic devices, implants and grafts

460

1.25

0.87

3.3

4.54

4.50

pmol/l

0.12

403

Other injuries of lower limb, level unspecified

129

1.51

0.86

2.3

3.5

4.58

4.68

pmol/l

0.21

115

Occupational exposure to risk-factors

524

1.23

0.85

3.5

3.7

4.57

4.53

pmol/l

0.15

464

Dermatitis herpetiformis

310

1.31

0.84

3.5

3.2

4.43

4.59

pmol/l

0.65

273

Multiple gestation

333

3066

1.09

0.84

3.6

3.5

4.53

4.52

pmol/l

0.08

311

2757

Viral agents as the cause of diseases classified to other chapters

418

1.26

0.83

2.3

3.3

4.46

4.57

pmol/l

0.46

369

Assault by unspecified means

382

1.27

0.83

3.1

3.9

4.44

4.79

pmol/l

1.25

350

Schistosomiasis [bilharziasis]

0.00

0.82

0.0

3.7

—

4.40

—

Hereditary nephropathy, not elsewhere classified

1.73

0.81

10.0

2.8

4.61

4.41

pmol/l

—

Pseudopolyposis of colon

1.72

0.81

1.1

3.4

4.84

4.56

pmol/l

—

Malignant neoplasm of other connective and soft tissue

321

1.29

0.81

4.6

3.2

4.56

4.53

pmol/l

0.06

275

Toxic effect of corrosive substances

1.60

0.80

3.0

3.9

4.85

4.82

pmol/l

0.03

Contact with other sharp object(s)

150

1328

1.14

0.80

2.5

3.4

4.60

4.65

pmol/l

0.27

135

1197

Sequelae of poliomyelitis

0.50

0.79

1.0

2.5

3.76

4.31

pmol/l

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

547

1.21

0.78

3.4

2.9

4.18

4.39

pmol/l

1.22

465

Use of memantine

377

3041

1.08

0.78

2.3

3.0

4.29

4.24

pmol/l

0.56

309

2562

Use of other anti-dementia drugs

377

3041

1.08

0.78

2.3

3.0

4.29

4.24

pmol/l

0.56

309

2562

Primary angle-closure glaucoma

649

1.20

0.78

2.7

3.0

4.42

4.36

pmol/l

0.26

555

Benign neoplasm: Connective and other soft tissue of abdomen

1.77

0.78

4.7

4.1

4.43

4.72

pmol/l

—

Carcinoma in situ of skin, other sites/unspecified

132

1.46

0.77

2.3

2.5

4.45

4.24

pmol/l

0.46

117

Contact with other hot metals

244

1.33

0.77

4.1

3.4

4.44

4.65

pmol/l

0.56

216

Arthropathic psoriasis

261

2387

1.10

0.77

2.7

3.4

4.49

4.50

pmol/l

0.02

226

2137

Malignant neoplasm of breast, HER2-negative

1523

11603

0.96

0.76

3.0

3.3

4.44

4.42

pmol/l

0.20

1352

10224

conjunctival degenerations and deposits

378

1.26

0.76

3.5

3.1

4.40

4.53

pmol/l

0.37

328

UC patients in KELA-register (code 208), prior to 1994

790

1.17

0.76

4.0

3.3

4.29

4.49

pmol/l

1.37

690

Struck by thrown, projected or falling objec

827

1.17

0.76

2.8

3.5

4.72

4.63

pmol/l

0.24

746

Toxic colitis

1.69

0.76

2.3

3.0

4.37

4.48

pmol/l

—

Torticollis

316

1.28

0.75

3.6

4.15

4.71

pmol/l

2.84

282

Acquired atrophy of ovary and fallopian tube

1.69

0.75

2.5

2.7

4.41

4.67

pmol/l

0.48

LeFortI or BSSRO operation

116

1016

1.15

0.75

3.3

3.4

4.47

4.58

pmol/l

0.65

108

920

Fitting and adjustment of other devices

718

6336

1.06

0.75

2.8

3.2

4.33

4.42

pmol/l

1.67

616

5524

Methotrexate

383

3565

1.08

0.75

2.8

3.4

4.39

4.51

pmol/l

0.82

344

3145

Alzheimer’s disease, wide definition, excluding more controls

261

1621

1.10

0.74

2.5

3.3

4.33

4.37

pmol/l

0.27

207

1418

Benign neoplasm: Endocrine gland, other/unspecified

1.66

0.74

1.7

3.8

4.37

4.66

pmol/l

—

Residual foreign body in soft tissue

103

894

1.16

0.74

2.4

3.5

4.64

4.54

pmol/l

0.28

811

Cleft lip and palate

109

0.54

0.74

5.3

3.4

4.33

4.83

pmol/l

—

Fracture of neck

857

1.16

0.74

2.7

3.5

4.27

4.47

pmol/l

1.27

754

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

425

1.24

0.74

4.3

3.2

4.33

4.56

pmol/l

0.98

367

Mantle cell lymphoma

1.55

0.73

1.5

3.3

3.94

4.41

pmol/l

1.89

Melanocytic naevi of scalp and neck

480

1.22

0.73

2.7

3.4

4.67

4.59

pmol/l

0.14

426

Pedal cyclist injured in transport accident

557

5254

1.06

0.73

3.1

3.3

4.52

4.54

pmol/l

0.23

487

4695

Glaucoma secondary to drugs

1.63

0.73

3.2

2.9

4.75

4.57

pmol/l

—

Occlusion and stenosis of arteries, not leading to stroke

142

1.42

0.73

3.4

3.1

4.34

4.31

pmol/l

0.03

123

Dislocation, sprain and strain of joints and ligaments of elbow

157

1404

1.13

0.73

3.2

4.41

4.59

pmol/l

1.98

139

1249

Benign neoplasm: Endocrine gland, other/unspecified

1.63

0.73

1.7

3.8

4.37

4.62

pmol/l

—

Malignant neoplasm of breast, HER-negative

590

5573

1.06

0.72

2.9

3.2

4.38

4.40

pmol/l

0.15

522

4875

Use of bromocriptine

2.01

0.72

7.2

1.9

4.24

4.40

pmol/l

—

MS-disease / Multiple Sclerosis

212

1929

1.11

0.72

3.5

3.4

4.47

4.55

pmol/l

0.60

184

1737

Fourth [trochlear] nerve palsy

372

1.25

0.72

2.6

3.2

4.48

4.55

pmol/l

0.21

322

Other ulcerative colitis

137

1217

1.13

0.71

3.6

3.4

4.43

4.58

pmol/l

1.26

122

1091

Chronic lymphocytic leukaemia

336

1.26

0.71

2.3

3.2

4.10

4.32

pmol/l

1.01

289

Allergic contact dermatitis due to drugs in contact with skin

427

1.23

0.71

4.0

3.4

4.38

4.54

pmol/l

0.41

383

Unspecified jaundice

739

1.17

0.71

3.7

3.3

4.56

4.44

pmol/l

0.38

651

Impacted maxillary molar

162

1455

1.12

0.71

3.4

3.5

4.78

4.71

pmol/l

0.36

152

1308

Recurrent and persistent haematuria

135

1.44

0.71

3.3

3.5

4.49

4.57

pmol/l

0.17

118

Livedoid vasculitis

1.70

0.71

2.0

3.3

3.80

4.25

pmol/l

—

Abnormalities of forces of labour

328

3529

0.92

0.71

3.3

4.51

pmol/l

0.01

300

3213

Lesion of medial popliteal nerve

1.69

0.70

2.7

2.9

4.62

4.43

pmol/l

—

Benign neoplasm: Cranial nerves

464

1.22

0.70

2.5

3.3

4.55

4.48

pmol/l

0.13

402

Chronic hepatitis, not elsewhere classified

686

1.18

0.69

2.6

3.4

4.36

4.56

pmol/l

0.92

601

Other and unspecified injuries of thorax

311

1.27

0.69

2.1

3.5

4.35

4.65

pmol/l

1.11

279

Other articular cartilage disorders

401

1.23

0.69

2.0

3.5

4.40

4.48

pmol/l

0.28

364

Malignant neoplasm of breast

1585

11820

0.97

0.69

3.0

3.3

4.44

4.42

pmol/l

0.20

1405

10424

Injury of cranial nerves

119

1.46

0.69

3.1

2.9

4.80

4.58

pmol/l

0.26

106

Slow fetal growth and fetal malnutrition

1.53

0.69

2.1

2.7

5.19

5.27

pmol/l

0.11

Dementia due to Parkinson's disease

222

1.32

0.69

2.7

2.5

4.32

4.23

pmol/l

0.25

191

Hip and thigh

1.69

0.69

7.4

4.2

5.01

4.47

pmol/l

—

Ill-defined and unknown causes of mortality

844

0.85

0.68

3.1

3.3

4.28

4.36

pmol/l

0.30

723

IgA nephropathy (IgA glomerulonephritis)

393

1.23

0.68

3.4

3.5

3.91

4.63

pmol/l

4.13

350

Injury of nerves at forearm level

223

1.32

0.68

2.5

3.8

3.98

4.69

pmol/l

3.03

194

Other and unspecified vasculitis limited to skin

375

1.24

0.68

2.2

3.2

4.10

4.54

pmol/l

2.32

337

Other and unspecified hydrocephalus

285

1.28

0.68

2.8

3.0

4.54

4.55

pmol/l

0.01

247

Impetigo

103

903

1.15

0.67

4.5

3.4

4.61

4.72

pmol/l

0.53

811

Systemic sclerosis (FG)

504

1.20

0.67

1.8

3.2

4.15

4.50

pmol/l

2.40

445

Contracture of muscle

1.66

0.67

5.6

2.5

4.27

4.59

pmol/l

—

Other congenital malformations of kidney

1.66

0.67

2.4

3.8

4.29

4.68

pmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

449

1.22

0.66

2.3

3.3

4.20

4.61

pmol/l

2.81

398

Other/unspecified postprocedural disorders of ear and mastoid process

1.64

0.66

1.6

2.2

4.31

4.30

pmol/l

—

Pneumococcal septicemia

513

1.20

0.66

3.3

4.64

pmol/l

0.01

455

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

826

6738

0.95

0.66

3.1

3.0

4.24

4.42

pmol/l

5.21

728

5880

Biological medication for rheuma

423

3976

1.07

0.65

2.9

3.4

4.49

4.55

pmol/l

0.40

392

3574

Malignant neoplasm of rectum

127

1424

0.89

0.65

3.4

3.1

4.31

4.38

pmol/l

0.31

118

1229

Sequelae of infectious and parasitic diseases

164

1483

1.11

0.64

3.4

4.39

4.48

pmol/l

0.53

150

1313

Carcinoma in situ of uteri, other/unspecified

147

1.40

0.64

5.3

3.0

4.55

4.64

pmol/l

0.18

131

Hydrocephalus

135

1208

1.12

0.64

2.9

3.1

4.53

4.45

pmol/l

0.37

116

1047

Generalized epilepsy, mode (most common among epilepsy diagnosis)

692

1.17

0.64

2.3

3.4

4.48

4.70

pmol/l

1.21

624

Corrosions classified according to extent of body surface involved

1.75

0.63

2.2

2.4

4.88

4.66

pmol/l

—

Other disorders of skin and subcutaneous tissue related to radiation

1.73

0.63

8.0

2.7

4.78

4.44

pmol/l

—

Right hemicolectomy

100

880

1.14

0.62

3.3

4.24

4.40

pmol/l

0.97

754

727

1.16

0.62

2.9

3.3

4.55

4.49

pmol/l

0.21

620

Paralytic ileus

535

1.19

0.62

2.1

3.2

4.31

4.54

pmol/l

1.08

462

Eclampsia

1.60

0.62

3.6

3.3

4.46

4.71

pmol/l

0.42

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

113

1.44

0.62

3.4

2.6

4.30

4.37

pmol/l

0.11

Cleft palate

232

0.72

0.61

1.8

3.8

4.75

4.82

pmol/l

0.09

206

Exposure to excessive heat of man-made origin

105

1.45

0.61

1.8

2.8

4.39

4.60

pmol/l

0.33

Alcohol withdrawal state with delirium

108

957

1.13

0.61

2.4

3.5

4.41

4.48

pmol/l

0.22

858

Injury of blood vessels at lower leg level

1.57

0.61

3.1

3.95

4.54

pmol/l

1.53

Other obstructed labour

252

2336

1.09

0.60

3.2

3.3

4.59

4.49

pmol/l

0.63

233

2099

HSIL lesion of the cervix uteri, vagina or vulva

720

6889

1.05

0.60

3.4

4.59

4.53

pmol/l

0.71

644

6238

Cardiovascular disorders originating in the perinatal period

1.57

0.60

1.5

2.2

5.15

5.29

pmol/l

—

Aneurysms, operations, SAH

363

3407

1.07

0.60

3.1

3.2

4.47

4.44

pmol/l

0.25

322

3015

Acquired keratosis [keratoderma] palmaris et plantaris

1.60

0.60

1.6

3.7

4.51

4.50

pmol/l

—

Rheumatoid arthritis, including avohilmo

1053

10152

1.04

0.60

2.8

3.3

4.33

4.43

pmol/l

2.00

927

8954

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.59

0.0

2.1

—

4.41

—

Neonatal jaundice from other and unspecified causes

212

1.29

0.59

2.2

2.9

5.63

5.21

pmol/l

0.49

194

Acute alcohol intoxication ICD-9

492

1.19

0.59

2.4

3.5

4.00

4.51

pmol/l

3.27

440

Mumps

465

1.19

0.59

2.4

3.4

4.33

4.57

pmol/l

1.51

410

Abscess of anal and rectal regions

172

1569

1.10

0.59

2.8

3.4

4.51

4.59

pmol/l

0.36

149

1405

Systemic sclerosis

512

1.18

0.58

1.8

3.1

4.15

4.49

pmol/l

2.31

452

Other intracranial haemorrhages

364

1.22

0.58

2.8

3.1

4.34

4.42

pmol/l

0.16

312

Carcinoma in situ of uteri, other/unspecified

150

1.37

0.58

5.3

3.3

4.55

4.59

pmol/l

0.08

133

Congenital hydrocephalus

1.58

0.57

4.0

3.4

5.01

4.74

pmol/l

—

Benign neoplasm: Connective and other soft tissue of abdomen

1.58

0.57

4.7

4.4

4.43

4.74

pmol/l

—

Lymphoid leukaemia

812

1.14

0.57

3.3

3.2

4.43

4.47

pmol/l

0.13

712

Tumor necrosis factor alpha inhibitors

381

3592

1.06

0.57

2.9

3.4

4.50

4.55

pmol/l

0.26

356

3229

Small plaque parapsoriasis

1.66

0.56

4.8

3.5

4.57

4.34

pmol/l

—

Colorectal cancer

385

4082

0.94

0.56

3.1

3.2

4.26

4.37

pmol/l

1.46

339

3551

Medicines for HER+ breast cancer

1034

10430

0.96

0.56

3.1

3.2

4.50

4.41

pmol/l

1.53

922

9144

Injury of nerves at hip and thigh level

1.54

0.55

3.0

3.3

4.59

4.36

pmol/l

—

Motorcycle rider injured in noncollision transport accidents

515

1.17

0.55

2.9

3.6

4.83

4.80

pmol/l

0.08

470

Molar incisor enamel hypoplasia

624

1.16

0.55

2.8

3.4

4.91

4.94

pmol/l

0.10

575

Systemic sclerosis, icd10

516

1.17

0.54

1.8

3.1

4.15

4.50

pmol/l

2.33

453

Sulfonylureas

630

5258

0.95

0.54

3.0

3.2

4.14

4.35

pmol/l

5.89

527

4565

Other congenital malformations of nervous system

232

1.27

0.54

3.7

4.58

4.82

pmol/l

0.59

209

Desensitization to allergens

150

1368

1.10

0.54

2.8

3.4

4.75

4.66

pmol/l

0.19

132

1232

Psoriasis (vulgaris), strict definition

535

1.17

0.53

2.0

3.4

4.28

4.59

pmol/l

1.84

480

Inflammatory bowel disease, strict (require KELA)

622

5952

1.05

0.53

3.3

3.4

4.53

4.55

pmol/l

0.17

557

5353

Obstructed labour due to malposition and malpresentation of fetus

805

7877

0.96

0.53

3.6

3.4

4.54

4.55

pmol/l

0.07

737

7146

Systemic atrophies primarily affecting the central nervous system

591

1.16

0.53

2.4

3.3

4.31

4.48

pmol/l

0.62

517

Other Crohn's disease

169

1551

1.10

0.53

3.3

4.38

4.58

pmol/l

2.29

156

1399

Cicatricial alopecia [scarring hair loss]

126

1.37

0.53

3.2

3.5

4.16

4.55

pmol/l

1.20

107

Tetraplegia

100

1.42

0.53

2.9

4.71

4.48

pmol/l

0.27

Benign neoplasm of ovary

516

4921

1.05

0.52

3.1

3.2

4.46

4.43

pmol/l

0.22

457

4332

Intracerebral haemorrhage

195

1800

1.09

0.52

3.1

3.2

4.13

4.39

pmol/l

3.85

165

1553

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

1.45

0.52

4.2

3.1

4.22

4.50

pmol/l

0.47

Exposure to uncontrolled fire in building or structure

109

1.40

0.52

2.3

3.7

4.40

4.53

pmol/l

0.26

Benign neoplasm: Vagina

270

1.24

0.51

3.3

3.0

4.57

4.55

pmol/l

0.05

236

Other congenital malformations of urinary system

1.52

0.51

2.8

3.6

4.95

4.85

pmol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

382

2164

1.06

0.51

3.2

3.1

4.46

4.42

pmol/l

0.30

339

1933

Use of ropinirole

538

1.16

0.51

2.8

3.3

4.35

4.39

pmol/l

0.14

468

Sickle-cell disorders

1.60

0.50

3.1

2.9

4.23

4.66

pmol/l

—

Cleft lip, lip and palate or palate

345

0.80

0.50

2.7

3.6

4.54

4.73

pmol/l

0.54

308

Carcinoma in situ of skin, other sites/unspecified

145

1.33

0.49

2.3

2.7

4.45

4.26

pmol/l

0.41

122

Benign neoplasm: Ciliary body

1.56

0.49

2.4

4.0

4.31

4.54

pmol/l

—

Benign neoplasm: Ciliary body

1.56

0.49

2.4

4.1

4.31

4.67

pmol/l

—

Other infiltrative disorders of skin and subcutaneous tissue

1.48

0.49

3.4

2.8

4.31

4.53

pmol/l

0.44

Suppurative otitis media, unspecified

503

1.16

0.48

2.8

3.5

4.48

4.64

pmol/l

0.58

450

Gender identity disorders

272

1.23

0.48

3.5

4.93

4.77

pmol/l

0.35

241

Other congenital malformations of digestive system

1.50

0.48

1.6

2.7

4.46

4.58

pmol/l

—

Bacterial meningitis

635

1.14

0.48

3.1

3.4

4.31

4.58

pmol/l

1.08

554

Foreign body on external eye

272

2555

1.07

0.48

3.4

4.61

4.57

pmol/l

0.24

246

2295

Use of interferon beta-1a

589

1.15

0.48

3.3

3.6

4.47

4.53

pmol/l

0.22

532

Benign neoplasm: Lip

300

1.21

0.47

4.8

3.1

4.51

4.61

pmol/l

0.28

260

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

179

1657

1.08

0.47

3.0

2.9

4.22

4.39

pmol/l

1.85

154

1408

Fetus and newborn affected by maternal complications of pregnancy

1.41

0.47

1.3

2.6

5.26

5.14

pmol/l

0.19

Disorder of carbohydrate metabolism, other/unspecified

1.46

0.47

2.1

3.2

4.26

4.53

pmol/l

—

Other complications of labour and delivery, not elsewhere classified

425

3903

1.05

0.47

3.1

3.5

4.59

pmol/l

0.06

387

3530

Hypoplasia of dental enamel , including avohilmo

592

1.14

0.46

2.9

3.4

4.90

4.92

pmol/l

0.07

546

CR(E)ST syndrome

320

1.20

0.46

2.1

3.1

4.07

4.47

pmol/l

1.83

281

therapeutic use

459

1.16

0.46

2.5

3.1

4.01

4.43

pmol/l

2.58

395

N06DA Anticholinesterases

486

4114

0.95

0.45

2.4

3.0

4.37

4.26

pmol/l

1.78

390

3499

Use of anticholinesterases

486

4114

0.95

0.45

2.4

3.0

4.37

4.26

pmol/l

1.78

390

3499

Postpartum haemorrhage due to anatomy

382

3637

1.05

0.45

3.7

3.5

4.52

4.61

pmol/l

1.30

335

3324

Benign neoplasm: Vagina

275

1.22

0.45

3.3

3.0

4.57

4.55

pmol/l

0.05

239

Cyst of Bartholin Gland

117

1068

1.10

0.45

3.2

3.4

4.53

4.47

pmol/l

0.25

104

963

Foreign body in ear

349

1.19

0.44

2.0

3.2

4.60

4.62

pmol/l

0.04

308

Donors of organs and tissues

248

1.22

0.44

2.5

3.5

4.33

4.64

pmol/l

1.66

222

Single delivery by forceps and vacuum extractor

527

3345

0.96

0.43

3.2

3.5

4.74

4.56

pmol/l

2.38

474

2987

Other early complications of trauma

0.00

0.43

0.0

2.7

—

4.27

—

Other ill-defined and unspecified causes of mortality

745

0.88

0.43

3.2

4.26

4.37

pmol/l

0.38

639

Adenocarcinomas of cervix

1.39

0.43

4.2

3.2

4.22

4.48

pmol/l

0.43

L04AC Interleukin inhibitors

110

1003

1.10

0.43

2.4

3.2

4.39

4.58

pmol/l

1.39

893

Labyrinthine dysfunction

0.00

0.42

0.0

4.0

—

4.32

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1471

9377

1.03

0.42

3.0

4.44

4.45

pmol/l

0.09

1308

8240

HSIL lesion of the cervix uteri

658

6352

1.04

0.42

3.4

4.59

4.54

pmol/l

0.52

590

5751

Choroidal haemorrhage and rupture

1.54

0.42

2.2

3.5

4.54

4.52

pmol/l

—

Pedal cyclist injured in noncollision transport accidents

257

2426

1.06

0.41

3.0

3.4

4.50

4.56

pmol/l

0.40

225

2173

Male infertility

568

1.13

0.40

2.6

4.0

4.55

4.77

pmol/l

1.19

523

Generalized epilepsy, strict definition

465

1.15

0.40

2.2

3.5

4.55

4.77

pmol/l

0.76

414

Foreign body granuloma of skin and subcutaneous tissue

1.33

0.40

1.6

3.5

4.67

4.68

pmol/l

—

Prolonged pregnancy

520

4930

0.96

0.40

3.2

3.4

4.56

4.57

pmol/l

0.02

474

4448

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

100

1096

0.91

0.40

2.3

2.9

4.24

4.44

pmol/l

0.71

935

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1469

9374

1.03

0.40

3.0

4.44

4.45

pmol/l

0.09

1306

8237

1.45

0.40

4.2

2.5

4.86

5.25

pmol/l

—

Contact with sharp glass

769

1.11

0.40

3.3

3.4

4.58

4.67

pmol/l

0.33

690

Malignant neoplasm of prostate

500

3287

0.96

0.39

3.1

3.5

4.37

4.34

pmol/l

0.27

442

2933

Burn and corrosion of wrist and hand

703

1.12

0.39

2.9

3.4

4.79

4.70

pmol/l

0.17

630

Hand

1.37

0.39

2.8

3.8

4.51

4.59

pmol/l

0.10

Cleft lip and cleft lip and palate

136

0.73

0.38

4.4

3.3

4.09

4.87

pmol/l

—

122

Vaginal lichen planus

1.35

0.38

2.3

3.3

4.24

4.43

pmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

115

1248

0.92

0.38

2.9

3.4

4.54

4.46

pmol/l

0.41

101

1099

Medical treatment for female infertility

805

7797

1.03

0.38

3.6

3.4

4.51

4.56

pmol/l

0.89

733

7078

Malignant neoplasm, without specification of site

345

1.17

0.38

3.0

3.96

4.34

pmol/l

2.17

293

Other corneal oedema

107

1.33

0.38

2.9

3.0

4.74

4.48

pmol/l

0.33

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

123

1329

0.92

0.37

3.1

2.9

4.27

4.41

pmol/l

0.79

116

1145

Exposure to uncontrolled fire, not in building or structure

1.50

0.37

5.7

4.0

4.44

4.56

pmol/l

—

Need for immunization against single bacterial diseases

1.46

0.36

1.3

3.6

4.75

5.25

pmol/l

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

1.46

0.36

4.8

3.5

3.60

4.43

pmol/l

—

Use of rivastigmine

198

1861

1.06

0.36

2.3

2.9

4.25

4.27

pmol/l

0.15

163

1546

Small kidney of unknown cause

1.43

0.36

2.5

3.5

4.27

4.41

pmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

128

1378

0.93

0.36

3.1

2.9

4.29

4.41

pmol/l

0.74

121

1187

Hypertension, portal

1.42

0.36

5.5

3.2

3.57

4.26

pmol/l

—

Monocytic leukaemia

1.42

0.35

15.0

3.6

4.65

4.43

pmol/l

—

Pneumoconiosis due to dust containing silica

1.41

0.35

2.3

3.9

4.30

4.35

pmol/l

—

Apocrine sweat disorders, other sweat gland disorders

1.40

0.35

2.5

2.9

4.67

4.51

pmol/l

—

Caries in Clefts patients

211

0.80

0.35

3.6

3.7

4.39

4.80

pmol/l

1.29

189

Syndactyly

1.39

0.35

1.7

3.4

4.67

4.92

pmol/l

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

622

1.11

0.35

2.6

3.1

4.21

4.51

pmol/l

1.27

537

Carcinoma in situ of cervix uteri

306

2923

1.05

0.35

3.4

4.63

4.54

pmol/l

0.68

269

2626

Congenital malformations of lung

1.39

0.35

1.3

2.9

4.62

5.11

pmol/l

—

Delivery

1421

7356

1.02

0.35

3.3

3.2

4.51

4.47

pmol/l

0.75

1269

6426

Ulcerative enterocolitis

662

1.11

0.34

3.9

3.5

4.46

4.56

pmol/l

0.44

591

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

100

1.31

0.34

3.1

2.7

4.19

4.32

pmol/l

0.22

Crohn's disease NAS

148

1386

1.07

0.33

3.7

3.3

4.41

4.59

pmol/l

1.63

130

1245

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.66

0.33

3.7

3.6

4.62

4.58

pmol/l

—

Pemphigoid

350

1.15

0.33

2.8

3.1

4.14

4.41

pmol/l

0.89

300

Abnormality of red blood cells

1.35

0.33

3.1

3.6

4.10

4.59

pmol/l

0.74

Other demyelinating diseases of the central nervous system

905

1.09

0.32

3.1

3.3

4.39

4.56

pmol/l

1.41

811

Psoriatic arthropathies, ICD10

240

2284

1.05

0.32

2.6

3.4

4.49

4.48

pmol/l

0.04

212

2049

Alcohol-induced acute pancreatitis

474

1.12

0.32

2.4

3.5

4.35

4.61

pmol/l

0.61

428

Postpartum haemorrhage due to retained placenta

442

4267

1.04

0.32

3.7

3.4

4.63

4.55

pmol/l

0.53

403

3894

Alzheimer’s disease (Late onset)

309

2535

1.05

0.32

2.4

3.0

4.30

4.23

pmol/l

0.64

244

2132

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

209

1.19

0.31

3.4

3.0

5.35

5.13

pmol/l

0.38

190

Polyarteritis nodosa

0.70

0.31

1.3

2.9

4.48

4.33

pmol/l

—

Benign neoplasm of other and unspecified female genital organs

1047

0.92

0.31

5.8

3.2

4.58

4.45

pmol/l

0.47

915

Other nonthrombocytopenic purpura

138

1.25

0.31

3.1

3.3

4.61

4.53

pmol/l

0.08

117

Vascular dementia (undefined)

302

1.15

0.31

2.2

2.5

4.30

4.19

pmol/l

0.19

250

Other endophthalmitis

1.35

0.31

2.8

2.6

4.40

4.57

pmol/l

—

Acute appendicitis, with complications

427

4422

0.96

0.31

3.9

3.4

4.45

4.48

pmol/l

0.25

386

3938

Other secondary coxarthrosis

581

1.11

0.31

2.5

3.2

4.41

4.51

pmol/l

0.37

510

Premature separation of placenta [abruptio placentae]

688

1.10

0.30

3.0

3.4

4.36

4.53

pmol/l

0.97

620

Lumbosacral plexus disorders

1.27

0.30

1.6

3.3

4.19

4.36

pmol/l

—

Cleft hard palate NOS

107

0.74

0.30

2.6

3.3

4.83

4.86

pmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

344

1.14

0.30

4.2

3.4

3.95

4.30

pmol/l

1.30

299

Toxic effect of contact with venomous animals

765

1.09

0.30

3.6

3.4

4.46

4.57

pmol/l

0.54

680

Benign neoplasm: Uterine tubes and ligaments

109

0.72

0.29

20.8

2.9

5.83

4.44

pmol/l

—

Carcinoma in situ of breast, intraductal

222

2117

1.05

0.29

2.7

3.2

4.32

4.45

pmol/l

1.34

192

1870

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

1.24

0.29

2.4

3.4

4.03

4.64

pmol/l

—

Cirrhosis of liver, NAS

718

1.09

0.29

2.3

3.4

3.67

4.43

pmol/l

8.92

630

Rubella [German measles]

421

1.12

0.29

3.7

3.8

4.52

4.64

pmol/l

0.39

389

Other psoriatic arthropathies

233

2226

1.05

0.29

2.6

3.4

4.49

4.48

pmol/l

0.04

205

1998

Toxic effect of other noxious substances eaten as food

1.31

0.28

4.0

3.2

4.45

4.64

pmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

242

1.16

0.28

2.4

2.9

4.22

4.37

pmol/l

0.38

204

Carcinoma in situ of oral cavity, oesophagus and stomach

1.28

0.28

1.5

2.6

3.97

4.25

pmol/l

—

Use of selegiline

642

1.09

0.28

2.4

3.4

4.40

4.34

pmol/l

0.26

558

Arthropod-borne viral fevers and viral haemorrhagic fevers

174

1833

0.95

0.28

3.7

3.4

4.52

4.47

pmol/l

0.33

160

1626

Other primary thrombocytopenia

1.27

0.28

1.4

4.0

4.67

4.60

pmol/l

—

Injury of nerves at wrist and hand level

652

1.09

0.28

2.6

3.6

4.56

4.66

pmol/l

0.30

593

Severe visual impairment, binocular

1.26

0.28

1.5

3.0

4.46

4.33

pmol/l

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

205

1.18

0.27

5.0

2.9

4.18

4.36

pmol/l

0.26

170

Contact with lifting and transmission devices, not elsewhere classified

279

0.85

0.27

3.8

3.6

4.52

4.71

pmol/l

0.51

250

Other disorders of carbohydrate metabolism

1.22

0.27

2.1

3.4

4.26

4.56

pmol/l

—

Transient global amnesia

176

1673

1.05

0.27

3.2

3.1

4.33

4.39

pmol/l

0.41

155

1452

Fibrosarcoma

104

1.26

0.27

3.6

3.5

4.59

4.80

pmol/l

0.40

Orthopaedic devices associated with adverse incidents

253

1.15

0.26

2.6

2.9

4.10

4.37

pmol/l

0.85

212

Carcinoma in situ of oral cavity, oesophagus and stomach

1.20

0.26

1.5

2.8

3.98

4.29

pmol/l

—

Thiamine deficiency

1.32

0.26

3.7

3.8

4.41

4.60

pmol/l

—

Use of galantamine

801

0.92

0.26

2.4

2.8

4.53

4.24

pmol/l

1.97

665

Dementia in Alzheimer disease

224

2000

0.96

0.26

2.7

3.0

4.22

4.23

pmol/l

0.02

173

1684

Burn and corrosion of hip and lower limb, except ankle and foot

444

1.11

0.26

3.3

3.5

4.71

4.70

pmol/l

0.02

391

Moderate visual impairment, monocular

1.23

0.26

3.9

3.7

4.18

4.49

pmol/l

—

Prepatellar bursitis

665

1.09

0.25

3.2

3.6

4.59

4.49

pmol/l

0.43

601

Otosclerosis

167

1590

1.05

0.25

2.9

3.3

4.44

pmol/l

0.00

144

1411

Benign neoplasm: Eye, unspecified

1.18

0.25

1.8

3.8

4.65

4.44

pmol/l

—

Benign neoplasm: Eye, unspecified

1.18

0.25

1.8

3.9

4.65

4.50

pmol/l

—

Acute hepatitis B

1.18

0.25

4.4

4.1

4.70

4.68

pmol/l

—

Other obstetric trauma

162

1699

0.95

0.24

3.4

3.3

4.62

4.57

pmol/l

0.25

146

1541

Cyst of spleen

1.38

0.24

5.8

3.9

4.75

4.62

pmol/l

—

L02BX Other hormone antagonists and related agents

513

1.09

0.24

3.6

3.5

4.40

4.30

pmol/l

0.24

446

Assault by sharp object

284

1.13

0.24

1.9

3.5

4.35

4.76

pmol/l

1.88

260

Foreign body or object entering through skin

120

1134

1.06

0.24

2.6

3.5

4.47

4.60

pmol/l

0.96

110

1012

Aortic arch syndrome [Takayasu]

1.30

0.23

5.8

2.8

4.78

4.40

pmol/l

—

Cholesteatoma of middle ear

853

1.07

0.23

3.4

3.3

4.34

4.47

pmol/l

0.68

743

Other parasitologically confirmed or unspecified malaria

1.30

0.23

5.0

5.1

4.36

4.56

pmol/l

—

Multiple delivery

256

2654

0.96

0.23

3.2

3.3

4.48

4.46

pmol/l

0.16

232

2357

Other cestode infections

1.29

0.23

6.4

3.0

4.46

4.33

pmol/l

—

Malignant neoplasm of stomach

640

1.08

0.23

3.6

3.2

4.23

4.39

pmol/l

0.54

548

L02BB Anti-androgens

846

0.93

0.23

3.1

3.5

4.32

4.23

pmol/l

0.28

723

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

290

2999

0.97

0.23

3.0

2.9

4.25

4.38

pmol/l

1.66

258

2584

Use of entacapone

0.73

0.22

2.0

2.9

4.49

4.26

pmol/l

—

Kissing spine

1.24

0.22

1.2

4.0

4.02

4.74

pmol/l

—

General- and plastic-surgery devices associated with adverse incidents

1.23

0.22

1.0

3.7

3.92

4.71

pmol/l

—

Other fluke infections

0.00

0.22

0.0

6.1

—

4.52

—

Brucellosis

0.00

0.22

0.0

4.8

—

4.48

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

4.5

—

4.75

—

Acquired ichthyosis

0.00

0.22

0.0

5.6

—

4.23

—

Cerebral arteritis

1.20

0.22

3.6

3.4

4.10

4.67

pmol/l

—

Echinococcosis

0.00

0.22

0.0

3.1

—

4.53

—

Benign neoplasm: Uterine tubes and ligaments

101

0.78

0.21

20.8

3.0

5.84

4.53

pmol/l

—

Mucinous and mucinous cystic tumor

1.25

0.21

9.1

3.5

4.65

4.40

pmol/l

0.51

Tuberculosis, wide

116

1100

1.06

0.21

2.4

3.3

4.35

4.38

pmol/l

0.08

107

945

Laparoscopic right hemicolectomy

847

1.07

0.21

3.1

3.2

4.30

4.38

pmol/l

0.32

729

Perineal laceration during delivery

609

5312

1.02

0.21

3.5

3.4

4.60

pmol/l

0.03

557

4797

Otorrhoea

1.29

0.21

3.3

3.7

4.10

4.72

pmol/l

—

Melanocytic naevi of ear and external auricular canal

111

0.80

0.20

1.9

3.2

4.57

4.68

pmol/l

—

100

1.24

0.20

3.8

3.6

5.09

4.56

pmol/l

—

Effects of other external causes

538

1.08

0.20

2.6

3.5

4.88

4.68

pmol/l

0.47

489

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

317

1.11

0.20

3.2

3.5

4.60

4.67

pmol/l

0.25

279

Adalimumab

217

2094

1.04

0.20

2.9

3.4

4.40

4.57

pmol/l

2.44

201

1887

Pterygium

384

1.10

0.20

2.6

3.2

4.50

4.39

pmol/l

0.34

335

Tuberculosis

881

0.94

0.20

2.5

3.3

4.45

4.34

pmol/l

0.25

755

Use of donepezil

265

2630

0.97

0.19

2.6

3.0

4.38

4.24

pmol/l

1.53

201

2215

Chorioretinal scars

1.16

0.19

1.3

3.4

4.43

4.45

pmol/l

—

Other sideroblastic anaemias

1.16

0.19

4.2

3.6

3.40

4.40

pmol/l

—

Respiratory distress of newborn

197

1.14

0.19

3.2

2.8

5.71

5.23

pmol/l

1.15

179

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

1.24

0.19

3.1

2.7

3.58

4.40

pmol/l

—

L02BG Aromatase inhibitors

804

8174

0.98

0.18

3.1

3.2

4.51

4.38

pmol/l

1.94

716

7148

Contact with nonpowered hand tool

668

1.07

0.18

4.4

3.6

4.51

4.62

pmol/l

0.51

603

Adhesive middle ear disease

310

1.10

0.18

2.4

3.5

5.09

4.68

pmol/l

0.23

276

Calcific tendinitis

157

1.15

0.17

2.7

3.4

4.20

4.39

pmol/l

0.41

144

Contact with sharp object, undetermined intent

368

1.09

0.17

3.1

3.6

4.62

4.70

pmol/l

0.16

330

Subarachnoid haemorrhage

177

1834

0.96

0.17

3.0

3.1

4.47

4.44

pmol/l

0.20

160

1597

Congenital malformations of ear causing impairment of hearing

0.76

0.17

2.4

3.3

4.28

4.93

pmol/l

—

0.72

0.17

1.4

3.0

4.30

4.70

pmol/l

—

Obstructed labour due to maternal pelvic abnormality

465

4747

0.98

0.17

3.1

3.2

4.43

4.46

pmol/l

0.31

413

4250

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.17

0.17

6.5

3.6

4.64

4.48

pmol/l

—

Single spontaneous delivery

1393

7326

1.01

0.17

3.3

3.2

4.51

4.47

pmol/l

0.90

1232

6398

Hair colour and hair shaft abnormalities

1.15

0.16

8.9

3.2

4.19

4.41

pmol/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

317

3092

1.03

0.16

2.9

4.27

4.39

pmol/l

1.56

277

2663

Oesophageal varices

576

0.94

0.16

2.7

3.5

3.81

4.49

pmol/l

3.19

497

Pedal cyclist injured in collision with motor vehicle

623

1.06

0.16

3.3

4.60

4.65

pmol/l

0.13

556

Deaf mutism, not elsewhere classified

1.22

0.16

3.5

3.3

4.35

4.46

pmol/l

—

Unspecified event, undetermined intent

478

1.07

0.15

2.5

3.4

4.64

4.65

pmol/l

0.03

421

0.79

0.15

4.3

3.7

3.99

4.75

pmol/l

—

Diving or jumping into water causing injury other than drowning or submersion

0.80

0.15

1.0

4.1

4.57

4.68

pmol/l

—

Abscess of Bartholin gland

723

1.06

0.15

3.1

3.4

4.41

4.53

pmol/l

0.44

649

Malignant neoplasm of colon

247

2407

1.03

0.14

3.0

3.2

4.24

4.36

pmol/l

1.25

212

2082

Accidental poisoning by and exposure to alcohol

353

1.08

0.14

1.9

3.5

4.69

pmol/l

0.01

317

Tuberculosis, IBD comorbidity

111

1067

1.04

0.14

2.2

3.3

4.34

4.37

pmol/l

0.11

102

917

Other and unspecified disease of Bartholin gland

676

1.05

0.13

3.3

3.4

4.44

4.49

pmol/l

0.18

596

Pedal cyclist injured in other and unspecified transport accidents

240

2342

1.03

0.13

3.0

3.4

4.48

4.53

pmol/l

0.34

206

2092

Carcinoma in situ of skin of upper limb, including shoulder

257

1.09

0.13

2.4

3.0

4.22

4.33

pmol/l

0.24

226

Melanocytic naevi of ear and external auricular canal

105

0.85

0.13

1.9

3.1

4.57

4.70

pmol/l

—

Any dementia

644

4473

1.01

0.13

2.8

3.1

4.27

4.30

pmol/l

0.29

514

3838

Crohn's disease of large intestine

115

1110

1.04

0.13

3.8

3.2

4.47

4.58

pmol/l

0.62

997

Bus occupant injured in other and unspecified transport accidents

123

1.15

0.13

4.7

3.3

4.83

4.49

pmol/l

0.27

109

Need for immunization against other single viral diseases

324

0.92

0.12

3.5

4.22

4.65

pmol/l

1.75

287

Pleural plaque

108

1042

1.04

0.12

3.9

3.3

4.20

4.30

pmol/l

0.46

891

Abnormal spermatozoa

127

1311

0.97

0.12

3.3

3.7

4.34

4.35

pmol/l

0.05

114

1158

Benign neoplasm of other and unspecified female genital organs

1006

0.96

0.12

5.8

2.9

4.58

4.47

pmol/l

0.39

877

Benign neoplasm: Lip

337

1.07

0.11

4.8

3.3

4.51

4.57

pmol/l

0.17

291

Ankylosing spondylitis, strict definition

916

1.04

0.11

2.2

3.4

4.69

4.61

pmol/l

0.11

826

Inhalation and ingestion of food causing obstruction of respiratory tract

124

1.13

0.11

3.5

2.9

4.60

4.59

pmol/l

0.02

105

Parodontitis or/and operation codes

2124

12540

1.01

0.11

3.2

3.3

4.49

pmol/l

0.01

1851

11285

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

134

1.13

0.11

2.1

3.4

4.46

4.48

pmol/l

0.02

118

malignant neoplasm of male genital organs

531

3418

0.99

0.11

3.0

3.5

4.41

4.35

pmol/l

0.58

467

3057

Alzheimer’s disease, wide definition

335

2848

0.98

0.10

2.4

3.1

4.31

4.25

pmol/l

0.47

265

2408

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

125

1.13

0.10

4.0

3.2

4.52

4.81

pmol/l

0.64

111

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

125

1.13

0.10

3.6

3.4

4.29

4.53

pmol/l

0.64

109

Immunodeficiency associated with other major defects

1.14

0.10

6.0

2.9

4.66

4.85

pmol/l

—

Unspecific neurodegenerative disorder

669

4664

0.99

0.10

2.6

3.1

4.28

4.29

pmol/l

0.04

551

3979

Actinomycosis

1.09

0.09

4.0

3.6

4.18

4.71

pmol/l

—

Universal erythroderma, KELA reimbursement

207

0.91

0.09

2.1

3.7

3.73

4.60

pmol/l

2.39

185

Caught, crushed, jammed or pinched in or between objects

871

1.03

0.09

2.4

3.5

4.99

4.66

pmol/l

1.36

781

Congenital ichthyosis

1.07

0.09

4.4

3.4

4.80

4.64

pmol/l

—

Malignant neoplasm of thymus

1.04

0.09

2.8

3.6

4.00

4.61

pmol/l

—

Pneumonia due to Haemophilus influenzae

1.04

0.09

3.8

3.0

4.14

4.51

pmol/l

—

Oher contracture of tendon (sheath)

1.04

0.09

2.0

3.2

3.30

4.32

pmol/l

—

Labyrinthine fistula

1.14

0.09

3.2

2.6

3.57

4.41

pmol/l

—

Pediculosis and phthiriasis

1.10

0.09

1.3

4.3

4.85

4.74

pmol/l

—

Ulcerative rectosigmoiditis

182

1784

1.02

0.08

3.4

3.3

4.48

4.52

pmol/l

0.28

165

1599

Benign neoplasm: Vulva

481

0.95

0.08

5.7

3.0

4.36

4.47

pmol/l

0.42

420

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.80

0.08

4.0

2.5

5.88

5.21

pmol/l

—

Neuroendocrine tumor and carcinoma of stomach

0.79

0.08

2.4

3.1

4.38

4.28

pmol/l

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.77

0.08

2.4

2.9

4.38

4.39

pmol/l

—

Listeriosis

1.12

0.08

5.4

3.1

3.77

4.34

pmol/l

—

Complications specific to multiple gestation

123

0.89

0.08

2.9

3.9

4.25

4.65

pmol/l

0.87

110

Effects of air pressure and water pressure

1.14

0.08

4.0

4.4

4.33

4.87

pmol/l

—

Degenerative conditions of globe

1.10

0.08

3.1

2.6

3.99

4.46

pmol/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

951

7657

1.01

0.08

3.1

3.0

4.48

4.43

pmol/l

0.54

844

6684

Degenerative diseases of the nervous system

535

3985

1.01

0.08

2.6

3.0

4.24

4.28

pmol/l

0.42

435

3396

Defect, injury or illness of lumbar spine

0.83

0.08

1.5

3.3

4.10

4.73

pmol/l

—

Blood alcohol or alcohol intoxication level

451

1.04

0.07

3.3

3.4

4.91

4.71

pmol/l

0.68

406

Feeding problems of newborn

1.09

0.07

3.0

5.13

5.17

pmol/l

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.82

0.07

2.0

2.9

4.23

4.41

pmol/l

—

Noise effects on inner ear

511

1.04

0.07

3.1

3.7

4.54

4.53

pmol/l

0.04

465

Ulcerative colitis (strict definition, all Crohn cases excluded)

345

3412

1.01

0.06

3.2

3.4

4.62

4.54

pmol/l

0.82

310

3046

Typhoid and paratyphoid fevers

1.12

0.05

2.9

4.53

4.42

pmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

439

4354

1.01

0.05

3.5

3.4

4.52

4.53

pmol/l

0.14

395

3903

Degeneration of nervous system due to alcohol

263

0.95

0.05

2.7

3.8

4.15

4.51

pmol/l

0.77

236

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

185

1825

1.01

0.05

3.1

2.9

4.34

4.41

pmol/l

0.45

168

1576

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

656

6601

0.99

0.05

2.9

3.3

4.27

4.43

pmol/l

4.25

579

5806

Crowding of teeth, including avohilmo

236

1925

1.01

0.05

3.1

3.3

4.76

4.81

pmol/l

0.26

215

1740

Other disorders of breast and lactation associated with childbirth

515

1.03

0.05

2.8

3.3

4.59

4.62

pmol/l

0.08

460

Normal-pressure hydrocephalus

646

0.97

0.05

3.2

2.9

4.38

4.32

pmol/l

0.20

552

Other/unspecified seropositive rheumatoid arthritis

665

6688

0.99

0.04

2.8

3.3

4.27

4.43

pmol/l

4.02

588

5877

Dementia

735

5101

0.99

0.04

2.7

3.2

4.29

4.31

pmol/l

0.22

598

4389

Other sexually transmitted chlamydial diseases

182

1800

1.01

0.04

2.7

3.4

4.85

4.67

pmol/l

0.55

148

1630

Golimumab

733

0.98

0.03

2.9

3.3

4.83

4.62

pmol/l

0.27

655

Degeneration of the brain due to alcohol

260

0.96

0.03

2.7

3.7

4.15

4.51

pmol/l

0.76

232

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

391

3888

1.01

0.03

3.3

3.4

4.55

4.54

pmol/l

0.06

353

3484

Mandibular prognathia AND surgery (LeFortI or BSSRO)

108

0.92

0.03

1.7

4.0

4.58

4.79

pmol/l

—

Maternal care for known or suspected disproportion

145

1436

1.01

0.03

3.5

3.4

4.52

4.50

pmol/l

0.08

130

1286

Alzheimer disease

448

3362

1.00

0.02

2.7

3.0

4.25

4.26

pmol/l

0.02

363

2848

Inguinal hernia

1339

9009

1.00

0.02

2.9

3.4

4.48

4.52

pmol/l

0.71

1192

8027

Motorcycle rider injured in other and unspecified transport accidents

104

1029

1.01

0.02

3.8

3.4

4.81

4.71

pmol/l

0.52

929

Colorectal cancer, excluding all cancers (controls excluding all cancers)

474

4599

1.00

0.02

2.9

3.0

4.27

4.40

pmol/l

2.33

418

3997

Bullous pemphigoid

258

0.97

0.02

2.8

2.9

3.94

4.40

pmol/l

1.14

223

Sulfasalazine

748

7498

1.00

0.02

2.7

3.4

4.35

4.51

pmol/l

4.68

674

6662

Long labour

898

7856

1.00

0.01

3.3

3.4

4.54

4.55

pmol/l

0.06

810

7102

Alzheimer disease, including avohilmo

543

3930

1.00

0.01

2.7

3.1

4.24

4.28

pmol/l

0.37

447

3330

Benign neoplasm: Vulva

468

0.98

0.01

5.7

2.9

4.36

4.53

pmol/l

0.78

403

Colon adenocarcinoma

179

1781

1.01

0.01

3.0

3.1

4.22

4.36

pmol/l

1.40

154

1530

Leiomyosarcoma

104

1.06

0.01

3.3

3.5

4.33

4.53

pmol/l

0.40

Small cell lung cancer

234

1.03

0.00

5.0

3.3

4.18

4.32

pmol/l

0.21

203

Small cell lung cancer, helper endpoint

234

1.03

0.00

5.0

3.3

4.18

4.32

pmol/l

0.21

203

Dementia, including avohilmo

795

5482

1.00

0.00

2.7

3.2

4.28

4.31

pmol/l

0.27

650

4730

Seropositive rheumatoid arthritis, wide

677

6775

1.00

0.00

2.9

3.3

4.27

4.43

pmol/l

4.15

598

5953

Carcinoma in situ of breast, other/unspecified

257

1.01

0.00

2.1

2.8

4.59

4.45

pmol/l

0.23

218

Carcinoma in situ of breast, other/unspecified

263

0.99

0.00

2.1

2.9

4.59

4.47

pmol/l

0.19

226

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

536

1.01

0.00

3.9

3.2

4.03

4.33

pmol/l

1.34

463

Unspecified parasitic disease

138

1.02

0.00

4.0

3.2

4.26

4.57

pmol/l

0.45

126

Systemic sclerosis,strict definition

198

1.01

0.00

1.6

3.2

4.43

4.51

pmol/l

0.18

177

Discontinuity and dislocation of ear ossicles

1.01

0.00

2.7

3.7

4.52

4.79

pmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

121

0.99

0.00

5.3

3.0

4.50

4.53

pmol/l

0.03

107

Nontraumatic intracranial haemmorrhage

351

3505

1.00

0.00

3.0

3.2

4.29

4.39

pmol/l

1.16

306

3035

Exclusion endpoint for supernumerary teeth

255

1.02

0.00

3.2

3.4

4.64

4.84

pmol/l

0.46

230

Ulcerative colitis (strict definition, require KELA)

404

4042

1.00

0.00

3.4

4.54

pmol/l

0.00

364

3623

Carcinoma in situ of cervix uteri, exocervix

191

0.99

0.00

4.5

3.5

4.61

4.62

pmol/l

0.03

169

Amputation of thigh

287

1.01

0.00

1.8

3.0

3.71

4.33

pmol/l

2.25

244

Viral haemorrhagic fevers, not elsewhere classified/unspecified

149

1493

1.00

0.00

3.8

3.4

4.56

4.49

pmol/l

0.48

137

1329

Peptic ulcer

126

1.03

0.00

1.9

3.3

4.44

4.38

pmol/l

0.08

111

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

123

0.97

0.00

5.3

2.9

4.50

4.55

pmol/l

0.07

106

Carcinoma in situ of cervix uteri, exocervix

193

0.98

0.00

4.5

3.7

4.61

4.64

pmol/l

0.05

173

Heredofamilial amyloidosis, unspecified

0.00

0.0

2.0

—

3.91

—

Sclerodactyly

0.00

0.0

5.6

—

4.94

—

Mucinous and mucinous cystic tumor of rectum

0.92

0.00

5.4

3.6

4.63

4.29

pmol/l

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

1.2

—

4.38

—

Generalized pustular psoriasis

0.93

0.00

1.3

3.4

4.61

4.60

pmol/l

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.94

0.00

5.4

3.3

4.63

4.45

pmol/l

—

Fetus and newborn affected by maternal use of alcohol

0.00

0.0

5.5

—

6.50

—

Carcinoma in situ of prostate

0.98

0.00

4.7

3.1

4.08

4.28

pmol/l

—

Malignant neoplasm of gum

0.92

0.00

4.0

3.0

4.08

4.47

pmol/l

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

1.02

0.00

3.4

3.3

5.38

4.47

pmol/l

—

Pinta [carate]

0.00

0.0

1.4

—

4.01

—

Traumatic anuria

0.00

0.0

5.5

—

4.52

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.98

0.00

5.3

3.1

4.13

4.59

pmol/l

—

Disorders of glycosaminoglycan metabolism

0.00

0.0

3.2

—

4.63

—

Malignant neoplasm of other and unspecified parts of mouth

0.97

0.00

2.7

3.1

4.36

4.39

pmol/l

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

5.4

—

4.13

—

Niacin deficiency [pellagra]

0.00

0.0

1.6

—

4.58

—

Carcinoma in situ, other/unspecified

0.00

0.0

3.8

—

4.78

—

Melanoma in situ of lip

0.00

0.0

1.8

—

4.86

—

Toxic liver disease with cholestasis, drug-induced

0.00

0.0

7.4

—

4.28

—

Total (external) ophthalmoplegia

0.00

0.0

4.0

—

4.56

—

Malignant neoplasms of independent (primary) multiple sites

0.00

0.0

4.3

—

4.14

—

Malignant neoplasms of independent (primary) multiple sites

0.00

0.0

4.9

—

4.46

—

Other hyperphenylalaninaemias

0.00

0.0

1.6

—

4.78

—

Alopecia mucinosa

0.00

0.0

4.0

—

4.63

—

Glanders and melioidosis

0.00

0.0

4.3

—

4.66

—

Other and unspecified acantholytic disorders

0.00

0.0

4.3

—

4.57

—

Malignant neoplasm of floor of mouth

1.02

0.00

2.5

3.6

4.02

4.56

pmol/l

—

Sequelae of transport accidents

0.94

0.00

5.1

4.0

4.51

4.54

pmol/l

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

5.9

—

3.86

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

0.0

3.8

—

3.88

—

Other accidental hanging and strangulation

0.00

0.0

3.2

—

4.87

—

Freckles

0.00

0.0

3.0

—

4.51

—

Congenital malformations of oesophagus

1.01

0.00

1.9

3.2

5.26

5.00

pmol/l

—

Chlamydial lymphogranuloma (venereum)

0.00

0.0

3.5

—

4.45

—

Malignant neoplasm of placenta

0.00

0.0

4.2

—

4.24

—

Malignant neoplasm of pyriform sinus

0.00

0.0

1.7

—

4.23

—

Ischaemic infarction of muscle

0.00

0.0

8.8

—

4.32

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.0

3.9

—

4.53

—

Anthrax

0.00

-0.00

0.0

5.8

—

4.52

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS